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THE REGULATORY ROLE OF INTERLUKIN-1 RECEPTOR ASSOCIATED 
KINASE M IN TOLL-LIKE RECEPTOR SIGNALING  
 
HAO ZHOU 
 
ABSTRACT 
 
Toll-like receptors (TLRs) are one of the major groups of pattern recognition 
receptors. TLRs are able to recognize the pathogen-associated molecular patterns and 
transduce their signals through the adaptor molecule MyD88 and members of the IL-1R-
associated kinase family (IRAK1, 2, M and 4). 
IRAKM was previously known to function as a negative regulator that prevents the 
dissociation of IRAKs from MyD88, thereby inhibiting downstream signaling. However, 
we now found that IRAKM was also able to interact with MyD88-IRAK4 to form IRAKM 
Myddosome to mediate TLR7-induced MEKK3-dependent second wave NFκB activation. 
As a result, the IRAKM-dependent pathway only induced expression of genes that are not 
regulated at the posttranscriptional levels (including inhibitory molecules SOCS1, SHIP1, 
A20 and IκBα), exerting an overall inhibitory effect on inflammatory response. On the 
other hand, through interaction with IRAK2, IRAKM inhibited TLR7-mediated production 
of cytokines and chemokines at translational levels.  
While the TLR-mediated inflammatory response is critical for innate immunity and 
host defense against infections, uncontrolled inflammation is detrimental to the host, 
leading to chronic inflammatory diseases. Alcohol-induced liver injury is induced by 
necrosis of hepatocytes and increased translocation of endotoxin from the intestinal tract 
v 
into hepatic portal system, which trigger chronic inflammation that is damaging to the liver 
together. We found that mice deficient of IRAKM, are protected from alcohol-induced 
liver injury. IRAKM mediates the up-regulation of Mincle, a receptor for danger signals 
release by damaged cells, in response to low level of LPS. Biochemical analysis revealed 
that low-dose LPS preferentially induces the formation of IRAKM Myddosome, leading 
to MEKK3-dependent NFκB activation. Mincle-deficient mice are also protected from 
alcohol-induced liver injury. We found IRAKM deficiency and Mincle deficiency 
drastically reduced alcohol feeding induced inflammasome activation in the mouse liver. 
Ex vivo studies showed that both IRAKM and Mincle are required for inflammasome 
activation by endogenous Mincle ligand, SAP130, which is a danger signal release by 
damaged hepatocytes. Taken together, we identifies an IRAKM-Mincle axis critical for the 
pathogenesis of alcohol induced liver disease through the activation of inflammasome. 
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CHAPTER I 
 INTRODUCTION 
 
 
A. The Mammalian Immune System 
 
The main purpose of the immune system is to detect and appropriately respond to 
foreign objects and pathogens [1]. The mammalian immune system is comprised of two 
parts: innate and adaptive immunity. The innate immune system, the first line of immune 
defense system, applies multiple layers to defend against invading pathogens[2]. One layer 
includes the physical barrier surface such as skin and epithelium[3]. Another layer is the 
immune cells which can active phagocytosis and inflammatory response.  Macrophages 
and dendritic cells (DC), two important cell types of phagocytes, can recognize different 
groups of invading pathogens through conserved molecular patterns [4-6]. These 
recognition events lead to the subsequent production of inflammatory mediators by 
macrophages and DCs, such as pro-inflammatory cytokines, chemokines and interferons 
[7, 8]. These mediators can further promote inflammatory responses by modifying vascular 
endothelial cells to increase permeability to recruit leukocytes to infect tissues [9, 10]. They 
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can also enhance macrophage-mediated phagocytosis or even induce the apoptosis 
(programmed cell death) of infected cells [11].  
While the activation of innate immune response depends on the recognition of 
pathogen associated patterns (PAMPs) as non-self ligands, the adaptive immune response 
is characterized by antigen specificity [4, 12]. Lymphocytes, including B cells and T cells, 
bear a large repertoire of antigen-specific receptors that are generated by gene 
rearrangement [13, 14]. Interaction between antigen-presenting cells and lymphocytes 
stimulates the expansion and activation of a sub-group of lymphocytes that bear receptors 
specific to the invading pathogens. Upon activation, B cells differentiate in plasma cells 
and secrete a large amount of antibodies, each of which recognize a specific antigen and 
mediate the neutralization of invading pathogens. Cytotoxic T cells can induce apoptosis 
of pathogen-infected cells and T helper cells are critical to regulate immune response. 
 
B. Pattern Recognition Receptors   
The innate immune system is the primary barrier to the invading pathogens and acts 
immediately. To eliminate the pathogens, the host immune system must be able to detect 
the difference between pathogens and host tissues, e.g. “non-self” and “self”. Recognition 
of microbial pathogens is essential for initiating the innate immune response. Germline-
encoded pattern-recognition receptors (PRRs) that recognize pathogen-associated 
molecular patterns (PAMPs) play a central role in host cell recognition and immune 
response to invading pathogens [15]. Upon PAMPs recognition, PRRs initiate a series of 
signaling events which execute the first line of host defense[16]. The first PRR, the Toll 
3 
receptor, was identified in a mutant Drosophila line highly susceptible to fungal infection 
[17]. Subsequent screening studies identified the human and murine homologue of Toll 
receptor and lipopolysaccharide (LPS), a component of Gram-negative bacteria cell wall 
was confirmed as the ligand [18-20]. To date, four PRR families have been identified, 
including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), retinoic acid-
inducible gene (RIG)-I-like receptors (RLRs) and Nucleotide oligomerization domain 
(NOD)-like receptors (NLRs).  
Toll-like receptors 
Among all the PPRs, the members of TLR family have been studied most 
extensively[21]. So far, 13 mammalian members of the TLR family have been 
identified[22]. TLRs belongs to type I integral transmembrane glycoproteins characterized 
by an extracellular domain and a cytoplasmic signaling domain [8].  The cytoplasmic 
domain of TLRs is similar to that of the IL-1 receptor (IL-1R) family and appropriately 
named the Toll/IL-1 receptor (TIR) domain [23]. Therefore, the TLRs and IL-1Rs are 
grouped into a TLR/IL-1R superfamily. While the extracellular domains are markedly 
different: IL-1R family has an immunoglobulin (Ig) domain and TLRs contain a leucine-
rich repeats (LRR) [24]. The LRR domain of TLR4 was shown to form a horseshoe 
structure with LPS binding to the concave surface [25]. The intracellular signaling of TLRs 
are primarily mediated by recruiting different TIR domain containing adaptor molecules 
such as MyD88, TRIF, TIRAP and TRAM [26-28]. All TLRs, except TLR3, recruit 
MyD88 and initiate MyD88-dependent pathway to activate multiple transcription factors, 
including NFκB, AP-1, C-Fos/Jun. TLR3 and TLR4 recruit TRIF and initiate TRIF-
4 
dependent signaling to activate NFκB and IRF3 to induce production of pro-inflammatory 
and type I interferons[29].  
TLR1, TLR2, TLR4, TLR5, TL6 and TLR11 are expressed on the cytoplasmic 
membrane, while TLR3, TLR7, TLR8 and TLR9 are expressed in intracellular vesicles, 
such as endosomes [25]. TLR4, together with myeloid differentiation factor 2 (MD2), 
recognize LPS, a component of the Gram-negative bacterial cell walls [20]. Recent studies 
have also identified oxidized low-density lipoprotein (Ox-LDL) and free fatty acid (FFA) 
as endogenous ligands of TLR4 [30]. TLR2 forms heterodimers with TLR1 or TLR6. The 
TLR1/2 and TLR2/6 heterodimers recognize lipoproteins derived from gram-positive 
bacteria [31]. TLR5 recognizes flagellin which is a conserved protein component of 
bacteria flagella [32]. TLRs which recognize nucleotides derived from invading pathogens 
including TLR3, TLR7, TLR8 and TLR9, are localized in intracellular compartments, such 
as endosomes and early lysosomes. Both of TLR7 and TLR 8 recognize uridine or 
guanosine-rich single strand (ss) RNA [24, 27, 33]. TLR3 can recognize double strand (ds) 
RNA, which is typically an intermediate product during replication of ssRNA viruses [34]. 
TLR9 is responsible for the recognition of genomic DNA derived from invading bacteria 
and viruses distinguished by a high abundance of unmethylated CpG nucleotides compared 
to mammalian genomic DNA [35]. (Fig. 1) 
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Figure 1. Toll-like receptors and their ligands. 
 
C-type lectin receptors 
C-type lectin receptor (CLR) is another important family member of PPRs. It is 
designed to bind to carbohydrates and named as C-type due to the requirement for calcium 
to bind carbohydrates initially [36, 37]. CLRs constitute a group of over 1000 members. 
They are characterized by a carbohydrate recognition domain (CRD) and a calcium binding 
motif[38]. Subsequent studies found that not all the CLRs are calcium dependent and these 
receptors can recognized multivalent ligands. 
The N-terminal region of the genes encodes the extracellular domain which 
contains at least a CRD, while the C-terminal region encodes the intracellular domain[39]. 
Based on the features of intracellular domain, CLRs can be divided into two distinct groups: 
Dectin1 group (including Dectin-1 a, CLEC1, CLEC2, CLEC9A, CLEC12B, LOX1 and 
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MICL) and Dectin2 group (including Dectin2, Mincle, Clescsf8, BDCA-2, DCAR and 
DCIR)[40].  
CLRs from the Dectin1 group all have a long intracellular tail including an 
immunoreceptor tyrosine-based activation motif (ITAM) for signaling transduction [41]. 
The cytoplasmic tail of Dectin1, CLEC9A, CLEC2 and LOX1 contains an immunoreceptor 
tyrosine-based activation motif which is required for signaling activation after ligation. In 
contrast, the cytoplasmic tail of CLEC12A, CLEC12B, MICL and DCIR contains an 
immunoreceptor tyrosine-based inhibitory motif (ITIM). The ligation of these receptors 
leads to a suppression of transcription factor activation. 
CLRs from the Dectin2 group have the similar structure with the Dectin1 group 
with a notable exception: a short cytoplasmic tail [41]. The short cytoplasmic tail lacks the 
ability to transduce signal. Thus these receptors typically pair with an FcRγ chain which 
harbors an ITAM motif to activate signaling transduction. 
Recent studies show that Dectin1 and Dectin2 mediated signaling activation are 
both critical for anti-fungal responses [42, 43]. Dectin1 is able to recognize β-glucan while 
Dectin2 recognizes high mannose [44, 45]. Mincle, a Dectin-2 member, has multiple 
ligands including cord factor of Mycobacterium tuberculosis and α-mannose on the surface 
of pathogenic fungus, Malassezia[46-51]. Mincle also recognized the endogenous protein 
SAP130, a component of small nuclear ribonucloprotein released from damaged/nectrotic 
cells [52]. Activation of CLRs usually leads to the activation of a tyrosine kinase SyK 
which transduce the signal through CARD9-Bcl10-MALT1 complex. It has been 
suggested that formation of this complex leads to the canonical NFκB activation through 
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TAK1-IKK pathway, followed by pro-inflammatory cytokine and chemokine secretion [53, 
54]. Overall, CLRs are essential for host immune response and homeostasis. (Fig. 2) 
 
Figure 2. C-type lectins receptors and their ligands.  
 
NOD-like receptors  
NOD-like receptors (NLRs), are essential in recognizing cytosolic bacterial 
components.  Generally, they have a leucine-rich repeat (LRR) motif that mediates ligand 
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recognition, a nucleotide binding oligomerization domain (NOD), and a caspase 
recruitment domain (CARD) to mediate the recruitment and activation of downstream 
signaling components. So far, at least 23 human and 34 murine NLR genes have been 
identiﬁed, amongst which NOD1 and NOD2 are the best-characterized members and 
recognize distinct structural motifs in bacterial peptidoglycans [55]. NOD1 recognizes γ-
D-glutamyl-meso-diaminopimelic acid (iE-DAP) in all Gram-negative bacterial as well as 
several Gram-positive bacteria, while, NOD2 recognizes muramyl dipeptide (MDP) in all 
Gram-negative and Gram-positive bacteria [56-58]. After ligand binding, the CARD 
domain of NOD1 and NOD2 interacts with a serine/threonine kinase, RIP2 (RICK) that 
initiates a signaling cascade resulting NFκB activation, as well as the activation of MAPKs 
[52, 59].     
RIG-I-like receptors  
The RIG-I-like receptor family is another group of cytosolic PRRs which are 
essential for the detection of viral RNA in the cytoplasm of most cell types. It includes 
RIG-I, melanoma differentiation associated gene 5 (MDA5) and LGP2. RIG-I and MDA5 
contain a central DExD/H-box helicase domain and a C-terminal domain (CTD), both of 
which are responsible for binding viral RNA [60-62]. It is well established that the signal-
transducing activities of RIG-I and MDA5 are tightly regulated by a combination of 
phosphorylation and ubiquitination.  Interferon-beta promoter stimulator 1 (IPS-1, also 
called MAVS, VISA or CARDIF) is an essential adaptor molecule for both RIG-I- and 
MDA-5- mediated signaling.  It associates with RIG-I and MDA-5 through CARD domains 
upon viral infection, and activates downstream signaling components.  The third RIG-I-
9 
like receptor, LGP2, lacks the CARD domain and has been shown to exert a regulatory role 
in RLR signaling [63]. However, its precise action has not been well defined yet.  
 
C. TLR-mediated Signaling Activation  
The intracellular signaling cascades activated by PRRs results in the production of 
inflammatory mediators, including a variety of pro-inflammatory cytokines and 
chemokines. The production of pro-inflammatory cytokines, such as tumor necrosis factor 
alpha (TNFα), interleukin-1 (IL-1β), and IL-6, are essential to promote inflammatory 
responses [64].   
All TLRs have a conserved intracellular TIR domain. After binding with the ligands, 
TLRs undergo conformational changes, and recruit adapter molecules through interaction 
with TIR domains [65]. Five TIR-containing adaptor molecules have been identified, 
including MyD88, MAL, TRIF, TIRAP and TRAM. TLRs utilize different adaptor 
molecules to activate downstream signaling cascades, which can be roughly divided into 
the MyD88-dependent pathway and the TRIF-dependent pathway [29, 66].   
The MyD88-dependent pathway 
MyD88 is employed by all TLRs except TLR3 as an adaptor molecule.  In addition 
to a TIR domain, MyD88 also has a death domain (DD) [25].  Stimulation of TLRs by their 
respective ligands causes the recruitment of MyD88 through TIR domain interaction. After 
binding to the receptor complex, MyD88 interacts with the IL-1 receptor-associated 
kinases (IRAKs) via the respective death domains. The MyD88-IRAK4-IRAK2/1 
signaling complex has been named as Myddosome [67]. Formaiton of Myddsome leads 
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the activation the kinase activity of IRAK4, which activates IRAK1 and IRAK2 through 
subsequent phosphorylation[68]. The activated IRAKs recruit TNFR-associated factor 6 
(TRAF6), which is an E3-ubiquitin protein ligase. TRAF6, ubiquitination conjugating 
enzymes (E2) UBC13 and UEV1A add lysine 63-linked polyubiquitin chain to TRAF6 as 
well as to other signaling components [69]. The ubiquitinated TRAF6 recruits a protein 
complex that is composed of TGF-β-activated kinase 1 (TAK1) and the TAK1 binding 
proteins TAB1, TAB2, and TAB3.  The activated TAK1 complex activates IKB kinase 
(IKK) complex (composed of IKKα, IKKβ and /IKKγ) and mitogen-activated protein 
kinase kinase (MAPKK) through phosphorylation [70]. The activated IKK complex 
phosphorylates NF-κB inhibitory protein (IκBα), leading to the lysine 48-linked 
polyubiquitination and degradation of IκBα[71]. The degradation of IκBα releases NFκB, 
which translocates into the nucleus and induces the transcription of a series of NFκB target 
genes, including pro-inflammatory cytokines and cytokines.  Activation of MAP kinase 
leads to the activation of another transcription factor, activator protein 1 (AP-1), which also 
regulates the transcription of pro-inflammatory cytokine genes. 
Recent studies also suggest that there is a parallel pathway which is TAK1-
independent MEKK3 dependent downstream of MyD88 [65, 72, 73]. In contrast to TAK1-
dependet pathway results in IKKα/β phosphorylation and IKKγ activation, leading to 
classical NFκB activation via IκBα phosphorylation and degradation, MEKK3-dependent 
pathway entails to IKKγ phosphorylation and IKKα activation, which leads to NFκB 
activation by IκBα phosphorylation and its subsequent dissociation from NFκB, but 
without IκBα degradation. IRAK4 kinase activity is not required for MEKK3-dependent 
pathway, suggesting by the study of IRAK4 kinase activity dead knock-in mice [65]. 
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However, the precise mechanism of how MEKK3-dependent pathway gets activated is still 
not well understood. (Fig. 3) 
 
Figure 3. TLR-induced MyD88-dependent signaling pathway. 
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The TRIF-dependent pathway 
The TLR3 signaling pathway is mediated exclusively by the TRIF adaptor [74].  
TRIF-mediated activation of TRAF3 leads to the activation of the non-canonical IKKs, 
including TBK1 and IKKi. The subsequent phosphorylation of IRF3 by TBK1/IKKi leads 
to the translocation IRF3 and the induction of type I IFNs and IL-10. TRIF recruitment and 
activation of TRAF6 and RIP1 lead to NF-κB activity through TAK1. 
TLR4 uses both the MyD88-dependent and the TRIF-dependent pathways to 
induce the production of pro-inflammatory cytokines [20, 26].  MyD88 and TRIF double-
deficient cells show complete loss of NFκB activation in response to LPS stimulation [75].  
(Fig. 4) 
 
Figure 4. TLR-induced TRIF-dependent signaling pathway.  
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D. Post-transcriptional Regulation of Proinflammtory Cytokine Production 
Although proinflammatory cytokines promote host defense against infection, their 
prolonged production may lead to chronic inflammation that can cause substantial tissue 
damage. Therefore, it is crucial to maintain tight control of proinflammatory cytokine 
production, not only to induce them promptly respond to infection, but also to shut them 
off quickly after the pathogens are eliminated.  
 Regulation of mRNA stability  
Cellular mRNA levels are established by both mRNA synthesis and degradation. 
Many cytokine mRNAs have adenine and uridine-rich elements (AREs) in their 3’ 
untranslated regions (UTRs), characterized by a pentamer “AUUUA” or a nonamer 
“UUAUUUAUU”. It has been shown that AREs are crucial for rapid mRNA decay [76-
78]. Numerous pro-inflammatory cytokines undergo ARE mediated regulation including 
IL-6, TNFα, IL-1β, GM-CSF, TGFβ and CXCL1. Over twenty different ARE-binding 
proteins have been identified which associate with AREs mediate interactions between 
these mRNAs and exosome complexes, the major machinery for intracellular mRNA 
degradation. Tristetraprolin (TTP), the prototype of an ARE binding protein, plays a critical 
role in inhibiting TNFα production by destabilizing TNFα mRNA [79, 80]. By contrast, 
the ELAV (embryonic lethal and abnormal vision) family members Hu-antigen R (HUR) 
and HUD stabilize their targets by competing with the destabilizing ARE-binding proteins 
for ARE occupancy [81].  
Recently, Regnase 1 (Zc3h12a) has been identified as another negative regulator of 
pro-inflammatory cytokine production [82]. Regnase 1 is induced rapidly and 
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phosphorylated by IKKβ in response to TLR ligand stimulation. It binds to the 3’UTR 
regions of multiple proinflammatory cytokine mRNAs, including IL-6 and IL-20p40, and 
leads to mRNA degradation. Further studies indicated that Regnase 1 degrades mRNA via 
its endonucleolytic activity[83]. These results demonstrate that the stability of mRNA 
encoding different pro-inflammatory cytokines is regulated by different mechanisms.  
Regulation of protein translation  
In addition to stabilize mRNA, initiation of protein translation is also crucial for 
prompt and robust cytokine production in response to pathogen infection. Among all 
translation initiation factors, eukaryotic translation initiation factor 2 (eIF2) and eIF4e are 
most well studied in innate immunity. eIF2 forms a ternary complex with the initiator 
methionyl-tRNA and GTP. The binding of eIF2 complex to 40S ribosomal subunit is 
essential for start codon recognition, followed by recruitment of the 60S ribosomal subunit 
[84]. eIF4E is a cap-binding protein which interacts with 5’mRNA cap structure and the 
scaffold initiation factor eIF4G[51]. In most cells, eIF4E levels are limited, therefore, the 
regulation of its activity has strong impact on the translation efficiency. Two MAPK-
interacting protein kinase, MNK1 and MNK2, are activated in response to LPS and 
subsequently activate eIF4E through phosphorylation which greatly promote the 
translation of a variety of pro-inflammatory genes [85-87]. 
 
E. Inflammasome Activation 
IL-1 signaling is a key component of the immune and inflammatory responses.  IL-
1β is synthesized as an inactive 31-kD precursor molecule which requires cleavage by the 
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cysteine protease caspase-1 to release biologically active mature 17-kD IL-1β [88, 89]. 
Inflammasomes are multiprotein complex which contain a member of the nucleotide-
binding domain leucine-rich repeat (NLR) or AIM2-like receptor (ALR) family, an adaptor 
molecule known as apoptosis associated speck-like protein containing a CARD (ASC) and 
a caspase. Inflammasomes are activated in response to a diverse range of microbial, stress 
and damage signals that trigger caspase-1 activation, resulting in maturation of the pro-
inflammatory cytokines interleukin (IL)-1β, IL-18 and IL-33 [90-92]. A great deal of work 
over the past ten years has been committed to elucidating the mechanism by which the 
inflammasome is activated, and the particular ligands that are capable of initiating this 
activation.    
The NOD-like receptors are a diverse family of intracellular pattern recognition 
receptors that contain a C-terminal leucine-rich repeat (LRR) that is thought to contribute 
to ligand recognition, a central NACHT nucleotide-binding domain that is involved in 
orchestrating oligomerization, and an N-terminal “effector” domain that, in the case of 
inflammasome-associated NLRs, consists of a either a caspase-1 recruitment domain 
(CARD) or a Pyrin domain.  The adaptor molecule ASC consists of an N-terminal CARD 
domain and a C-terminal Pyrin domain [93].  The classical role for ASC is to function as a 
“bridge”, linking NLRs containing an N-terminal Pyrin domain with caspase-1 via PYD-
PYD and CARD-CARD interactions, respectively [94].  Caspase-1 is a member of the 
caspase family of cysteine proteases that function to carry out a variety of cellular programs, 
including programmed cell death and inflammation.  The caspases, including caspase-1, 
are produced as zymogens and must be activated in order to commence catalytic activity.  
Caspase-1 exists as a tetramer comprised of two p10 and two p20 subunits, and undergoes 
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autoactivation following its recruitment to the inflammasome complex. Upon activation, 
caspase-1 functions by processing the pro-IL-1β, pro-IL-18, and pro-IL-33 to their active 
forms in preparation for extracellular secretion.  
The NOD-like receptors (NLRs) are a large and diverse family of intracellular 
pattern recognition receptors (PPRs). All NLRs, with the exception of NLRP10, contain a 
C-terminal leucine-rich repeat (LRR) which is thought to contribute to ligand recognition. 
The NLRP1, NLRP3 and NLRC4 (Ipaf) inflammasomes are only inflammasome 
complexes that have been shown to lead to the activation of the inflammatory caspases. 
Of the inflammasomes, the NLRP3 inflammasome is by far the best characterized, 
and is the model from which essentially all mechanistic data on inflammasome activation 
is derived.  So far, the NLRP3 inflammasome has been found to be activated in response 
to a surprisingly wide variety of triggers, including pathogen-associated molecular patterns 
(PAMPs) such as the flagellin component of Salmonella, danger-associated molecular 
patterns (DAMPs) of which ATP and mitochondrial DNA are considered prototypes, and 
even to whole pathogens such as Staphylococcus aureus, Candida albicans, and influenza 
virus. 
Despite much effort, the exact mechanism by which the NLRP3 inflammasome is 
activated remains elusive.  It is known that in the resting state, NLRP3 is located in the 
cytoplasm and is accompanied by the chaperone molecules HSP90 and SGT1, which are 
thought to stabilize the inactive state.  By some mechanisms, the NLRP3 molecules “senses” 
one of its many activators and oligomerizes, with the Pyrin domains having been shown 
by x-ray crystallographic studies to “stack” and therefore allow for homotypic interaction 
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with the Pyrin domain of the adaptor ASC [94]. Following ASC association, procaspase-1 
is recruited and cleaved and forms an active caspase-1 tetramer. 
At this time, there are essentially three models for the initiation of NLRP3 
activation, and all three have approximately equal support in the literature.  One model 
posits that when inflammasome agonists are phagocytosed and enter the lysosome, some 
property of the agonist leads to lysosomal rupture, and the presence of lysosomal enzymes 
or other constituents in the cytoplasm are sensed by NLRP3 [67, 95, 96]  Another model 
hypothesizes that ATP, a powerful inflammasome activator in macrophages, signals via 
the P2X7-receptor, leading to potassium efflux through activation of the cell membrane 
channel protein Pannexin-1 [97-103]. A third model suggests that all of the inflammasome 
activators lead to the generation of reactive-oxygen species (ROS), and that the presence 
of cytoplasmic ROS, either by change in cellular redox state or another factor, leads to 
NLRP3 activation.  This model is supported by very recent work suggesting that the 
mitochondria is a key mediator of ROS production, and that inflammasome components, 
including ASC and NLRP3, colocalize to the mitochondria during activation [92, 104]. 
 
F. Alcohol-induced Liver Diseases 
Alcoholism results in about 2.5 million deaths annually worldwide and has long 
been associated with various liver diseases accounting for about 4% of all deaths [105-107]. 
Alcoholic liver disease (ALD) ranges from steatosis to hepatitis, fibrosis, cirrhosis and 
hepatocellular carcinoma. Hepatic steatosis is the earliest response to alcohol consumption 
and develops in 90% of heavy alcohol drinkers. Simple steatosis usually is asymptomatic 
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and reversible. 20-25% of alcoholics will develop alcoholic hepatitis, about 15% develop 
alcoholic cirrhosis and about 10% develop hepatocellular carcinoma [108]. Meanwhile, 
pharmacological treatment options are limited and the outcomes from the therapies are 
poor. Thus understanding the detailed mechanisms involved in the pathogenesis and 
progress of ALD is critical, which serves the need of developing novel and more effective 
pharmacological agents for treatment. 
The pathogenesis of ALD is multifactorial and is still not fully understood. 
Emerging evidences suggest that the damage is the end result of the interplay among 
ethanol metabolism, inflammation and innate immunity. Acetaldehyde, a direct 
metabolism of ethanol, is a highly reactive and toxic chemical to hepatocytes which 
contributes to liver tissue damage because it forms a variety of protein and DNA adducts 
that promote glutathione depletion, lipid peroxidation and mitochondrial dysfunction. It 
also leads to the formation of reactive oxygen species (ROS), which are potent inducers of 
lipid peroxidation and leads to the eventual cell death of hepatocytes. Increased endotoxin 
levels in the serum have been documented in both ALD patients and alcohol-fed 
experimental animals [109]. One intriguing paradigm suggests that alcohol drinking 
promotes altered gastrointestinal microbiota and increased intestinal permeability. 
Translocation of bacterial related products from gut into blood stream arrive at the liver 
through the portal vein. Antibiotic treatment significantly reduced the pathologic change 
of livers in rats exposed to ethanol, which suggested endotoxin is a crucial mediator of 
ALD [110-114]. Previous studies have shown Kupffer cells, the resident macrophages of 
liver, express TLRs and are responsible for the uptake of gut-derived toxins such as LPS. 
Seki et.al showed that Kupffer cells could response to various concentrations LPS 
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stimulation to produce pro-inflammatory cytokines (TNFα, IL-1β, IL-6, IL-12, and IL-18) 
and chemokines. Notably, induction of chemokines (MIP-1α, MIP-1β, RANTES, and 
MCP-5) gene expression in livers from mice induced by LPS was reduced by 80–97% after 
selective depletion of Kupffer cells [115, 116]. Furthermore, long-term ethanol 
administration results in sensitization of LPS-induced liver injury and secretion of TNFα 
by Kupffer cells. Thus TLRs, especially TLR4 expressed on Kupffer cells, are activated by 
these PAMPs, resulting in pro-inflammatory cytokine and chemokine production and 
recruitment of other immune cells such as neutrophils. All of these inflammatory responses 
are critical contributors to disease progression. Consistent with this, both TLR4-mutated 
(C3H/HeJ) mice and TLR4-deficient mice displayed dramatically reduced levels of 
proinflammatory cytokines in the liver and protected mice from liver injury in a long-term 
intragastric ethanol feeding model. Several studies have shown the role of inflammasome-
IL-1 signaling in acute and chronic liver injury including ALD [19, 26, 115]. Petrasek et.al. 
showed that IL-1β signaling is required for the development of alcohol-induced liver 
steatosis, inflammation, and injury, using mice deficient in regulators of IL-1β activation 
(caspase-1and ASC) or signaling (IL-1 receptor) as well as treating mice with IL-1 receptor 
antagonist [117]. It is suggested that IL-1R/TLRs signaling and/or inflammasome 
pathways are potential therapeutic targets to treat ALD.  
Hepatocyte cell death is a major hallmark of ethanol-induced liver injury, reflected 
by increased levels of serum alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST). It is also used to risk stratify and monitor ALD patients. Multiple 
forms of cell death, including necrosis, apoptosis and necroptosis, commonly exist in ALD, 
all of which may promote liver disease progression through distinct mechanisms. DAMPs 
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released from dying cells, such as high-mobility group box 1 (HMGB1), are believed to 
trigger sterile inflammation and thus exacerbation of injury in acute liver diseases [118]. 
However, the significance of DAMPs-induced sterile inflammation involved in the 
progression of alcohol-induced chronic liver injury is underestimated.  
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A. Abstract 
Toll-like receptors transduce their signals through the adaptor molecule MyD88 
and members of the IL-1R-associated kinase family (IRAK1, 2, M and 4). IRAK1 and 
IRAK2, known to form Myddosomes with MyD88-IRAK4, mediate TLR7-induced 
TAK1-dependent NFκB activation. IRAKM was previously known to function as a 
negative regulator that prevents the dissociation of IRAKs from MyD88, thereby inhibiting 
downstream signaling. However, we now found that IRAKM was also able to interact with 
MyD88-IRAK4 to form IRAKM Myddosome to mediate TLR7-induced MEKK3-
dependent second wave NFκB activation, which is uncoupled from posttranscriptional 
regulation. As a result, the IRAKM-dependent pathway only induced expression of genes 
that are not regulated at the posttranscriptional levels (including inhibitory molecules 
SOCS1, SHIP1, A20 and IκBα), exerting an overall inhibitory effect on inflammatory 
response. On the other hand, through interaction with IRAK2, IRAKM inhibited TLR7-
mediated production of cytokines and chemokines at translational levels. Taken together, 
IRAKM mediates TLR7-induced MEKK3-dependent second wave NFκB activation to 
produce inhibitory molecules as a negative feedback for the pathway, while exerting 
inhibitory effect on translational control of cytokines and chemokines. 
 
B. Introduction 
Toll-like receptors (TLRs) detect microorganisms and protect multicellular 
organisms from infection by inducing the production of proinflammatory cytokines and 
chemokines [18, 24, 33, 119-121]. TLRs transduce their signals through the adaptor 
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molecule MyD88 and members of the IL-1R-associated kinase (IRAK) family, which 
consists of four members: IRAK1, IRAK2, IRAKM and IRAK4[122-126]. The crystal 
structure of the MyD88–IRAK4–IRAK2 death domain (DD) complex, referred as 
Myddosome complex, demonstrated their sequential assembly, in which MyD88 recruits 
IRAK4 and the MyD88-IRAK4 complex recruits the IRAK4 substrates IRAK2 or the 
related IRAK1[127]. Subsequently, the IRAK1/2 form complex with TRAF6 and 
dissociate from the receptor complex to activate cascades of downstream kinases, leading 
to the activation of transcription factor NFκB [69].On the other hand, IRAKM is believed 
to function as a negative regulator that prevents the dissociation of IRAK1/2 from receptor 
complex, thereby inhibiting downstream signaling [128]. 
We previously reported the co-existence of the two parallel TLR/IL-1R-mediated 
NFκB activation: TAK1-dependent and MEKK3-dependent, respectively. The TAK1-
dependent pathway leads to IKKα/β phosphorylation and IKKγ activation, resulting in 
classical NFκB activation through IκBα phosphorylation and degradation [129]. The 
TAK1-independent MEKK3-dependent pathway involves IKKγ phosphorylation and 
IKKα activation, which leads to NFκB activation through IκBα phosphorylation and 
subsequent dissociation from NFκB but without IκBα degradation. While TLR/IL-1R 
regulates gene transcription, they also induce gene expression by stabilizing otherwise 
unstable mRNAs of pro-inflammatory genes. Many cytokine and chemokine mRNA 
exhibit very short half-lives due to the presence of AU-rich sequence elements (ARE) 
located within their 3’ untranslated regions [130]. Therefore, the regulation of mRNA 
stability is an important control of inflammatory gene expression. We have previously 
reported that the kinase activity of IRAK4 is required for TAK1-dependent NFκB 
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activation and mRNA stabilization of cytokines and chemokines, but not for MEKK3-
dependent NFκB activation [131, 132]. Based on these findings, we propose that IRAK4 
mediates IL-1R-TLR-induced receptor-proximal signaling events through its kinase 
activity to coordinately regulate TAK1-dependent NFκB activation and mRNA 
stabilization pathways to ensure robust production of cytokines and chemokines during 
inflammatory response. In addition to mRNA stabilization, TLR signaling is also necessary 
for efficient and sustained translation of cytokine and chemokine mRNAs [133, 134]. The 
ratios of LPS-induced cytokine and chemokine mRNAs in translation-active versus 
translation-inactive pools were lower in IRAK2-deficient macrophages compared with 
wild type macrophages, indicating the requirement of IRAK2 for sustained translation of 
these mRNAs[135]. 
In this study, we investigated the functional relationships among IRAK family 
members and their roles in TLR signaling by analyzing mice deficient in IRAK1, IRAK2 
and/or IRAKM. We found that IRAK1 and IRAK2, substrates of IRAK4, are required for 
TAK1-dependent NFκB activation and mRNA stabilization of cytokines and chemokines, 
but not for MEKK3-dependent NFκB activation. In contrast to the direct inhibitory role of 
IRAKM in TLR signaling, IRAKM was able to interact with MyD88-IRAK4 to form 
IRAKM Myddosome to mediate TAK1-independent MEKK3-dependent NFκB activation 
in the absence of IRAK1 and IRAK2. This IRAKM-dependent pathway is required for the 
second wave of TLR7-induced NFκB activation in the presence of IRAK1/IRAK2, which 
is uncoupled from posttranscriptional regulation. Thus, the IRAKM-dependent pathway 
only induced expression of genes that are not regulated at the posttranscriptional levels 
(including inhibitory molecules SOCS1, SHIP1, A20 and IκBα), exerting an overall 
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inhibitory effect on inflammatory response. Taken together, this study for the first time 
demonstrates unique positive engagement of IRAKM in transmitting signaling upon TLR 
activation, providing important insight into the mechanistic roles of IRAKM in modulating 
TLR signaling.  
 
C. Results 
IRAKM mediates TLR-induced MEKK3-dependent NFκB activation in the absence 
of IRAK1 and IRAK2 
Although IRAKM has been implicated as a negative regulator in TLR signaling, 
the precise molecular mechanism for how IRAKM participates and modulates TLR 
signaling remains unclear. We recently found that substantial TLR7-induced NFκB 
activation was retained in IRAK1/2-double deficient (DKO) BMDMs, whereas completely 
abolished in MyD88- or IRAK4-deficient BMDMs (Fig. 5A and data not shown). These 
results suggest that MyD88-IRAK4 either themselves or in conjunction with IRAKM can 
mediate NFκB activation in IRAK1/2-DKO-BMDMs. To determine the role of IRAKM in 
this process, we compared TLR7-mediated NFκB activation in IRAK1/2-DKOwith that in 
IRAK1/2/M-deficient (TKO) BMDMs.TLR7-mediated NFκB activation was completely 
abolished in IRAK1/2/M-TKO-BMDMs, indicating the importance of IRAKM in 
mediating TLR7-dependent NFκB activation in the absence of IRAK1 and IRAK2 (Fig. 
5A).  
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Figure 5. IRAKM mediates TLR7-induced NFκB activation in the absence of IRAK1 
and IRAK2. A. Nuclear extracts prepared from wild-type (WT), IRAK1/2-double 
deficient (IRAK1/2 DKO), IRAK1/2/M-triple deficient (IRAK1/2/M TKO), IRAK4-
deficient (IRAK4 KO) bone marrow-derived macrophages (BMDMs) untreated or treated 
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with TLR7 ligand R848 (1μg/ml) for the indicated times were analyzed by electrophoresis 
mobility shift assay using an NFκB-specific probe. B. Cell lysates from wild-type (WT), 
IRAK1/2- double deficient (IRAK1/2 DKO), IRAK1/2/M-triple deficient (IRAK1/2/M 
TKO) bone marrow-derived macrophages (BMDMs) untreated or treated with TLR7 
ligand R848 (1μg/ml) for the indicated times were analyzed by Western blot analysis with 
antibodies against IRAK1, IRAK2, p-IKKα/β, TAK1, MEKK3, p-IκBα, IκBα, p-JNK, p-
p38, p-ERK and actin. The experiments were repeated for five times with similar results. 
 
We previously uncovered two parallel TLR-mediated MyD88/IRAK4-dependent 
signaling pathways for NFκB activation, TAK1-dependent and independent, respectively 
[129]. The TAK1-dependent pathway leads to IKKα/β phosphorylation and IKKα 
activation, resulting in classical NFκB activation through IκBα phosphorylation and 
degradation. The TAK1-independent pathway involves activation of MEKK3 and IKKα, 
resulting in NFκB activation through IκBα phosphorylation and subsequent dissociation 
from NFκB but without IκBα degradation. TLR7-induced TAK1 activation (shown as 
slower mobility shift bands) was greatly reduced in IRAK1/2-DKO-BMDMs, while 
IRAK1/2-double deficiency also substantially decreased TLR7-induced IKKα/β 
phosphorylation, indicating the important role of IRAK1/IRAK2 in mediating TAK1-
dependent NFκB activation.TLR7-induced TAK1-mediated IKK activation leads to the 
phosphorylation and degradation of IκBα.  Indeed, TLR7-induced IκBα degradation was 
attenuated in theIRAK1/2-DKO-BMDMs.  
However, consistent with the NFκB gel-shift assay, TLR7-induced IκBα 
phosphorylation was still retained in IRAK1/2-DKO-BMDMs, which was completely 
abolished in IRAK1/2/M-TKO-BMDMs, indicating the importance of IRAKM in 
mediating TLR7-induced TAK1-independent NFκB activation in IRAK1/2-DKO-
BMDMs (Fig. 5B). Importantly, through co-immunoprecipitation we found that IRAKM 
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formed a complex with MEKK3, but not with TAK1 (Fig. 5A-B). Furthermore, TLR7-
induced MEKK3 modification was still retained in IRAK1/2-DKO-BMDMs, whereas 
abolished in IRAK1/2/M-TKO-BMDMs (Fig. 5A).  Taken together, these results suggest 
that IRAKM probably mediates TLR7-induced NFκB activation through the TAK1-
independent MEKK3-dependent pathway in the absence of IRAK1 and IRAK2. In addition 
to NFκB activation, TLR7-mediated JNK and ERK phosphorylation were completely 
abolished in IRAK1/2/M-TKO-BMDMs, although some levels of phosphorylation of p38 
was still retained. Importantly, this positive signaling role of IRAKM was not restricted to 
TLR7. Similarly, TLR2- and TLR9-induced phosphorylation of IκBα were still retained in 
IRAK1/2-DKO-BMDMs, which was completely abolished in IRAK1/2/M-TKO-BMDMs, 
implicating the participation of IRAKM in TLR2- and TLR9-mediated signaling. However, 
it is important to point out, while TLR9-induced IκBα phosphorylation in IRAK1/2-DKO-
BMDMs was comparable to that in wild-type cells, TLR2-induced IκBα phosphorylation 
in IRAK1/2-DKO-BMDMs was substantially reduced compared to that in wild-type cells, 
suggesting differential utilization of IRAKM by different TLRs (Fig. 7).  
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Figure 6. IRAKM forms Myddosome with MyD88-IRAK4 to mediate signaling 
through MEKK3 and TRAF6. A.  IRAKM-deficient mouse embryonic fibroblast(MEFs) 
infected with retroviruses containing empty vector construct (Vector) and FLAG-IRAKM 
were treated with IL-1β (1ng/ml) for the indicated times, followed by immunoprecipitation 
(IP) with anti-FLAG antibody and analyzed by Western blot analyses using antibodies 
against MyD88, IRAK4, TRAF6, MEKK3, TAK1 and FLAG. The whole cell lysates 
(WCL) were subjected to the same Western analyses, including actin as a control. The 
experiments were repeated for five times with similar results.  B. IRAK1/2/M-triple 
deficient (IRAK1/2/M TKO) BMDMs infected with adenovirus containing empty vector 
construct (Vector) and HA-tagged IRAKM (HA-IRAKM) were  treated with R848 (1ng/ml) 
for the indicated times, followed by immunoprecipitation (IP) with anti-HA antibody and 
analyzed by Western blot analysis with antibody against MyD88, IRAK4, TRAF6, 
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MEKK3, TAK1 and FLAG. The whole cell lysates (WCL) were subjected to the same 
Western analyses, including actin as a control. The experiments were repeated for five 
times with similar results 
 
 
Figure 7. IRAKM mediates TLR2/9-induced NFκB activation in the absence of 
IRAK1 and IRAK2. A. Cell lysates from wild-type (WT), IRAK1/2- double deficient 
(IRAK1/2 DKO), IRAK1/2/M-triple deficient (IRAK1/2/3 TKO) bone marrow-derived 
macrophages (BMDMs) untreated or treated with TLR2 ligand Pam3CSK4 (200ng/ml) for 
the indicated times were analyzed by Western blot analysis with antibodies against p-
IKKα/β, p-IκBα, IκBα, and actin. The experiments were repeated for five times with 
similar results. B. Cell lysates from wild-type (WT), IRAK1/2- double deficient (IRAK1/2 
DKO), IRAK1/2/M-triple deficient (IRAK1/2/3 TKO) bone marrow-derived macrophages 
(BMDMs) untreated or treated with TLR9 ligand CpG B (1μg/ml) for the indicated times 
were analyzed by Western blot analysis with antibodies against p-IKKα/β, p-IκBα, IκBα, 
and actin. The experiments were repeated for five times with similar results. 
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IRAKM mediates IL-1R-induced NFκB activation through formation of Myddosome 
with MyD88-IRAK4 
Lin et al recently reported the crystal structure of the MyD88–IRAK4–IRAK2 
death domain (DD) complex, which revealed a left-handed helical oligomer that consists 
of 6 MyD88, 4 IRAK4 and 4 IRAK2 DDs[127]. This helical signaling tower is referred as 
Myddosome complex and its assembly is sequential, in which MyD88 recruits IRAK4 and 
the MyD88-IRAK4 complex recruits the IRAK4 substrates IRAK2 or the related IRAK1. 
This study has provided great insight into how IL-1R and also TLRs utilize adaptor 
molecule MyD88 to recruit IRAKs to mediate its signaling. The question here was how 
TLR/IL-1R utilizes IRAKM to mediate signaling in the absence of IRAK1 and IRAK2. 
Since MyD88- or IRAK4-deficient BMDMs had completely abolished TLR/IL-1R-
mediated NFκB activation, indicating that TLR/IL-1R-induced IRAKM-mediated NFκB 
activation in the IRAK1/2-DKO-BMDMs must be MyD88-IRAK4-dependent. In the light 
of the crystal structure of MyD88-IRAK4-IRAK2 DD Myddosome, we hypothesized that 
IRAKM might also be capable of forming a complex with MyD88-IRAK4 to mediate 
signaling. We indeed detected IL-1-induced interaction of IRAKM with MyD88, IRAK4, 
TRAF6 and MEKK3, but not with TAK1 when we restored IRAKM-deficient MEFs with 
tagged-IRAKM (Fig. 6A). Furthermore, TLR-induced interaction of IRAKM with 
MyD88, IRAK4, TRAF6 and MEKK3 (but not with TAK1) can take place in the absence 
of IRAK1 and IRAK2 when we introduced tagged-IRAKM into the IRAK1/2/M-TKO-
BMDMs (Fig. 6B). These data indicate the formation of IRAKM Myddosome (MyD88-
IRAK4-IRAKM), which is probably responsible for TLR-induced IRAKM-mediated 
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NFκB activation in the absence of IRAK1 and IRAK2 through the MEKK3-dependent, but 
not the TAK1-dependent pathway.  
The N-terminal DD of IRAKM shares a considerable sequence identity to those of 
other members of the IRAK family. The similarity of topologies within this region (DD) 
of IRAKM to the region of IRAK2 suggested that this region of IRAKM may adopt a 
similar protein fold. To test this prediction, we built a three-dimensional model of the 
region of IRAKM DD (residues 14-105). The model has secondary structure elements 
similar to those of  other IRAK DDs with a hexahelical bundle [136]. The model places a 
cluster of hydrophilic residues on the surface that is reminiscent to that of IRAK2 DD when 
bound to IRAK4 DD[127].  IRAK4-binding residues with IRAK2 are highly conserved in 
IRAKM DD, suggesting that IRAKM is assembled with IRAK4 DD in a similar manner 
to IRAK2 (Fig. 8). In particular, the conserved W74 (W62 in IRAK2) in helix H4 of the 
IRAKM DD is likely a key residue for interacting with IRAK4 DD. The model also a 
conserved salt bridge between E71 (E59 in IRAK2) in helix H4 of the IRAKM and R54 in 
IRAK4, suggesting a critical role of the helix H4 segment in IRAKM for recognizing 
IRAK4. Interestingly, Q78 in IRAKM is a polar residue and distinct from the equivalent 
residue in IRAK2 (M66) but the hydrophobic side chain portion of Q78 seems to make the 
hydrophobic interaction with IRAK4 whereas the hydrophilic part of Q78 in IRAKM may 
interact with the backbone oxygen atoms of F25, E92, and F93 in IRAK4. 
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Figure 8. Computer modeling of IRAKM Myddosome complex. Conserved binding 
interface in the interaction of IRAKM with IRAK4 (Left). A three-dimensional model of 
the MyD88-IRAK4-IRAKM Myddosome complex (Middle). A putative binding interface 
in the death domain (DD) between IRAKM (blue) and IRAK4 (yellow), as guided by 
molecular modeling study. The helix H4 of IRAKM DD seems to be a critical element for 
the interaction with IRAK4 DD. Putative binding residues in the helix H4 in the IRAKM 
in the interaction with IRAK4 are highlighted. Specifically, the surface exposed E71 on the 
helix H4 of IRAKM makes a salt bridge with R54 from one IRAK4 DD molecule, and this 
salt bridge formation is conserved in the IRAK2 DD/IRAK4 DD interface. The E71-
mediated IRAKM DD/IRAK4 DD interaction is further stabilized by a hydrophilic 
interaction with Q29 from another neighboring IRAK4 DD molecule upon the Myddosome 
formation. W74 of IRAKM is situated in the center of the helix H4 and packs against a 
hydrophobic environment that is created by two IRAK4 DD monomers upon Myddosome 
formation. Q78 in IRAKM may play an important role both in the hydrophilic and 
hydrophobic interactions with IRAK4 (see text). The significance of these side chains of 
IRAKM in the interaction with IRAK4 was verified by our site-directed mutagenesis study 
(Right).   The interaction interface in the DD between IRAK2 (magenta) and IRAK4 
(yellow), as evidenced by crystallographic study. 
 
To test the proposed binding interface, we made individual and combined point 
mutants of IRAKM in retroviral vector. We have previously shown that IRAKM was able 
to restore IL-1-induced NFκB activation in 293-derived IRAK1-deficient cells (293-I1A 
cells), in which IRAKM and IRAK2 expression were not detectable (absent or very low) 
[125]. Therefore, this cell line was used to test the ability of IRAKM to form Myddosome 
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in response to IL-1 stimulation. Fig 2C shows that E71A and Q78G each showed partial 
defect whereas the combination of these two mutations (E71A/Q78G) drastically decreased 
the binding of IRAKM to IRAK4. Furthermore, the W74A IRAKM mutant completely lost 
the interaction with IRAK4 (Fig. 9A). We next used this cell line to examine the ability of 
IRAKM mutants in mediatingIL-1-dependent NFκB activation. IRAKM wild-type and 
mutants were co-transfected with NFκB-dependent luciferase reporter construct (E-
selectin-Luc) into 293-I1A cells, followed by IL-1 treatment and luciferase assay. The 
W74A IRAKM mutant completely lost the ability to activate NFκB in 293-I1A cells upon 
IL-1 stimulation (Fig. 9B). On the other hand, while E71A and Q78G exhibited partial 
defect, the combination of these two mutations (E71A/Q78G) greatly decreased the IL-1-
induced NFκB-dependent luciferase activity in 293-I1A cells (Fig. 9B). The same results 
were obtained from the analysis of the IRAKM mutants in NFκB electrophoretic mobility 
shift assay (Fig. 9C). Consistent with its ability in mediating IL-1-induced NFκB 
activation, IRAKM was also able to restore IL-1-induced IL-8 and TNFα gene expression 
in 293-I1A cells (Fig. 9D). Importantly, W74A and E71A/Q78G IRAKM mutants failed 
to restore the IL-8 and TNFα gene expression in 293-I1A cells in response to IL-1 
stimulation (Fig. 9D). Moreover, since we predict the hydrophilic part of Q78 in IRAKM 
may interact with the backbone oxygen atoms of F25 in IRAK4, we generated the IRAK4 
F25D mutant. When tested in IRAK4-deficient cells, this F25D mutant showed decreased 
interaction with IRAKM compared with wild-type IRAK4 upon IL-1 stimulation (Fig. 10), 
confirming the critical contact between Q78 in IRAKM and F25 in IRAK4. 
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Figure 9. Restoration of IRAKM wild-type and mutants in 293-I1A cell. A. IRAK1-
deficient 293-IL1R (I1A) cells transfected with empty vector, FLAG-tagged wild-type 
IRAKM (WT), FLAG-tagged IRAKM mutants (F18A, E71A, Q78A, W74A and 
E71A/Q78G) were treated with IL-1β (1ng/ml) for the indicated times, followed by 
immunoprecipitation (IP) with anti-IRAK4 antibody and analyzed by Western blot analysis 
with antibody against FLAG to detect IRAKM. B. IRAKM wild-type and mutants (F18A, 
E71A, Q78A, W74A and E71A/Q78G) were transiently co-transfected with NFκB-
dependent luciferase reporter construct (E-selectin-Luc) into IRAK1-deficient 293-IL1R 
(293-I1A) cells, followed by IL-1 (1ng/ml) treatment for 6 hours and luciferase assay. The 
experiment was repeated three times. Data represent mean ± SEM; *, p<0.05(two tailed t-
test). C. Nuclear extracts prepared from 293-I1A cells transiently co-transfected with wild-
type (WT), W74A and E71A/Q78A untreated or treated with IL-1β (1ng/ml) for the 
indicated times were analyzed by electrophoretic mobility shift assay using an NFκB 
specific probe. D. IRAK1-deficient 293-IL1R (I1A) cells transiently transfected with 
empty expression vector, wild-type IRAKM, and IRAKM mutants (W74A and 
E71A/Q78G) were treated with IL-1β (1ng/ml) for the indicated times. Total RNAs from 
these cells were subjected to real-time PCR analysis for the levels of human IL-8 and TNFα 
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mRNAs. The experiments were repeated three times. Data represent mean ± SEM; *, 
p<0.05 (two tailed t-test). 
 
 
Figure 10. F25 in IRAK4 is required for the interaction with IRAKM. IRAK4 wild-
type (WT) and F25D mutant (F25D) were retrovirally expressed together with FLAG-
tagged IRAKM in IRAK4 deficient fibroblasts. Cells were treated with IL-1β (1ng/ml) for 
the indicated times, followed by immunoprecipitation (IP) with IRAK4 antibody and 
analyzed by Western blot analyses using antibodies against FLAG and IRAK4. WCL 
(whole cell lysates). The experiments were repeated for five times with similar results. 
 
We then confirmed the binding interface of IRAKM with IRAK4 in response to 
TLR7 stimulation. IRAKM wild-type and mutants were expressed in IRAK1/2/M-TKO-
BMDMs by adenovirus infection. Consistent with the results for the IL-1 response, wild-
type IRAKM was able to interact with IRAK4 and restored TLR7-induced NFκB activation 
in IRAK1/2/M-TKO-BMDMs, whereas W74A mutant lost its ability to interact with 
IRAK4 and failed to mediate NFκB activation. While E71 and Q78G showed partial 
reduction, the combinational mutant E71A/Q78G was unable to interact with IRAK4 with 
abolished TLR7-induced NFκB activation (Fig. 11A-B). Furthermore, W74A and 
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E71A/Q78G mutants also failed to restore CXCL1, TNFα and IL-6 gene expression in 
IRAK1/2/M-TKO-BMDMs upon TLR7 stimulation (Fig. 11C). Taken together, these 
results provide strong supporting evidence for the interaction between DDs of IRAKM and 
IRAK4 and demonstrate that this interaction is critical for IRAKM to mediate IL-1R/TLR-
induced NFκB activation. 
 
Figure 11. Restoration of wild-type and IRAKM mutants in IRAK1/2/M-triple 
deficient cells. A. IRAK1/2/M-triple deficient (IRAK1/2/M TKO) BMDMs infected with 
adenovirus expressing HA-tagged wild-type IRAKM (WT) and HA-tagged IRAKM 
mutants (F18A, E71A, Q78A, W74A and E71A/Q78G) were treated with R848 (1ng/ml) 
for the indicated times, followed by immunoprecipitation (IP) with anti-IRAK4 antibody 
and analyzed by Western blot analysis with antibody against HA to detect IRAKM. The 
experiments were repeated for five times with similar results. B. IRAK1/2/M-triple 
deficient (IRAK1/2/M TKO) BMDMs infected with adenovirus expressing HA-tagged 
wild-type IRAKM (WT) and HA-tagged IRAKM mutants (F18A, E71A, Q78A, W74A 
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and E71A/Q78G) were treated with R848 (1ng/ml) for the indicated times, followed by 
Western blot analyses with antibodies against p-p65 p-IκBα, IκBα, and actin. The 
experiments were repeated for five times with similar results. C. IRAK1/2/M-triple 
deficient (IRAK1/2/M TKO) BMDMs infected with adenovirus expressing HA-tagged 
wild-type IRAKM (WT) and HA-tagged IRAKM mutants (F18A, E71A, Q78A, W74A 
and E71A/Q78G) were treated with R848 (1ng/ml) for the indicated times. Total RNAs 
from these cells were subjected to real-time PCR analysis for the levels of mouse CXCl1, 
TNFα and IL-6 mRNAs. The experiment was repeated three times. Data represent mean ± 
SEM; *, p<0.05(two tailed t-test). 
 
IRAKM deficiency resulted in decreased second wave TLR7-induced NFκB 
activation in the presence of IRAK1 and IRAK2 
Previous studies suggested that IRAKM functions as a negative regulator that 
prevents the dissociation of IRAKs from MyD88, thereby inhibits all downstream signaling 
events including NFκB activation [128]. Considering how IRAKM can form Myddosome 
and is capable of mediating TLR/IL-1R signaling in the absence of IRAK1/IRAK2, we 
decided to re-investigate the impact of IRAKM single deficiency on TLR7-mediated 
signaling. To our surprise, IRAKM deficiency decreased TLR7-induced late phase NFκB 
activation (after 0.5h) in a gel-shift assay (Fig. 12A). The TAK1-dependent downstream 
signaling events (phosphorylation of TAK1 and IKKα/β and IκBα degradation) were 
similar or slightly enhanced in IRAKMKO-BMDMs compared to that in control cells. 
However, whereas TLR7-induced IκBα and p65 phosphorylation were comparable at early 
times (within 10min), they were substantially reduced at later times (after 30min) (Fig. 
12B). These results suggest that IRAKM Myddosome contributes to the second wave of 
TLR7-induced NFκB activation in the presence of IRAK1 and IRAK2, probably through 
the TAK1-independent pathway.  
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Figure 12. The role of IRAKM in second wave of TLR-mediated NFκB activation. A. 
Nuclear extracts prepared from wild-type (WT), and IRAKM deficient (MKO) BMDMs 
untreated or treated with R848 (1μg/ml) for the indicated times were analyzed by 
electrophoretic mobility shift assay using an NFκB specific probe. The experiments were 
repeated for five times with similar results. B. Cell lysates from wild-type (WT), and 
IRAKM deficient (MKO) BMDMs untreated or treated with R848 (1μg/ml) for the 
indicated times were analyzed by Western blot analyses with antibodies against TAK1, 
MEKK3, p-IKKα/β, p-p65, p-IκBα, IκBα, p-JNK, p-ERK, p-p38 and actin. The 
experiments were repeated for five times with similar results. 
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Our previous studies showed MG132, which inhibits proteasome-dependent 
protein degradation, can block TLR-mediated TAK1-depenent pathway (phosphorylation 
of TAK1 and IKKα/β and IκBα degradation), since IRAK1 ubiquitination and degradation 
is critical for TAK1-dependent downstream signaling [137] (Fig. 13A). On the other hand, 
MG132 does not block the TLR-induced MEKK3-dependent pathway, as evident by intact 
TLR-induced phosphorylation of MEKK3 and IκBα; and substantial residual JNK, p38 and 
ERK activation after MG132 treatment. Therefore, to confirm the role of IRAKM in TLR7-
induced TAK1-independent MEKK3-dependent signaling, we examined the impact of 
MG132 on TLR7-induced signaling in IRAKMKO BMDMs. We indeed found that 
pretreatment of MG132 greatly reduced TLR7-induced phosphorylation of MEKK3, IκBα, 
JNK, p38 and ERK in IRAKM-deficient BMDMs compared to its impact on wild-type 
control cells. These results showed that IRAKM-mediated signaling becomes the dominant 
pathway when the TAK1 pathway is blocked by MG132, supporting that IRAKM 
Myddosome might mediate the second wave of TLR7-induced NFκB activation through 
the TAK1-independent MEKK3-dependent pathway (Fig. 13B). To confirm the role of 
MEKK3 in IRAKM-mediated NFκB activation, IRAKM was co-transfected with NFκB-
dependent luciferase reporter construct (E-selectin-Luc) into scramble shRNA-transfected 
or MEKK3 knock-down 293-I1A cells, followed by IL-1 treatment and luciferase assay. 
IL-1-induced IRAKM-mediated NFκB activation was greatly reduced in MEKK3 knock-
down cells compared to that in the control cells (Fig. 14C&D). Taken together, these data 
support that IRAKM Myddosome-mediated NFκB activation is through the MEKK3-
dependent pathway.  
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Figure 13. IRAKM-mediated NFκB activation is dependent on MEKK3. A. BMDMs 
from wild-type (WT) were pre-treated with/without MG132 (20μM) for 2 hours followed 
by R848 (1μg/ml) treatment for the indicated time. B. BMDMs from wild-type (WT) and 
IRAKM deficient (MKO) mice were pre-treated with MG132 (20μM) for 2 hours followed 
by R848 (1μg/ml) treatment for the indicated time. Western blot analysis was performed 
by antibodies againstTAK1, MEKK3, p-IKKα/β, p-IκBα, IκBα, p-JNK, p-ERK, p-p38 and 
actin. The experiments were repeated for five times with similar results. C. MEKK3 knock-
down (MEKK3 KD) cells and control (Scrambled) cells were transiently co-transfected 
with IRAKM and NFκB-dependent luciferase reporter construct (E-selectin-Luc) followed 
by IL-1 (1ng/ml) treatment for 6 hours and luciferase assay. The experiments were repeated 
three times. Data represent mean ± SEM; *, p<0.05(two tailed t-test).  D.  FALG-tagged 
IRAKM transfected MEKK3 knock-down (MEKK3 KD) cells and control (Scrambled) 
cells were treated with  IL-1 (1ng/ml)  for indicated time, followed by Western blot 
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analyses with antibodies against MEKK3, FLAG, p-IκBα, IκBα and actin. The experiments 
were repeated for five times with similar results. 
 
IRAKM is required for TLR7-induced expression of inhibitory molecules SHIP1, 
SOCS1, A20 and IκBα 
One important question is then whether TLR-induced IRAKM-mediated signaling 
has any impact on gene expression.IRAK1/IRAK2 double deficiency results insubstantial 
impairment of TLR-mediated production of pro-inflammatory cytokines and chemokines 
[138]. It is important to note that the TLR-induced IRAKM-mediated signaling events in 
IRAK1/2-DKO-BMDMs allowed the induction of cytokines and chemokines mRNAs at 
early times (peak at 30min), such as TNFα and CXCL1 (KC), which was completely 
abolished in IRAK1/2/M-TKO-BMDMs (Fig. 14A). However, since IRAK2 is required 
for posttranscriptional control of the TNFα and CXCL1 (KC) mRNAs, we failed to detect 
TNFα and CXCL1 (KC) mRNAs at later times (after 1 hour) and thus little protein 
production of TNFα and CXCL1 (KC) in IRAK1/2-DKO-BMDMs (Fig. 14B).Therefore, 
the IRAK1/IRAK2-mediated coupling of the TAK1-dependent NFκB activation and 
posttranscriptional regulation plays an essential role in the production of these pro-
inflammatory cytokines and chemokines. Although TLR7-induced IRAKM-mediated 
signaling in IRAK1/2 DKO-BMDMs can mediate the induction of cytokines and 
chemokines mRNAs at early times, this IRAKM-mediated pathway alone in the absence 
of IRAK1 and IRAK2 is insufficient to induce the production of cytokines and chemokines 
that are under the posttranscriptional control. Similar results were obtained for TLR2 and 
TLR9 signaling pathways (Fig. 15). 
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Fig. 14. IRAK1 and IRAK2 are required for TLR7-induced pro-inflammatory gene 
expression. A. Total mRNAs from BMDMs of wild-type (WT), IRAK1/2-double deficient 
(DKO) and IRAK1/2/M-triple deficient (TKO) mice treated with R848 (1μg/ml) for the 
indicated times, were subjected to RT-PCR analyses for the levels of CXCL1, IL-6 and 
TNFα expression. B. BMDMs from wild-type (WT), IRAK1/2 double deficient (DKO) 
and IRAK1/2/M triple deficient (TKO) mice were treated with R848 (1μg/ml) for the 
indicated time. CXCL1, IL-6 and TNFα concentrations in the supernatant were measured 
by ELISA. The experiments were repeated three times. Data represent mean ± SEM; **, 
P<0.01; *, p<0.05(two tailed t-test). 
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Figure 15. IRAK1 and IRAK2 are required for TLR2/9-induced pro-inflammatory 
gene expression. A.  Total mRNAs from BMDMs of wild-type (WT), IRAK1/2-double 
deficient (DKO) and IRAK1/2/M-triple deficient (TKO) mice treated with Pam3CSK4 
(200ng/ml) for the indicated times, were subjected to RT-PCR analyses for the levels of 
CXCL1, IL-6 and TNFα expression. B. Total mRNAs from BMDMs of wild-type (WT), 
IRAK1/2-double deficient (DKO) and IRAK1/2/M-triple deficient (TKO) mice treated 
with CpG B (1μg/ml) for the indicated times, were subjected to RT-PCR analyses for the 
levels of CXCL1, IL-6 and TNFα expression. The experiments were repeated three times. 
Data represent mean ± SEM; **p<0.01, *p<0.05 (two tailed t-test). 
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We have previously also identified a group of TLR-induced genes that are not 
regulated at posttranscriptional levels [131]. The TLR7-induced IRAKM-mediated 
signaling events in IRAK1/2-DKO-BMDMs allowed sustained induction of these genes, 
which was completely abolished in IRAK1/2/M-TKO-BMDMs (Fig. 16A).Furthermore, 
the expression of these genes was also substantially reduced in IRAKM-KO-BMDMs 
compared to that in wild-type cells (Fig. 16B). Several of the genes are important for the 
activation and homeostasis of the macrophages (including ETS2, SOD2, Bcl-2A1D and 
GPR84) (Fig. 16A-B). Another group of IRAKM-dependent genes is inhibitory molecules, 
including A20, SOCS1, SHIP1 and IκBα (Fig. 16A-B, Fig. 17). The gene expression data 
were consistent with the role of IRAKM in TLR7-induced second wave NFκB activation, 
since most of the IRAKM-dependent genes were late genes (induced after 1 hour). 
Although A20 was readily induced at 30 min, its expression peaked at 4 hours of treatment. 
Taken together, these results suggest that at least one potential importance of TLR7-
induced IRAKM-mediated signaling is to induce the expression of several inhibitory 
molecules (SHIP1, SOCS1, A20 and IκBα, which might serve as a negative feedback 
control, implicating a novel inhibitory mechanism by which IRAKM modulates TLR 
signaling. 
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Figure 16. IRAKM is required for TLR7-induced expression of inhibitory molecules 
SHIP-1, SOCS1, A20 and IκBα. A. Total mRNAs from BMDMs of wild-type (WT), 
IRAK1/2-double deficient (DKO) and IRAK1/2/M-triple deficient (TKO) mice treated 
with R848 (1μg/ml) for the indicated times, were subjected to RT-PCR analyses for the 
levels of ETS2, SOD2, Bcl-2A1D, GPR84, SHIP-1, SOCS1, A20 and IκB expression. B. 
Total mRNAs from BMDMs of wild-type (WT) and IRAKM-deficient (MKO) mice 
treated with R848 (1μg/ml) for the indicated times, were subjected to RT-PCR analyses for 
the levels of ETS2, SOD2, Bcl-2A1D, GPR84, SHIP-1, SOCS1, A20 and IκBαexpression. 
The experiments were repeated three times. Data represent mean ± SEM; **, P<0.01;*, 
p<0.05(two tailed t-test). 
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Figure 17. IRAKM is required for TLR7-induced protein translation of SHIP1 and 
SOCS1. A. Cell lysates from wild-type (WT), IRAK1/2- double deficient (IRAK1/2 DKO), 
IRAK1/2/M-triple deficient (IRAK1/2/3 TKO) bone marrow-derived macrophages 
(BMDMs) untreated or treated with R848 (1μg/ml) for the indicated times were analyzed 
by Western blot analysis with antibodies against SHIP1, SOCS1, and actin. The 
experiments were repeated for five times with similar results. B. Cell lysates from wild-
type (WT), and IRAKM deficient (MKO) BMDMs untreated or treated with R848 (1μg/ml) 
for the indicated times were analyzed by Western blot analyses with antibodies against 
SHIP1, SOCS1, and actin. The experiments were repeated for five times with similar 
results. 
 
IRAKM inhibits translational control of proinflammatory cytokines via its 
interaction with IRAK2 
Although it is clear that IRAKM contributes to TLR7-induced gene transcription 
through the activation of second wave of NFκB activation, the production of somepro-
inflammatory cytokines and chemokines(including CXCL1, TNFα and IL-6) was actually 
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enhanced in the IRAKMKO-BMDMs compared to that in the control cells [128](Fig. 18B). 
Since the mRNAs of these pro-inflammatory genes were induced at similar or reduced 
levels in IRAKMKO-BMDMs as compared to wild-type cells (Fig. 18A), we investigated 
the possible role of IRAKM in regulation of cytokine and chemokine translation. BMDMs 
from IRAKM-deficient mice and wild-type mice were treated with TLR7 ligand R848 for 
1.5 hours and a sucrose gradient was used to separate the mRNA translation-inactive pool 
(free ribosome) and translation-active pool (poly-ribosomes) (Fig. 19A). Compared with 
wild-type BMDMs, IRAKM KO BMDMs had more cytokine and chemokine mRNAs (IL-
6, KC and TNFα) in the translation-active pool. IRAKM deficiency thus resulted in the 
increased ratios of TLR-induced cytokine and chemokine mRNAs in translation-active 
pool versus translation-inactive pool (Fig. 19B&E). On the other hand, IRAKM deficiency 
had no impact on the translation of mRNAs that are not regulated at the post-transcriptional 
levels, including the inhibitory molecules (ETS2, SOD2, Bcl-2A1D, GPR84, SHIP1, 
SOCS1, A20 and IκBα (Fig. 19C-D&E). 
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Figure 18. IRAKM inhibits TLR7-induced pro-inflammatory gene expression. A. 
Total mRNAs from BMDMs of wild-type (WT) and IRAKM-deficient (MKO) mice 
treated with R848 (1μg/ml) for the indicated times, were subjected to RT-PCR analyses for 
the levels of CXCL1, IL-6 and TNFα expression. B. BMDMs from wild-type (WT) and 
IRAKM-deficient (MKO) mice were treated with R848 (1μg/ml) for the indicated time. 
CXCL1, IL-6 and TNFα concentrations in the supernatant were measured by ELISA. The 
experiments were repeated three times. Data represent mean ± SEM; **P<0.01. 
*p<0.05(two tailed t-test). 
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Figure 19. IRAKM inhibits the translation of TLR7-induced pro-inflammatory genes. 
A. Translation-active and –inactive mRNAs from R848-treated BMDMs were isolated by 
sucrose gradient fraction. B-D.BMDMs from wild-type (WT) and IRAKM deficient (MKO) 
mice were treated with R848 (1μg/ml) for 90 min. (B) IL-6, KC and TNFα; (C)ETS2, 
SOD2, Bcl2A1D and GPR84; (D)A20, SOCS1, SHIP1 and IκBα and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNAs from unfractionated cell lysates, translation-
active pools, and translation-inactive pools were analyzed by quantitative RT-PCR and 
normalized to β-actin (see supple. Fig. 4). The ratios of mRNAs from R848-treated 
translation-active and –inactive pools are shown in B-D. The experiments were repeated 
three times. Data represent mean±SEM; **P<0.01. *p<0.05(two tailed t-test). E.IL-6, KC, 
TNFα, A20, SOCS1, SHIP1, IκBα and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) mRNAs from unfractionated cell lysates, translation-active pools, and 
translation-inactive pools were analyzed by quantitative RT-PCR and normalized to β-actin. 
Similar results were obtained in three independent experiments. One representative is 
shown. 
 
We previously reported that IRAK2 plays an important role in the regulation of 
TLR-mediated protein translation of cytokines and chemokines, including IL-6, CXCL1 
(KC) and TNFα. Through co-immunoprecipitation experiment, we found that IRAKM 
specifically bound to IRAK2, not IRAK1 (Fig. 20A). Furthermore, we have previously 
reported that IRAK2 is required for TLR-induced phosphorylation of MNK1, MK2 and 
eIF4e, which are involved in protein translational control. Interestingly, IRAKM 
deficiency resulted in increased TLR7-induced phosphorylation of MNK1, MK2 and eIF4e 
(Fig. 20B), supporting the role of IRAKM in inhibition of TLR7-induced proinflammatory 
cytokine and chemokine translation through its interaction with IRAK2. 
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Figure 20. IRAKM inhibits the translation of TLR7-induced pro-inflammatory genes 
through its interaction with IRAK2. A. IRAKM-deficient mouse embryonic fibroblast 
(MEFs) infected with retroviruses containing empty vector construct (Vector) and FLAG-
IRAKM were treated with IL-1β (1ng/ml) for the indicated times, followed by 
immunoprecipitation (IP) with anti-FLAG antibody and analyzed by Western blot analyses 
using antibodies againstIRAK1, IRAK2 and FLAG. WCL (whole cell lysates). The 
experiments were repeated for five times with similar results. B. Cell lysates from wild-
type (WT), and IRAKM deficient (MKO) BMDMs untreated or treated with R848 (1μg/ml) 
for the indicated times were analyzed by Western blot analyses with antibodies against p-
MKK3/6, p-MNK1, p-MK2, p-eIF4F and actin. The levels of the phosphorylated proteins 
were analyzed by ImageJ 1.43u and normalized to actin. * indicates non-specific band. The 
experiments were repeated for five times with similar results. 
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Figure 21. Model for the regulatory role of IRAKM in TLR-IL-1R signaling. IRAKM 
is able to function as an intermediate signaling component to transmit signaling upon TLR-
IL-1R activation. IRAKM interacts with MyD88-IRAK4 to form IRAKM Myddosome to 
mediate TLR-IL-1R-induced MEKK3-dependent second wave NFκB activation. However, 
this IRAKM-dependent pathway only induces expression of genes that are not regulated at 
the posttranscriptional levels (including inhibitory molecules SOCS-1, SHIP-1, A20 and 
r hand, 
IRAKM specifically interacts with IRAK2, but not IRAK1, and suppresses TLR-IL-1R-
induced IRAK2-mediated translation of cytokines and chemokines.  
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D. Discussion 
Although previous studies suggested that IRAKM prevents the dissociation of 
IRAKs from MyD88, suppressing all downstream signaling, there have not been sufficient 
experimental evidences to fully support this hypothesis. In this manuscript, we provided 
two novel mechanisms for the regulatory role of IRAKM in TLR signaling (Fig. 21). First, 
IRAKM is able to function as an intermediate signaling component to transmit signaling 
upon TLR activation. IRAKM interacts with MyD88-IRAK4 to form IRAKM Myddosome 
to mediate TLR7-induced MEKK3-dependent second wave NFκB activation. However, 
this IRAKM-dependent pathway only induces expression of genes that are not regulated at 
the posttranscriptional levels (including inhibitory molecules SOCS-1, SHIP-1, A20 and 
IκBα), exerting an overall inhibitory effect on inflammatory response. The second novel 
mechanism is that IRAKM specifically interacts with IRAK2, but not IRAK1, and 
suppressesTLR7-induced IRAK2-mediated translation of cytokines and chemokines. 
These findings present a new outlook for how IRAKM modulates TLR signaling and TLR-
mediated inflammatory responses.  
The role of IRAKM in MEKK3-dependent NFκB activation was best demonstrated 
in IRAK1/2-DKO- versus IRAK1/2/M-TKO-BMDMs. While IRAK1/2 double deficiency 
abolished TAK1-, but not MEKK3-dependent pathway, TLR7-induced NFκB activation 
was no longer detectable in IRAK1/2/M-TKO-BMDMs. It is intriguing that IRAKM single 
deficiency resulted in loss of TLR7-induced late NFκB activation (after 30min), 
implicating the role of the IRAKM-MEKK3 pathway in second wave of NFκB activation 
in the presence of IRAK1/2. The importance of IRAKM in NFκB activation was further 
demonstrated in the MG132 treatment experiment, in which IRAKM deficiency greatly 
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diminished TLR7-induced NFκB activation, since MG132 treatment was shown to block 
the TAK1-dependent pathway, mimicking IRAK1/2 deficiency [137]. These mouse 
genetic experiments on the novel role of IRAKM were nicely supported by biochemical 
studies. IRAKM-mediated NFκB activation was almost abolished in MEKK3 knock-down 
cells and IRAKM specifically interacted with MEKK3, but not TAK1, providing direct 
biochemical evidence for the role of IRAKM in MEKK3-, but not TAK1-dependent 
pathway. IRAK1 and IRAK2 are known to form Myddosomes with MyD88-IRAK4 to 
mediate TLR7-induced TAK1-dependent NFκB activation. Since IRAKM was able to 
mediate NFκB activation in the absence of IRAK1 and IRAK2, and interacted with MyD88 
and IRAK4, we proposed the formation of IRAKM Myddosome. Through protein 
modeling, we predicted the critical residues for interaction interface between death 
domains of IRAKM and IRAK4. Mutations in the conserved W74, E71 and Q78 in helix 
H4 of the IRAKM DD greatly reduced the interaction of IRAKM with IRAK4 and also 
diminished the ability of IRAKM to mediate NFκB activation. These results strongly 
suggest that IRAKM probably indeed has the ability to directly interact with MyD88-
IRAK4, like IRAK1/2, acting as an intermediate signaling component to transmit signal 
from the receptor to downstream signaling cascade (interaction with TRAF6-MEKK3) to 
mediate NFκB activation.   
One important question is what is the biological significance of the IRAK1/2-
mediated TAK1- versus IRAKM-mediated MEKK3-dependent pathway? We have 
previously shown that the kinase activity of IRAK4 is required TAK1-, but not MEKK3-
dependent NFκB activation [131, 132]. Furthermore, IRAK4 coordinately regulates 
TAK1-dependent NFκB activation and mRNA stabilization pathways to ensure robust 
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production of cytokines and chemokines during inflammatory response [139]. In addition 
to mRNA stabilization, TLR signaling is also necessary for efficient and sustained 
translation of cytokine and chemokine mRNAs. We have previously reported that IRAK2 
is essential for sustained translation of TLR-induced cytokine and chemokine mRNAs 
[135].Therefore, it is logical to find that IRAK1/2 (substrates of IRAK4) are required for 
TAK1- (not MEKK3-) dependent NFκB activation, which is coupled with 
posttranscriptional control to promote the production of pro-inflammatory cytokines and 
chemokines. On the other hand, the IRAKM-induced MEKK3-dependent pathway is 
uncoupled from posttranscriptional regulation. Therefore, the IRAKM-dependent pathway 
only induced expression of IRAK4-kinase-independent genes that are not regulated at the 
posttranscriptional levels, including inhibitory molecules SOCS1, SHIP1, A20 and IκBα. 
The important concept is that IRAKM is wired to engage an alternative NFκB activation 
pathway to produce inhibitory molecules, which can in turn to exert an overall inhibitory 
effect on inflammatory response. The advantage for such inhibitory mechanism could be 
that through the production of these inhibitory molecules, IRAKM could exert broader 
inhibitory effects not just on TLR-IL-1R but also on other cytokine signaling cascades, so 
that the inflammatory response can be effectively controlled.   
It is important to point out that IRAKM also has the ability to directly impact on 
TLR-induced production of cytokines and chemokines. Although IRAKM deficiency did 
not have much impact on TLR-induced mRNA levels of cytokines and chemokines, their 
protein production was enhanced in IRAKM-KO-BMDMs as early as 1 hour after 
stimulation. Through polysomal fractionation, we found that the mRNAs of cytokines and 
chemokines were more actively translated in the absence of IRAKM, indicating the critical 
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role of IRAKM in translational control. Consistent with the previous finding about the 
essential role of IRAK2 in TLR-mediated translational control, we found IRAKM specially 
interacts with IRAK2, but not IRAK1. These results suggest that in addition to the 
formation of IRAKM Myddosome, IRAKM probably has the ability to dock onto IRAK2 
Myddosome, thereby interfering IRAK2-dependent downstream signaling.  
While this study has provided important insight into the mechanistic roles of 
IRAKM in TLR signaling, many questions still remain regarding the functional 
relationship of the IRAK family members. Future studies are needed to determine how 
IRAKM specifically interacts with IRAK2, but not IRAK1 and what determines the 
distribution and dynamics of IRAKM in IRAKM Myddosome versus IRAK2 Myddosome. 
It will be important to determine how the newly found functions of IRAKM will impact on 
the interpretation of the role of IRAKM in inflammatory responses in vivo and the drug 
development of inhibitors for different IRAKs.  
E. Materials and Methods 
Biological reagents and cell Culture—Recombinant human IL-1 was purchased 
from R&D system. CpG Boligodeoxynucleotide (ODN) and Pam3CSK4 were purchased 
from Invivogen.  LPS (Escherichia coli 055:B5) was purchased from Sigma-Aldrich and 
R848 was obtained from GLSynthesis company. Antibodies against phosphorylated 
IκB(Ser32/S36), JNK, IKK/(Ser176/180), Mnk1 (Thr179/202), MK2 (Thr334), 
eIF4E(Thr70), MKK3(Ser189)/MKK6(Ser207), total IκB and SOCS1 were purchased 
from Cell signaling. Antibody to IRAK2 was purchased from Abcam. Antibody to IRAK4 
was purchased from Enzo. Antibody to FLAG (anti-FLAG) and hemagglutinin (anti-HA) 
were purchased from Sigma. Antibody to MEKK3 was purchased from BD Bio-sciences 
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Pharmingen. Antibodies against IRAK, TAK1, SHIP1 and Actin were from Santa Cruz 
Biotechnologies. MG132 was purchased from Calbiochem. 293-derived IRAK1-deficient 
cells (293-I1A cells), and mouse embryonic fibroblast (MEFs) were maintained in 
Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum, 
penicillin G (100 µg/ml), and streptomycin (100 µg/ml).  Bone-marrow derived 
macrophages were obtained from the bone marrow of tibia and femur by flushing with 
DMEM. The cells were cultured in DMEM supplemented with 20% fetal bovine serum 
(FBS), and 30% L929 supernatant for 5 days. 
Knock-down of MEKK3— Oligonucleotides encoding either scrambled or 
MEKK3-specific small hairpin RNAs were cloned into pSUPER to generate pSUPER-
scrambled or pSUPER-MEKK3 respectively. 1 μg of pSUPER-scrambled or pSuper-
MEKK3 was transfected into 293-I1A cells along with 0.1 μg of pBabe-puromycin by 
FuGENE 6 (Roche Applied Science). Two days after transfection, puromycin (1 μg/ml) 
containing DMEM was added to the cells to select for puromycin-resistant clones. After 
10 days of puromycin selection, single clones were picked and subjected to Western 
analysis to determine the levels of MEKK3. Clones with over 85% knock-down of MEKK3 
were pooled as MEKK3 knock down cells and used for experiments.  
Transfection and luciferase assay—Transfection of the 293-I1A cells was 
performed using the FuGENE 6 transfection reagent as recommended by the manufacturer 
(Roche Diagnostics). After 24 h, the cells were stimulated with IL-1β or left untreated for 
6 h before harvest. Luciferase activity was determined by using the luciferase assay system 
and chemiluminescent reagents from Promega. 
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Plasmids and retroviruses—Mouse IRAKM and IRAK4 cDNA were purchased 
from Open Biosystems. The IRAKM mutants and IRAK4 mutant were generated by site-
directed mutagenesis polymerase chain reaction (PCR). The wild-type and mutants of 
IRAKM and IRAK4 were cloned into pMX retroviral expression vector and transfected 
into phoenix cell for viral packaging. Cells were infected by the packaged retrovirus for 3 
days and selected by puromycin (2μg/ml) for 2days for stable viral integration. For all PCR 
reactions high fidelity Pfu Turbo polymerase was used (Stratagene).   
Adenovirus infection—IRAKM wild-type and mutants were cloned into 
pENTR™⁄D-TOPO® Vector (Invitrogen). The pENTER clones were packaged into an 
adenovirus destination vector pAd/CMV/V5-DEST™ using Gateway® Vector Kit 
according to manufacturer’s guidelines (Invitrogen).  The adenoviral stocks were prepared 
using ViraPower™ Adenoviral Expression System according to manufacturer’s guidelines 
(Invitrogen). The BMDMs were infected at multiplicity of infection (MOI) of 200. After 
sixteen hours of infection, the cells were changed to fresh L929 conditioned medium. 
Forty-eight hours after infection, the cells were used for experiments.    
Immunoblotting—Cell were harvested and lysed in a Triton-containing lysis 
buffer (0.5% Triton X-100, 20 mM HEPES (pH 7.4), 150 mM NaCl, 12.5 mM -
glycerophosphate, 1.5 mM MgCl2, 10 mM NaF, 2 mM dithiothreitol, 1 mM sodium 
orthovanadate, 2mM EGTA, 1 mM phenylmethylsulfonyl fluoride and complete protease 
inhibitor cocktail from Roche). Cell lysates were then separated by 10% SDS-PAGE, 
transferred to Immobilon-P membranes (Millipore), and subjected to immunoblotting. 
Quantitative real-time PCR—Total RNA was isolated using TRIzol reagent 
(Invitrogen). 3μg of total RNA was then used for reverse transcription reaction using 
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SuperScript-reverse transcriptase (Invitrogen). Q-PCR was performed in AB 7300 
RealTime PCR System, and the gene expression of human IL-8, TNFα, actin and mouse 
CXCL1 (KC), TNFα, IL-6, A20, SHIP1, SOCS1, IκBα, GPR84, ETS2, SOD2, Bcl-2AD1 
was examined by SYBR® GREEN PCR Master Mix (Applied Biosystems). PCR 
amplification was performed in triplicate, and water was used to replace cDNA in each run 
as a negative control.  The reaction protocol included preincubation at 95°C to activate 
FastStart DNA polymerase for 10 min, amplification of 40 cycles that was set for 15 s at 
95°C, and annealing for 60 s at 60°C. The results were normalized with the housekeeping 
gene human or mouse β-Actin. Primer sequences were designed using AlleleID 6.0. The 
following primers were used: mouse TNFα forward, CAAAGGGAGAGTGGTCAGGT; 
mouse TNFα reverse, ATTGCACCTCAGGGAAGAGT; mouse actin forward, 
GGTCATCACTATTGGCAACG; mouse actin reverse, 
ACGGATGTCAACGTCACACT; mouse CXCL1 forward, 
TAGGGTGAGGACATGTGTGG; mouse CXCL1 reverse, 
AAATGTCCAAGGGAAGCGT; mouse IL-6 forward, 
GGACCAAGACCATCCAATTC; mouse IL-6 reverse, 
ACCACAGTGAGGAATGTCCA; mouse SOCS1 forward, 
TGACTACCTGAGTTCCTTCC; mouse SOCS1 reverse, ATCTCACCCTCCACAACC; 
mouse SHIP1 forward, GAGGAGACAGGCAACATC; mouse SHIP1 reverse, 
TCTTGACACTGAAGGAACC; mouse GPR84 forward, TCAACCCTGTGCTCTATGC; 
mouse GPR84 reverse, GCCTGTCCTGGTGAATGG; mouse Bcl2A1D forward, 
GGAATGGAGGTTGGGAAGATGG; mouse Bcl2A1D reverse, 
CTGGTCCGTAGTGTTACTTGAGG; mouse SOD2 forward, 
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ACAACTCAGGTCGCTCTTCAG; mouse SOD2 reverse, 
GATAGCCTCCAGCAACTCTCC; mouse ETS2 forward, 
AGTGTGGTGCTTCCTGTCTTG; mouse ETS2 reverse, 
TTGCTCTGTCTGTGCTTCTGG; A20 forward, TGAGCAAGTAGGCAAGATAAG; 
A20 reverse, GTAGACGAGCAGCAATAGC; mouse IκBα forward, 
TGGAAGTCATTGGTCAGG; mouse IκBα reverse, ACAGGCAAGATGTAGAGG; 
human IL-8 forward, AGAGACAGCAGAGCACAC; human IL-8 reverse, 
GTTCTTTAGCACTCCTTGGC; human TNFα forward, TCAGCAAGGACAGCAGAG; 
human TNFα reverse, GTATGTGAGAGGAAGAGAACC; human actin forward, 
GTCGGTATGGGTCAGAAAG; human actin reverse, CTCGTTGTAGAAGGTGTGG. 
ELISA assay—Supernatants from cell cultures were collected and measured for 
the level of mouse cytokines CXCL1, IL-6 and TNFα using Duoset ELISA kits (R&D 
system) according to manufacturer’s instructions. 
Molecular modeling—A theoretical three-dimensional model of the IRAKM DD 
region (residues 14-105) was generated via a web-based molecular modeling server [140]. 
The crystal structure of the IRAK2 DD segment (PDB 3MOP) was used as a template 
because it shares a considerable sequence identity (30%) and topology with IRAKM DD, 
as analyzed by the structure prediction. The complex of the MyD88 DD-IRAK4 DD-
IRAKM DD was constructed via two steps. First, four homology models of the IRAKM 
DD were superposed onto each IRAK2 DD segment (chains K to N) in the Myddosome 
complex (PDB 3MOP) using the secondary structure matching algorism [141], as 
implemented in COOT [142]. Second, these four IRAKM DD models were assembled into 
the coordinates of the MyD88 DD-IRAK4 DD complex in the Myddosome complex after 
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removal of the regions of IRAK2 DD. Thus, the integrity and physicochemical property of 
the MyD88 DD-IRAK4 MM complex were maintained. The hypothetical IRAK4 DD-
IRAKM DD interface was examined by the server PISA [143] and inspected by the 
program PYMOL (www.pymol.org).  
Co-immunoprecipitation and immunoblotting—Bone marrow-derived 
macrophages and 293-I1A cells were cultured as indicated above. After stimulation with 
R848 (1μg/ml) or IL-1β (1ng/ml), the cells were harvested and co-immunoprecipitation 
and immunoblotting were performed as previously descried [144].  
Electrophoretic mobility shift assay (EMSA) — Bone marrow-derived 
macrophages and 293-I1A cells were cultured as indicated above. After stimulation with 
R848 (1 μg/ml) or IL-1β (1 ng/ml), the cells were harvested and nuclear extracts were 
prepared with the NE-PER Nuclear and Cytoplasmic Extraction Reagent (Thermo). 
Labeling of NFκB specific oligonucleotides (Santa Cruz) was performed with [γ-32P]-ATP 
(PerkinElmer) by using T4 polynucleotide kinase (NEB) following manufacturer’s 
guideline.  After purification over a Sephadex G-25 column (Amersham), radiolabelled 
oligonucleotides (around 20,000 cpm) were incubated with nuclear extracts at room 
temperature for 30 min in binding buffer containing 12 mM HEPES (pH 7.9), 4 mM Tris 
HCl (pH 7.8), 60 mM KCl, 1 mM ethylenediamine tetraacetic acid (EDTA), 1 mM 
dithiothreitol (DTT), 1 mM PMSF, 12% glycerol, 5 μg of bovine serum albumin (BSA) 
and 2 μg poly(dI-dC) (Sigma). The same amount of nuclear protein (around 5 μg) was used 
in each experiment. The protein concerntraction was measured using Quick Start Bradford 
Protein Assay Kit (Biorad) following manufacturer’s guideline. DNA–protein complexes 
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were separated using 6% non-denaturing polyacrylamide gel electrophoresis. Signals were 
visualized by exposing the dried gel to autoradiography film. 
Polysome fractionation analysis—Wild-type and IRAKM deficient macrophages 
were stimulated with R848 (1μg/ml) for 1.5h. Cytoplasmic extracts were prepared from 
BM-derived macrophages stimulated with R848 (1μg/ml) as described [144]. Cytoplasmic 
exacts were carefully layered over 10–50% linear sucrose gradients in polysome buffer (10 
mM HEPES, pH 7.5, 100 mMKCl, 2.5 mM MgCl2, 1 mM dithiothreitol, 50 units of 
recombinant RNasin (Promega), and 0.1% Igepal-CA630 (Sigma)) and centrifuged at 
17,000 rpm in a Beckman SW32.1 Ti rotor for 4h at 4C. Gradients were fractioned by 
using an ISCO gradient fractionation system equipped with a UA-6 detector. Light RNP 
fractions, 40S, 60S, and 80S and heavy polysome fractions were monitored by the 
continuous UV absorption profile at A254, and 12 tubes of 750 μl fractions were collected. 
The fractions representing light RNP and free ribosomes were used to isolate the 
translation-inactive pool of mRNAs, and the fractions presenting heavy polysomes were 
used to isolate the translation-active mRNAs. RNAs were isolated from these fractions by 
extraction with TRIzol. 
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CHAPTER III 
IRAKM-MINCLE AXIS CONTRIBUTES TO ALCOHOL-INDUCED LIVER 
INJURY VIA INFLAMMASOME ACTIVATION 
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A. Abstract 
Alcohol-induced liver injury is induced by necrosis of hepatocytes and increased 
translocation of endotoxin from the intestinal tract into hepatic portal system, which trigger 
chronic inflammation that is damaging to the liver together. In this study, we found that 
mice deficient of a Toll-like receptor proximal molecule, IRAKM, are protected from 
alcohol-induced liver injury. IRAKM mediates the up-regulation of Mincle, a receptor for 
danger signals release by damaged cells, in response to low dose of LPS. Biochemical 
analysis revealed that low-dose LPS preferentially induces the formation of IRAKM 
Myddosome, leading to MEKK3-dependent NFκB activation. Mincle-deficient mice are 
also protected from alcohol-induced liver injury. We found IRAKM deficiency and Mincle 
deficiency drastically reduced alcohol feeding induced inflammasome activation in the 
mouse liver. Ex vivo studies showed that both IRAKM and Mincle are required for 
inflammasome activation by endogenous Mincle ligand, SAP130, which is a danger signal 
release by damaged hepatocytes. Taken together, this study identifies an IRAKM-Mincle 
axis critical for the pathogenesis of alcohol induced liver disease through the activation of 
inflammasome.  
B. Introduction 
Alcoholic liver disease (ALD) ranges from simple steatosis to alcoholic hepatitis, 
fibrosis, cirrhosis and hepatocellular carcinoma [105-108]. Alcohol exposure induces 
endoplasmic reticulum (ER) stress and mitochondrial dysfunction in hepatocytes, which 
leads to hepatocyte apoptosis, necrosis and inflammation [145-147]. Alcohol disrupts the 
balance gut microflora associated with an increased intestinal permeability, resulting in 
increased translocation of bacterial products into the circulation [46, 51, 106, 114]. 
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Increased levels of LPS were indeed detected in alcoholic patients and alcohol-treated 
experimental animals [113, 148]. The activation of hepatic macrophages (Kupffer cells) to 
portal endotoxin/lipopolysaccharide (LPS) plays a key role in the early pathogenesis of 
alcohol-induced liver injury. LPS recognition by Toll-like receptor 4 (TLR4) on hepatic 
macrophages results in the release of inflammatory cytokines such as TNF and IL-1 that 
can impact on the function of hepatocytes. Mice deficient in TLR4 or IL-1R indeed showed 
reduced alcohol-induced liver diseases [115-117]. Conversely, previous studies have 
shown that signals from injured hepatocytes induced by alcohol are also critical to the 
activation of hepatic macrophages. Thus, one important question is how TLR-dependent 
inflammatory response and alcohol-induced cell damage coordinately lead to the 
pathogenesis of ALD. 
Toll-like receptors (TLRs) are molecules of the innate immune system that detect 
invading pathogens and protect multicellular organisms against infection by using 
proinflammatory chemokines and cytokines [149]. TLRs transduce signals through the 
adaptor molecule MyD88 and IL-1R-associated kinase (IRAK) family members, which 
include: IRAK1, IRAK2, IRAKM (also known as IRAK3) and IRAK4 [123-126]. The 
MyD88–IRAK4–IRAK2 death domain (DD) complex’s crystal structure, referred to as the 
Myddosome complex, is constructed in a sequential manner, in which MyD88 recruits first 
IRAK4 and then MyD88-IRAK4 complex recruits the IRAK4 substrates IRAK2 or the 
related IRAK1[127]. Subsequently, the IRAK1/2 creates a complex with TRAF6 and 
dissociates from the receptor complex, activating cascades of downstream kinases, thus 
resulting in the activation of the transcription factor NFκB [69].  However, on the other 
hand, IRAKM is believed to act as a negative regulator that suppress Myddosome 
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complexes from disassociating with the receptor complex, therefore preventing signaling 
downstream [128]. 
Previously, we had reported the presence of two parallel TLR/IL-1R-mediated 
NFκB activation pathways: TAK1-dependent and MEKK3-dependent. The activation of 
TAK1-dependent pathway results in IKKα/β phosphorylation and IKKγ activation, leading 
to classical NFκB activation via IκBα phosphorylation and degradation. The TAK1-
independent MEKK3-dependent pathway entails IKKγ phosphorylation and IKKα 
activation, which leads to NFκB activation by IκBα phosphorylation and its subsequent 
dissociation from NFκB, but without IκBα degradation [73, 129, 132]. We have recently 
been researching the functional relationships among IRAK family members and their roles 
in TLR signaling by analyzing mice with deficiencies in IRAK1, IRAK2 and/or IRAKM. 
We discovered that certain substrates of IRAK-4, specifically IRAK1 and IRAK2, are 
necessary for TAK1-dependent NFκB activation and mRNA stabilization of chemokines 
and cytokines, but not for MEKK3-dependent NFκB activation [135, 150-152]. IRAKM is 
able to interact with MyD88-IRAK4 to form IRAKM Myddosome, allowing it to control 
TAK1-independent MEKK3-dependent NFκB activation [153]. This IRAKM-dependent 
pathway is necessary for the second wave of TLR-induced NFκB activation in the company 
of IRAK1/IRAK2, a process which is independent on posttranscriptional regulation. Thus, 
the IRAKM-dependent pathway only induces expression of genes which are not controlled 
at posttranscriptional levels (including the inhibitory molecules SOCS1, SHIP1, A20 and 
IκBα), exerting an overall inhibitory effect on responses of inflammation.  
In this study, we were surprised to discover that IRAKM-deficient mice were 
protected from ethanol-induced liver injury and inflammation. Mechanistically, we found 
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that with low doses of LPS (100pg-1ng/ml), IRAKM-MEKK3-dependent NFκB activation 
is the dominant pathway in macrophages; the IRAK1-mediated TAK1 pathway is not 
activated. These results suggest that this IRAKM-dependent pathway induced by low 
concentration of TLR ligands might contribute to the pathogenesis of ALD, since alcohol-
induced increases in gut permeability result in low concentrations of TLR ligands in the 
circulation and liver. One of TLR4-induced IRAKM-dependent genes was Mincle (a C-
type lectin receptor) that senses non-homeostatic cell death [52]. Spliceosome-associated 
protein (SAP) 130, which was identified as the endogenous ligand of Mincle, was released 
from hepatocytes after exposing to alcohol, while recombinant SAP130 was able to activate 
the inflammasome and IL-1 production in macrophages. Importantly, we found Mincle 
expression was induced in liver of ALD patients, as well as in mice after ethanol feeding. 
Induction of Mincle was ablated in liver of IRAKM-deficient mice and Mincle-deficient 
mice were protected from ethanol-induced liver injury, accompanied by reduced 
inflammasome activation and IL-1 production. Since Mincle is a sensor for cell death and 
its expression is IRAKM-dependent, these results suggest that TLR-induced IRAKM-
dependent Mincle up-regulation in macrophages provides a critical link between alcohol-
induced cell death and onset of inflammatory responses, contributing to the pathogenesis 
of ALD.  
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C. Results 
IRAKM is required for low concentration LPS-mediated NFκB activation 
IRAKM has been known as a negative regulator of innate immune response. Our 
recent studies showed that IRAKM also interacts with MyD88-IRAK4 to form an IRAKM 
Myddosome to mediate TLR-induced MEKK3-dependent second wave NFκB activation. 
In response to normal does LPS (1 µg/ml), MEKK3 modification and second wave of IκBα 
phosphorylation were ablated in IRAKM-deficient macrophages, whereas LPS-induced 
IRAK1 and TAK1 modification and IKKα/β phosphorylation were not affected ([153] and 
Fig. 22).  
 
 
 
Figure 22. IRAKM is required for late phase high dose LPS-mediated NFκB 
activation. Cell lysates from wild-type (WT) and IRAKM KO bone marrow-derived 
macrophages (BMDMs) untreated or treated with high dose LPS (1 µg/ml) for the indicated 
times were analyzed by Western blot analysis with antibodies against, MEKK3, p-IκBα, 
IκBα, and actin. 
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This IRAKM-dependent second wave of NFκB activation only induces expression 
of genes that are not regulated at the posttranscriptional levels (including inhibitory 
molecules SOCS-1, SHIP-1, A20 and IκBα), further exerting an overall inhibitory effect 
on inflammatory response.  
Interestingly, we now found that upon stimulation with low dose LPS (100pg-
1ng/ml versus 1ug/ml, the commonly used dosage), the IRAKM-MEKK3-dependent 
NFκB activation is the dominant pathway. In bone marrow derived macrophages (BMDMs) 
treated with low dose LPS (100pg/ml), IRAK1 modification/degradation and IKKα/β 
phosphorylation were not observed, accompanied by the typical of MEKK3-dependent 
NFκB activation, evident by IκBα phosphorylation without IκBa degradation. Importantly, 
IκBα phosphorylation and MEKK3 modification induced by low LPS were completely 
abolished in IRAKM-deficient cells (Fig. 23A). Based on these results, we hypothesized 
that IRAKM is dominantly activated to mediate the MEKK3-dependent NFκB activation, 
whereas IRAK1-TAK1-dependent pathway was not activated by low dose of LPS 
(100pg/ml). In support of this, we found that inflammatory genes CXCL1, TNFα and IL-6 
mRNA induction in response to low dose of LPS (100pg/ml) was not affected in IRAK1/2 
double KO macrophages, but greatly reduced in IRAKM-deficient cells (Fig. 23B). Thus, 
these data suggest that low-dose LPS preferentially induces the formation of IRAKM 
Myddosome, leading to MEKK3-dependent NFκB activation. 
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Figure 23. IRAKM is required for low dose LPS-mediated NFκB activation. A. Cell 
lysates from wild-type (WT) and IRAKM KO bone marrow-derived macrophages 
(BMDMs) untreated or treated with low dose LPS (100 pg/ml) for the indicated times were 
analyzed by Western blot analysis with antibodies against IRAK1, p-IKKα/β, MEKK3, p-
IκBα, IκBα, and actin. B. Total mRNAs from BMDMs of WT, IRAK1/2-DKO and 
IRAKM KO mice treated with low dose LPS (1μg/ml) for the indicated times, were 
subjected to RT-PCR analyses for the levels of CXCL1, IL-6 and TNFα expression. Data 
represent mean ± SEM; *, P<0.05. 
 
Low-dose LPS preferentially induces the formation of IRAKM Myddosome via the 
death domain of IRAKM 
One important question is how low dose LPS activates the IRAKM-MEKK3 
pathway. We previously reported that upon high dose ligand stimulation, the kinase activity 
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of IRAK4 is required for TLR-induced TAK1-, but not MEKK3-dependent NFκB 
activation [73, 132]. IRAK1 and its phosphorylation is required for TLR-induced TAK1-, 
but not MEKK3-dependent NFκB activation [150, 151]. These results suggest that high 
dose of LPS might lead to quick clustering/aggregation of the TLR-MyD88-IRAK4 
complex and activation of IRAK4, which then recruits and phosphorylates IRAK1 thereby 
stabilizing the IRAK1 Myddosome, leading to TAK1-dependent NFκB activation. In 
support of this, our recent study showed that IRAK4 dimerization is required for its 
autophosphorylation and activation of the kinase activity. Thus, we hypothesize that the 
formation of TLR4 receptor complex induced by low dose LPS may not trigger the 
aggregation of IRAK4, which can then only attract IRAKM, but not IRAK1, leading to 
specific formation of IRAKM Myddosome and subsequent MEKK3-dependent NFκB 
activation. We indeed found that upon low dose LPS stimulation (100pg/ml), IRAKM, but 
not IRAK1 was recruited to IRAK4-MyD88 complex, whereas both IRAK1 and IRAKM 
interacted with IRAK4 upon high dose LPS stimulation (1ug/ml) (Fig. 25A). Furthermore, 
compared to BMDMs from wild-type control mice, low dose LPS-induced MEKK3 
modification and NFκB  activation were not affected in IRAK4 kinase inactive knock-in 
macrophages (Fig. 24). Taken together, these data suggest that although IRAK4 kinase 
activity was required for recruiting IRAK1 to mediate TAK1-dependent NFκB activation, 
IRAKM-dependent MEKK3-mediated NFκB activation does not require IRAK4 kinase 
activity.  
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Figure 24. IRAK4 kinase activity is not required for low dose LPS-mediated NFκB 
activation. Cell lysates from wild-type (WT) and IRAK4 kinase activity dead knock in 
(IRAK4 KI) bone marrow-derived macrophages (BMDMs) untreated or treated with high 
dose LPS (100 pg/ml) for the indicated times were analyzed by Western blot analysis with 
antibodies against, MEKK3, p-IκBα, IκBα, and actin. 
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Figure 25. Low-dose LPS preferentially induces the formation of IRAKM 
Myddosome via the death domain of IRAKM. A. Wild-type BMDMs were treated with 
high dose LPS (1 µg/ml) and low dose LPS (100 pg/ml) for the indicated times, followed 
by immunoprecipitation (IP) with anti-IRAK-4 antibody and analyzed by Western blot 
analysis with antibody against IRAK1, IRAKM and MyD88. B-D. IRAK-1/2/M-triple 
deficient immortalized BMDMs infected with adenovirus expressing FLAG-tagged 
IRAK1, FLAG-tagged chimeric IRAKM death domain with IRAK1 kinase domain 
(DD(M)+IRAK1) and FLAG-tagged IRAKM were treated with low dose LPS (100 pg/ml) 
for indicated times. B. Cell lysates were analyzed by Western blot analysis with antibodies 
against FLAG, p-IκBα, IκBα, and actin. C. followeing by immunoprecipitation (IP) with 
anti-IRAK-4 antibody and analyzed by Western blot analysis with antibody against FLAG 
and MyD88. D. Total mRNAs were subjected to RT-PCR analyses for the levels of CXCL1, 
IL-6 and TNFα expression. Data represent mean ± SEM; *, P<0.05. 
 
 
 
To further elucidate the mechanism for the specific activation of IRAKM-MEKK3-
dependent pathway by low dose LPS, we compared IRAKM versus IRAK1 in their 
differential recruitment to the TLR-MyD88-IRAK4 complex. The crystal structure of 
Myddosome complex suggests the assembly of MyD88-IRAK4 with IRAK1, IRAK2 or 
IRAKM via the interaction of their death domains. We thus hypothesized that the 
specificity lies in the death domain of IRAKM versus IRAK1 in their formation of 
Myddosome in response to receptor activation by low versus high dose of ligands. To test 
this hypothesis, we generated a chimera protein by replacing the IRAK1 death domain with 
IRAKM death domain: DD(M)-IRAK1. Flag-tagged wild-type IRAK1, IRAKM, and 
DD(M)-IRAK1 in retroviral vectors were infected into IRAK1/2/M-TKO macrophages, 
followed by stimulation with low or high dose of LPS. We found that wild-type IRAKM 
and DD(M)-IRAK1 were able to interact with MyD88-IRAK4 and restore the low dose 
LPS-induced IκBα phosphorylation and gene expression, whereas wild-type IRAK1 failed 
to rescue the low dose LPS-mediated signaling (Fig. 25B-D). Taken together, our results 
suggest that the death domain of IRAKM is responsible for the specific recruitment to the 
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TLR-MyD88-IRAK4 complex in response to low dose LPS, leading to MEKK3-dependent 
NFκB activation.  
 
IRAKM-dependent pathway is required for the development of alcohol-induced liver 
disease 
Alcohol intake increases gut permeability, which allows accumulation of low levels 
of TLR ligands in the circulation and liver. The activation of hepatic macrophages (Kupffer 
cells) to portal endotoxin/LPS plays a key role in the early pathogenesis of ALD [115, 116, 
148, 154, 155]. Thus, we propose that engagement of IRAKM-dependent signaling might 
be the dominant TLR-activated pathway during the development of ALD. To test this 
hypothesis, we subjected female IRAKM-deficient and littermate control wild-type mice 
to chronic ethanol feeding via the Lieber-DeCarli liquid diet to model steatosis and mild 
inflammation. Briefly, the ethanol-fed group was allowed free access to an ethanol-
containing diet with increasing concentrations of ethanol as part of a complete liquid diet 
for 25 days. Control mice were pair-fed a diet that isocalorically substituted maltose dextrin 
for ethanol. Compared to pair-fed control mice, the alcohol-fed WT mice had significant 
increase in hepatocyte injury [assessed by serum aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT) levels, Fig. 26A], steatosis [lipid droplets in hepatocytes 
(H&E and oil red staining), Fig. 26B and D] and hepatic triglyceride levels (Fig. 26C). 
Compared to WT mice, IRAKM-deficient mice had attenuated alcohol-induced 
hepatocelullar injury as evident by reduced serum AST and ALT levels (Fig. 26A). Notably, 
hepatic steatosis and triglyceride levels in alcohol-fed IRAKM-deficient mice were also 
significantly decreased compared with those in WT mice (Fig. 26B-D). Moreover, IRAKM 
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deficiency prevented the alcohol-induced upregulation of TNF-α, IL-6, and MCP-1 mRNA 
in the liver of alcohol-fed mice (Fig. 26E). Taken together, these data support the crucial 
role of IRAKM in the pathogenesis of alcohol-induced inflammatory responses in the liver.  
 
Figure 26. IRAKM-dependent pathway is required for the development of alcohol-
induced liver disease. Wild-type and IRAKM KO mice were allowed free access to 
ethanol (EtOH) or pair-fed control diets. A. AST and ALT activity was determined in 
plasma. B. Paraffin-embedded liver sections were stained with hematoxylin and eosin. C. 
Hepatic triglyceride content was measured in whole liver homogenates. D. Frozen liver 
sections were subjected to Oil Red O staining. All images were acquired using a 10X 
objective. E. Total mRNAs from livers of WT and IRAKM KO mice (pair-fed and EtOH-
fed) were subjected to RT-PCR analysis for the levels of MCP1, TNFα and IL-6 and 
normalized to 18sRNA. Data represent mean ± SEM; *, P<0.05. 
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IRAKM is required for TLR-mediated Mincle expression  
The next question was how IRAKM-mediated pathway contributes to pathogenesis 
of ALD. Since low dose of LPS only induced minute amount of inflammatory cytokines 
and chemokines in wild-type BMDMs (Fig. III-6), we suspected that the impact of 
IRAKM on ALD might not due to its direct role in TLR-mediated inflammatory gene 
expression. Through a search for novel IRAKM-dependent genes, we found that Mincle, a 
sensor for cell death, is strongly induced by low does LPS, which was greatly reduced in 
IRAKM-deficient cells (Fig. 28A). It is important to note that the induction of Mincle 
mRNA was not affected in IRAK1/2 double deficient macrophages (data not shown). 
Similarly, low LPS-induced Mincle protein levels were not reduced in IRAK1/2-deficient 
cells, but greatly reduced in IRAKM-deficient macrophages, indicating that Mincle 
expression is mostly dependent on IRAKM (Fig. 28B and data not shown). We then 
examined the expression of Mincle in the liver tissue in pair-fed and alcohol-fed WT and 
IRAKM-deficient mice. Interestingly, by immune fluorescent staining, we found that 
Mincle expression was increased in the liver of alcohol-fed wild-type mice, which was co-
localized with liver resident macrophage marker F4/80 (Fig. 28C). Importantly, ethanol-
induced expression of Mincle was attenuated in IRAKM-deficient mice, implicating the 
potential importance of Mincle in IRAKM-mediated impact on ALD.  
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Figure 27. Low dose of LPS induced minute amount of inflammatory cytokines and 
chemokines production. Bone marrow-derived macrophages (BMDMs) were treated with 
high dose LPS (1 µg/ml) or low dose LPS (100 pg/ml) for 24 hours. Cell-free supernatants 
were collected and CXCL1, TNFα and IL-6 concentrations were measured by ELISA assay. 
Data represent mean ± SEM; *, P<0.05. 
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Figure 28.  IRAKM is required for TLR and alcohol-induced Mincle upregulation.  
A. Cell lysates from wild-type (WT) and IRAKM KO bone marrow-derived macrophages 
(BMDMs) untreated or treated with low dose LPS (100 pg/ml) for the indicated times were 
analyzed by Western blot analysis with antibodies against Mincle and actin. B. Cell lysates 
from wild-type (WT) and IRAK1/2 double knock out (IRAK1/2 DKO) bone marrow-
derived macrophages (BMDMs) untreated or treated with low dose LPS (100 pg/ml) for 
the indicated times were analyzed by Western blot analysis with antibodies against Mincle 
and actin.  C. Immunostaining of F4/80 (green) and Mincle (red) was performed on frozen 
sections of liver from of WT and IRAKM KO mice (pair-fed and EtOH-fed). Confocal 
images are representative of five mice per group. 
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Mincle-mediated pathway is required for the development of alcohol-induced liver 
disease 
Mincle was originally discovered based on its strong induction in macrophages by 
inflammatory stimuli, including TLR ligands [156]. One of the identified ligands for 
Mincle is spliceosome-associated protein (SAP) 130, a component of small nuclear 
ribonucloprotein, that diffuses out of dying cells, leading to onset of inflammation [52]. It 
is well documented that alcohol exposure induces endoplasmic reticulum (ER) stress and 
mitochondrial dysfunction in hepatocytes, which results in hepatocyte apoptosis and 
necrosis. Interestingly, upon challenge with ethanol and low dose LPS, hepatocytes 
released SAP130 to the culture media (Fig. 29A), implicating SAP130 as an endogenous 
ligand in the ALD model. Since Mincle expression was induced in myeloid cells in the 
liver of ethanol-fed mice in an IRAKM-dependent manner, we hypothesized TLR-induced 
IRAKM-dependent Mincle upregulation in liver resident macrophages provides a critical 
link between alcohol-induced cell death and onset of inflammation, contributing to the 
pathogenesis of ALD. To test this hypothesis, female Mincle-deficient and C57BL/6 mice 
were exposed to chronic ethanol feeding via the Lieber-DeCarli liquid diet, as described 
above. In contrast to wild-type control mice, Mincle-deficient mice had reduced alcohol-
induced hepatocyte injury and steatosis, demonstrated by the levels of ALT/AST in the 
plasma, lipid drops in the hepatocytes (H & E and oil red staining), and TG levels in the 
liver (Fig. 29B-E). Moreover, Mincle deficiency attenuated the upregulation of TNF-α, IL-
6, and MCP-1 in the liver of alcohol-fed mice, supporting the crucial role of Mincle in the 
pathogenesis of alcohol-induced inflammatory responses in the liver (Fig. 29F).  
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Figure 29. Mincle-dependent pathway is required for the development of alcohol-
induced liver disease. A. Primary hepatocytes from WT mice were treated with EtOH (50 
mM) with/without TNFα (30 ng/ml) for 24 hours. Cell-free supernatants were collected 
and SAP130 was measured by Western blot analysis with anti-SAP130 antibody. Band 
densities from three independent experiments were measured by ImageJ software and 
normalized to actin. Data represent mean ± SEM; *, P<0.05. Wild-type and Mincle KO 
mice were allowed free access to ethanol (EtOH) or pair-fed control diets. B. AST and 
ALT activity was determined in plasma. C. Paraffin-embedded liver sections were stained 
with hematoxylin and eosin. D. Hepatic triglyceride content was measured in whole liver 
homogenates. E. Frozen liver sections were subjected to Oil Red O staining. All images 
were acquired using a 10X objective. F. Total mRNAs from livers of WT and IRAKM KO 
mice (pair-fed and EtOH-fed) were subjected to RT-PCR analysis for the levels of MCP1, 
TNFα and IL-6 and normalized to 18sRNA. Data represent mean ± SEM; *, P<0.05. 
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SAP130-mediated Mincle activation is required for low concentration LPS induced 
inflammation through inflammasome activation 
Since Mincle plays a critical in the pathogenesis of ALD, we then aimed to 
investigate how Mincle exerts its impact on the disease process. In addition to necrotic cell 
ligands, fungal and mycobacterial ligands for Mincle have been identified. Mincle is 
essential for recognition of the mycobacterial cord factor and its synthetic analog 
Trehalose-Dibehenate (TDB) [157]. Interestingly, while TDB has been shown to activate 
NLRP3 inflammasome [158, 159], Dectin-1, another member of C-type lectin receptors, 
activates processing of IL-1β via a noncanonical caspase-8 inflammasome [160]. Since we 
detected SAP130 in the culture media of hepatocytes treated with alcohol (Fig. 29A), it 
suggests that SAP130 might be an endogenous ligand in the ALD model. Thus, we 
examined whether SAP130 can also engage Mincle for inflammasome activation. 
Importantly, recombinant SAP130 indeed induced caspase-1 cleavage and IL-1β 
production in macrophages primed with low dose LPS (to up-regulate Mincle), which were 
abolished in Mincle-, ASC- and NLRP3-deficient macrophages (Fig. 30A-B). These 
results suggest that Mincle activation in macrophages results in activation of ASC-
dependent inflammasomes.  
Importantly, recent studies have shown that mice deficient in inflammasome 
components (adaptor ASC and caspase 1) or IL-1R are protected from ALD [117]. 
However, it remains unclear how inflammasome is activated in the liver of alcohol-fed 
mice. Based on the ability of SAP130 in activation of inflammasome, we hypothesized that 
Mincle senses necrotic cells induced by alcohol and subsequently activates ASC-dependent 
inflammasome(s), leading to caspase1 activation and IL-1β production. Importantly, we 
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indeed detected increased caspase-1 activity (shown as cleaved caspase 1 and processed 
IL-1β) in the liver of ethanol-fed mice, which was much reduced in IRAKM- and Mincle-
deficient mice (Fig. 30C-D). Taken together, these results suggest that while low 
circulating LPS upregulates Mincle expression in macrophages/Kupffer cells in an 
IRAKM-dependent manner, SAP130 released from hepatocytes injured by ethanol triggers 
Mincle activation, leading to inflammasome activation and IL-1β production. 
87 
 
 
88 
 
Figure 30. SAP130-mediated mincle activation is required for low concentration LPS 
induced inflammation through inflammasome activation. A. BMDMs from WT and 
Mincle KO mice B. BMDMs from WT, NLRP3 KO  and ASC KO mice were treated with 
PBS (NT), LPS (100 pg/ml) for 24 hours (L), LPS (100 pg/ml, 24 hours) + SAP130 (5 
µg/ml, 6 hours) (LS) or LPS (100 pg/ml, 24 hours) + TDB (100 µg/ml, 6 hours).  Cell 
lysates and supernatants were collected together and were immunoblotted with the 
antibodies against caspase1, cleaved caspase1 (p20) and actin. Cell-free supernatants were 
collected and IL-1β was measured by ELISA. Data represent mean ± SEM; *, P<0.05. C. 
Tissue lysates from the whole liver of WT and IRAKM KO mice (pair-fed and EtOH-fed) 
were analyzed by Western blot analysis with antibodies against cleaved IL-1β, cleaved 
caspase1 (p20) and actin.  Band densities were measured by ImageJ software and 
normalized to actin. Data represent mean ± SEM; *, P<0.05. D. Tissue lysates from the 
whole liver of WT and Mincle KO mice (pair-fed and EtOH-fed) were analyzed by Western 
blot analysis with antibodies against cleaved IL-1β, cleaved caspase1 (p20) and actin.  
Band densities were measured by ImageJ software and normalized to actin. Data represent 
mean ± SEM; *, P<0.05.  
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D. Discussion 
Emerging evidence indicates that activation of innate immunity in response to 
alcohol exposure plays a key role in the development and progression of ALD [110-115, 
117, 154, 161-166]. Here we report a novel TLR4-IRAKM-dependent signaling pathway 
that contributes to the pathogenesis of ALD. While alcohol intake increases gut 
permeability and accumulation of low levels of LPS in the circulation and liver, we found 
that low dose of LPS preferentially induces the formation of IRAKM Myddosome, leading 
to MEKK3-dependent NFκB activation in macrophages. Importantly, this novel IRAKM-
dependent signaling pathway leads to inflammsome activation during ALD through the 
upregulation of Mincle, a sensor for cell death. While SAP130, the endogenous ligand of 
Mincle, was released from hepatocytes after exposing to alcohol, recombinant SAP130 
activated ASC-dependent inflammasomes and IL-1 production in macrophages (Fig. 31). 
Induction of Mincle was ablated in liver of IRAKM-deficient mice and Mincle deficiency 
protected mice from ethanol-induced liver injury, accompanied by reduced inflammasome 
activation and IL-1β production. These results suggest that IRAKM-Mincle axis might 
provide a critical link for the cross-talks between alcohol-induced cell damage and innate 
immune activation during the development and pathogenesis of ALD.  
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Figure 31.  IRAKM-Mincle axis contributes to the pathogenesis and development of 
ALD. Chronic alcohol exposure results in increased intestinal permeability and changes in 
bacterial microflora increase levels of bacterial products in alcoholic patients and animal 
models of ALD. Further, alcohol exposure can induce endoplasmic reticulum (ER) stress 
and mitochondrial dysfunction in hepatocytes, contributing to hepatocellular injury and 
death. TLR4- induced IRAKM-mediated MEKK3-dependent NFκB activation is required 
for the up-regulation of Minlce in hepatic macrophages. Mincle sense the necroptotic 
hepatocytes-released nuclear protein, SAP130, which in turn activates the inflammasome 
activation in macrophages. Secreted IL-1β may further act on hepatocytes inducing 
pyroptosis or on Stellate cells which leads to fibrosis.  
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While low levels of LPS were detected in alcoholic patients and alcohol-treated 
experimental animals, mice deficient in TLR4 showed reduced alcohol-induced liver 
diseases [111, 112, 115, 116, 161, 162, 166]. TLR4 has ability to activate two distinct 
pathways: MyD88-dependent and MyD88-independent. MyD88-dependent pathway is 
activated by the adaptors TIRAP and MyD88, which leads to activation of NF-kB and to 
the induction of inflammatory cytokines. The second pathway (MyD88-independent) is 
activated by adaptors TRIF and TRAM, which activates IRF3 to induce Type I interferons 
(IFNs), as well as NF-kB activation [26, 122]. The TLR4-induced MyD88-independent 
TRIF/IRF3-dependent cascade has been directly implicated in steatosis and inflammation 
in ALD [166]. However, it remains unclear how MyD88-dependent pathway participates 
and contributes to the development and pathogenesis of ALD. This is the first study to 
show that MyD88 downstream component IRAKM is required for development and 
pathogenesis of ALD. Although the IRAK4 kinase activity was not required for IRAKM-
dependent pathway, IRAK4 was recruited to MyD88 upon low dose LPS stimulation, 
which in turn recruits IRAKM for the formation of IRAKM Myddosome. Thus, IRAK4 
probably functions as a structural protein in the IRAKM pathway. One important question 
is how the IRAKM Myddosome activates MEKK3. Since IRAKM does not have kinase 
activity, it is possible that MEKK3 is recruited to the IRAKM Myddosome for its activation, 
leading to the phosphorylation of IRAKM and consequent release of IRAKM-MEKK3 
from the receptor complex to activate the IκB kinase complex for NFκB activation. Future 
studies are required to elucidate the IRAKM-MEKK3 NFκB activation mechanism.  
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IRAKM is well known as a negative regulator of inflammatory response during acute 
inflammation. Our previous study shows that IRAKM is capable to form Myddosome 
complex with MyD88 and IRAK4 in response to TLR ligands stimulation as IRAK1/2. 
IRAKM Myddosome is required for late phase NFκB activation through MEKK3 
dependent pathway. This IRAKM-dependent pathway only induces expression of genes 
that are not regulated at the posttranscriptional levels (including inhibitory molecules 
SOCS-1, SHIP-1, A20 and IκBα), exerting an overall inhibitory effect on inflammatory 
response. Further, IRAKM specifically interacts with IRAK2, but not IRAK1, to suppress 
TLR-induced IRAK2 mediated translation of cytokines and chemokines [153]. Overall, 
IRAKM functions as suppressor of inflammation during infectious diseases and is required 
for the homeostasis.  However, the role of IRAKM in low level chronic diseases has not 
been reported. In this paper, our data suggests that TLR4-induced IRAKM Myddosome 
dependent pathway plays as pathogenic role in ALD. Further biochemical analysis suggests 
that IRAKM-dependent MEKK3-mediated NFκB activation does not require IRAK4 
kinase activity. The death domain of IRAKM is responsible for the specific recruitment to 
the TLR-MyD88-IRAK4 complex in response to low dose LPS, leading to MEKK3-
dependent NFκB activation. 
Since IRAK1 is not activated upon low dose LPS stimulation, we do not anticipate 
IRAK1 to be part of the receptor complex for the IRAKM pathway. We expect the death 
domain determines the specific recruitment of IRAKM the receptor complex induced by 
low dose ligands. Thus, we predict DD(M)-IRAK1, but not DD(1)-IRAKM, will restore 
TLR signaling in response to low dose TLR ligands.  
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Next important question we asked is that how IRAKM-dependent pathway 
mediates the pathogenesis of ALD. Since low dose of LPS only induced minute amount of 
inflammatory cytokines and chemokines in wild-type BMDMs, we suspect that the impact 
of IRAKM on ALD might not due to its direct role in TLR-mediated inflammatory gene 
expression. Through a search for novel IRAKM-dependent genes, we found that Mincle, a 
sensor for cell death, is strongly induced by low does LPS, which was greatly reduced in 
IRAKM-deficient cells. Mincle, a member of C-type lectin receptor, was discovered 
because it is strongly induced in macrophages by inflammatory stimuli, including TLR 
ligands [156]. Mincle-mediated pathway is critical for anti-fungal and anti-mycobacterial 
immune response [46, 51, 167, 168]. Recent study found that Mincle functions as a sensor 
non-homeostatic cell death which leads to sterile inflammation. Spliceosome-associated 
protein (SAP)130 was identified as the endogenous ligand that was recognized by Mincle 
following necrotic cell death [52]. In this study, we found that TLR-induced Mincle 
expression is dependent on IRAKM in BMDMs. Also, the upregulation of Mincle is also 
found in the liver of wild-type alcohol-fed mice and ablated in IRAKM deficient mice. 
Consistently, the alcohol-fed Mincle deficient mice also had significant decrease in 
hepatocyte injury, steatosis and liver inflammation levels. 
Fungal, mycobacterial and necrotic cell ligands for Mincle have been identified, 
implicating this receptor in anti-microbial immunity and homeostasis. Mincle is essential 
for recognition of the mycobacterial cord factor and its synthetic analog Trehalose-
Dibehenate (TDB) [157, 168, 169]. Interestingly, TDB has been shown to be able to 
activate NLRP3 inflammasome [158]. Further, Dectin-1, another member of C-type lectin 
receptors, is also able to activate processing of IL-1β via a noncanonical caspase-8 
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inflammasome [160]. Recent studies have shown that mice deficient in inflammasome 
components or IL-1R are protected from ALD [117]. However, how inflammasome gets 
activated in the alcohol-fed liver is still unclear. In this study, we found SAP130 is also 
capable to activate caspase-1 inflammasome in BMDMs. Alcohol-feeding induced 
caspase-1 and IL-1β activation was also decreased in the liver of IRAKM and Mincle 
deficient mice. However, how Mincle-mediated pathway activates inflammasome in 
cooperating with low dose LPS is still not unclear. This will be the future direction of this 
study.  
Overall, here we first report that IRAKM-dependent pathway induced by low 
concentration of TLR ligands contributes to the pathogenesis of ALD by upregulating 
Mincle expression in hepatic macrophages. Activation of Minlce-mediated pathway by 
sensing SAP130 which released from necrotic hepatocytes leads to further liver 
inflammation through inflammasome activation. It provides a novel mechanistic insight of 
ALD and may be crucial for future pharmaceutical target design.    
 
E. Materials and Methods 
Biological reagents and cell culture—LPS (Escherichia coli 055:B5) and ATP 
(A2383) were purchased from Sigma-Aldrich. TDB was purchased from Invivogen. 
Antibodies against phosphorylated IκB(Ser32/S36), JNK, IKK/(Ser176/180), and total 
IκB were purchased from Cell signaling. Antibody to IRAK-4 was purchased from Enzo 
Life Science. Antibody to FLAG (anti-FLAG) and hemagglutinin (anti-HA) were 
purchased from Sigma-Aldrich. Antibody to MEKK3 was purchased from BD Bio-
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sciences Pharmingen. Antibodies against IRAK1, TAK1 and Actin were from Santa Cruz 
Biotechnologies. Anti-IL-1β antibody (3ZD) was obtained from the Biological Resources 
Branch of the NIH. Anti-caspase-1 (p20) antibody was generated as previously described 
by L. Franchi and G. Nunez [170]. Anti-Mincle antibodies were generated as previously 
describes [52, 167].V5-tagged recombinant SAP130 was overexpressed in HEK-293 cells 
and purified as previously described [52]. Bone-marrow derived macrophages were 
obtained from the bone marrow of tibia and femur by flushing with DMEM. The cells were 
cultured in DMEM supplemented with 20% fetal bovine serum (FBS), penicillin G (100 
µg/ml), and streptomycin (100 µg/ml), and 30% L929 supernatant for 5 days. 
Plasmids and retroviruses—Mouse IRAKM and IRAK1 cDNA were purchased 
from Open Biosystems. IRAK1/IRAKM chimeric constructs were generated by 
overlapping PCR.  The wild-type IRAK1, IRAKM and IRAK1/IRAKM chimeric mutant 
were cloned into pMX retroviral expression vector and transfected into phoenix cell for 
viral packaging. Immortalized IRAK1/2/3 triple deficient BMDMs were infected by the 
packaged retrovirus for 3 days and selected by puromycin (2μg/ml) for 2days for stable 
viral integration. For all PCR reactions high fidelity Pfu Turbo polymerase was used 
(Stratagene).   
Immunoblotting—Cell were harvested and lysed in a Triton-containing lysis 
buffer (0.5% Triton X-100, 20 mM HEPES (pH 7.4), 150 mM NaCl, 12.5 mM -
glycerophosphate, 1.5 mM MgCl2, 10 mM NaF, 2 mM dithiothreitol, 1 mM sodium 
orthovanadate, 2mM EGTA, 1 mM phenylmethylsulfonyl fluoride and complete protease 
inhibitor cocktail from Roche). Cell lysates were then separated by 10% SDS-PAGE, 
transferred to Immobilon-P membranes (Millipore), and subjected to immunoblotting. 
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Quantitative real-time PCR—Total RNA was isolated using TRIzol reagent 
(Invitrogen). 3μg of total RNA was then used for reverse transcription reaction using 
SuperScript-reverse transcriptase (Invitrogen). Q-PCR was performed in AB 7300 
RealTime PCR System, and the gene expression of mouse CXCL1 (KC), TNFα, IL-6, 
MCP-1 Mincle, 18s RNA and β-actin was examined by SYBR® GREEN PCR Master Mix 
(Applied Biosystems). PCR amplification was performed in triplicate, and water was used 
to replace cDNA in each run as a negative control.  The reaction protocol included pre-
incubation at 95°C to activate FastStart DNA polymerase for 10 min, amplification of 40 
cycles that was set for 15 s at 95°C, and annealing for 60 s at 60°C. The results were 
normalized with the housekeeping gene β-actin or 18s RNA. Primer sequences were 
designed using AlleleID 6.0. The following primers were used: mouse TNFα forward, 
CAAAGGGAGAGTGGTCAGGT; mouse TNFα reverse, 
ATTGCACCTCAGGGAAGAGT; mouse actin forward, 
GGTCATCACTATTGGCAACG; mouse actin reverse, 
ACGGATGTCAACGTCACACT; mouse CXCL1 forward, 
TAGGGTGAGGACATGTGTGG; mouse CXCL1 reverse, 
AAATGTCCAAGGGAAGCGT; mouse IL-6 forward, 
GGACCAAGACCATCCAATTC; mouse IL-6 reverse, 
ACCACAGTGAGGAATGTCCA. 
ELISA assay—Supernatants from cell cultures were collected and measured for 
the level of mouse cytokines IL-1β, CXCL1, IL-6 and TNFα using Duoset ELISA kits 
(R&D system) according to manufacturer’s instructions. 
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Mouse models and samples collection— IRAKM KO and Mincle deficient mice 
were previously described [52, 128].  All procedures using animals were approved by the 
Cleveland Clinic Institutional Animal Care and Use Committee. Female mice were housed 
in shoe-box cages (2 animals/cage) with microisolator lids. Standard microisolator 
handling procedures were used throughout the study. Mice were age-matched, randomized 
into ethanol-fed and pair-fed groups and then adapted to a control liquid diet for 2 days. 
The ethanol-fed groups were allowed free access to an ethanol containing diet. Control 
mice were pair-fed a control diet which iso-calorically substituted maltose dextrins for 
ethanol over the entire feeding period. Chronic ethanol-induced liver injury: 1% (vol/vol) 
ethanol for 2 days followed by 2% ethanol (11% of total calories) for 2 days, 4% ethanol 
for 1 week, 5% ethanol for 1 week followed by 6% ethanol for the final week . Sample 
collection: At the end of the feeding protocols, mice were anesthetized, blood samples 
taken into non-heparinized syringes from the posterior vena cava and livers excised. 
Portions of each liver were then either fixed in formalin or frozen in optimal cutting 
temperature (OCT) compound (Sakura Finetek U.S.A. Inc.) for histology, frozen in 
RNAlater (Qiagen) or flash frozen in liquid nitrogen and stored at -80°C until further 
analysis.  Blood was transferred to EDTA-containing tubes for the isolation of plasma.  
Plasma was then stored at -80°C. Histopathology and immunohistochemistry of mouse 
liver: Formalin-fixed tissues were paraffin-embedded, sectioned, coded and stained with 
hematoxylin and eosin.  Frozen liver sections were used for staining F4/80 and Mincle. All 
images presented in the results are representative of at least 3 images per liver and 4 mice 
per experimental condition 
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ALT/AST and triglyceride measurement—Plasma samples were assayed for 
alanine aminotransferase (ALT) and aspartate aminotransferase (AST) using commercially 
available enzymatic assay kits (Diagnostic Chemicals) following the manufacturer’s 
instructions. Total hepatic triglycerides were assayed using the Triglyceride Reagent Kit 
from Pointe Scientific Inc. (Lincoln Park, MI). 
Inflammasome activation—BMDMs were plated in 6-well plates at a 
concentration of 2.0 X 106 cells per well the day before the experiment. The day of the 
experiment, cells were primed with low concentration of LPS (100 pg/ml), SAP130 (10 
µg/ml) or TDB (10 µg/ml) for the indicated time. Medium was then supplemented with 
ATP (5 mM) for indicated time points. For all experiments, cell-free supernatant was then 
either collected for ELISA analysis, or cell lysates and supernatants were collected together 
for immunoblotting by the addition of 1% Nonidet-P40 supplemented with complete 
protease inhibitor ‘cocktail’ (Roche) and 2 mM dithiothreitol directly to the well. Cells 
were scraped and lysed on ice for 30 minutes, then spun at 13,000 rpm. Protein 
concentration was measured. 4X Laemlli buffer was then added, samples were boiled and 
approximately 20 µg of sample was run on a 12% or 15% SDS-PAGE gel. 
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CHAPTER IV 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
With these studies, we have uncovered dual roles for IRAKM in TLR signaling 
pathways. First, during acute inflammation, IRAKM functions as an important negative 
regulator of inflammation. It forms an IRAKM Myddosome complex with MyD88-IRAK4 
complex similar to IRAK1/2 myddosome. IRAKM Myddosome is required for the late 
phase TLR-induced NFκB activation. This IRAKM Myddosome mediated TLR-induced 
NFκB activation through TAK1-independent MEKK3-dependent pathway only induces 
expression of genes that are not regulated at the posttranscriptional levels (including 
inhibitory molecules SOCS-1, SHIP-1, A20 and IκBα), exerting an overall inhibitory effect 
on inflammatory response. Further, IRAKM specifically interacts with IRAK2, but not 
IRAK1, and suppresses TLR-induced IRAK2-mediated translation of cytokines and 
chemokines.  
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Second, in low grade inflammation scenario, we found that IRAKM-dependent 
pathway is required for low dose TLR4 ligand-induced NFκB activation. Biochemical 
studies suggested low dose LPS-induced IRAKM-dependent NFκB activation is 
independent of IRAK4 kinase activity and the death domain of IRAKM is responsible for 
the specific recruitment to the TLR-MyD88-IRAK4 complex in response to low dose LPS. 
Ex-vivo experiments showed low dose of LPS only induced minute amounts of 
inflammatory cytokines and chemokines in wild-type BMDMs. IRAKM-deficient mice 
were protected from alcohol-induced liver injury. Through our analysis of low dose LPS-
induced IRAKM-dependent gene expression, we found a novel IRAKM dependent gene 
known as Mincle. As a sensor of cell death, Mincle is highly up-regulated upon low dose 
LPS stimulation which is dependent on IRAKM. Mincle deficient mice were also protected 
from alcohol-induced liver injury. Spliceosome-associated protein (SAP) 130 was 
identified as the endogenous ligand that was recognized by Mincle following necrotic cell 
death. Ex vivo studies showed that both IRAKM and Mincle are required for alcohol-
feeding-induced inflammasome activation in the liver.  Taken together, this study identifies 
an IRAKM-Mincle axis is critical for the pathogenesis of alcohol induced liver disease 
through the activation of inflammasome.
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A. The Role of IRAKM in Acute Inflammation 
IRAKM, also named as IRAK3, was identified in 1999, as an indispensable element 
of LPS-mediated signaling transduction [123]. It was found mainly expressed in cells of 
monomyeloic origin and was, therefore, designated IRAKM. Following studies with 
IRAKM deficient mice and cells suggest that IRAKM functions as a negative regulator of 
TLR signaling. Since IRAKM expression is induced by TLR ligands stimulation, it was 
thought to be a key component of a feedback regulatory system of innate immunity [128]. 
IRAKM deficient mice showed increased inflammatory cytokines and chemokines 
production or bacterial clearance, compared to wild-type control mice. IRAKM was shown 
to be required for endotoxin tolerance. On the molecular level, previous studies suggest 
that IRAKM prevents the dissociation of IRAKs from the adaptor MyD88, therefore, 
suppresses downstream signaling transduction. However, there has not been sufficient 
experimental evidences to support this. In our study, we provide two novel mechanisms 
for the regulatory role of IRAKM in TLR signaling.  
IRAKM Myddosome 
Myd88, an intracellular TIR domain containing protein, is utilized by IL-1R and all 
TLRs as an adaptor molecule except for TLR3. It contains an N-terminal death domain 
(DD) and a short intermediate domain (ID) [26, 122, 125, 171]. Through the DD, MyD88 
interacts with IRAKs, a group of receptor proximal Ser/Ther kinases including IRAK1, 
IRAK2, IRAKM and IRAK4. All of the IRAKs, except IRAK4, contain a TRAF binding 
site at C-terminal motif which is required for binding to TRAF6 and subsequent NFκB 
activation through the TAK1-IKK complex. Recent crystal structure study reveals that 6 
MyD88 DDs, 4 IRAK4 DDs and 4 IRAK2 DDs form a left-handed helical complex [127]. 
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This helical signaling complex is referred as Myddosome complex and its assembly is 
sequential, in which MyD88 recruits IRAK-4 and the MyD88-IRAK4 complex recruits 
IRAK2 or the related IRAK1.   
Our data suggested that IRAKM is also able to form a Myddosome complex with 
MyD88 and IRAK4, as IRAK1 and IRAK2. The DD of IRAKM shares a considerable 
sequence homology with IRAK2. By computational modeling, IRAKM DD has the 
capacity to dock to MyD88-IRAK4 complex to form a relatively stable complex. Detailed 
analysis suggested that IRAK4 binding residues with IRAK2 are highly conserved in 
IRAKM DD. E71, W74 and Q78 in IRAKM DD were suggested to be critical for binding 
with IRAK4 DD. By site-specific mutagenesis, we confirmed this TLR-induced binding 
interface between IRAK4 and IRAKM DD. Following functional tests, we confirmed the 
formation of IRAKM Myddosome complex is required for IRAKM-mediated signaling 
transduction. 
A recent study from Dr. Hao Wu’s group (the same group which resolved 
Myddosome crystal structure complex) indicates that formation of IRAK4 kinase domain 
(KD) dimers in Myddsosome complex is required for proximity-driven dimerization and 
activation of IRAK4 kinase activity. Our study indicated that IRAK1/2-mediated pathway 
is dependent on IRAK4 kinase activity, while IRAKM-mediated pathway is independent 
of IRAK4 kinase activity. Therefore, it is possible that IRAKM Myddosome complex may 
have a different structure with IRAK2 Myddosome. Future structural study on IRAKM 
Myddosome will be required to test this possibility.  
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 TLR-induced IRAKM-mediated MEKK3-dependent NFκB activation  
The previous work from our lab uncovered two parallel TLR/IL-1R-mediated 
NFκB activation pathways: TAK1-dependent and MEKK3-dependent, respectively. 
IRAK4 kinase activity and IRAK1 are required for TAK1-dependent pathway which leads 
to IKKα/β phosphorylation and IKKγ activation, resulting in NFκB activation through 
IκBα phosphorylation and degradation. The MEKK3-dependent pathway involves IKKα 
activation and IKKγ phosphorylation, which only leads to IκBα phosphorylation without 
degradation [65, 73, 129, 150, 151]. 
In this study, we found that IRAKM is required for TAK1-independent MEKK3-
pathway. In response to TLR ligand simulation, IRAKM specifically interacts with 
MEKK3, not TAK1, through TRAF6, resulting in the phosphorylation of IKKγ and 
activation of IKKα. Furthermore, IRAK4 kinase activity is not required for IRAKM-
mediated MEKK3 dependent pathway. One important question here is how the IRAKM 
Myddosome activates MEKK3. In regards to this question, testing whether IRAKM has 
kinase activity certainly warrants future study. 
IRAKM has been considered to be a member of the pseudokinase family. 
Overexpression of IRAKM in HEK 293 cells did not lead to robust autophosphorylation 
as IRAK1 in in vitro kinase assay, rather an extremely weak autophosphorylation was 
observed [123]. Structurally, IRAKM lacks an aspartic acid residue in HRD motif in the 
catalytic loop which is crucial for the kinase activity. Interestingly, it was reported that 
murine IRAKM does has a weak but detectable autophosphorylation in in vitro kinase 
assay [172]. However, there was not enough experimental evidence to support this. Further 
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detailed biochemical study is required to define whether IRAKM has kinase activity or not 
and the potential role in IL-1R/TLR signaling.  
Since IRAKM interacts with MEKK3, another possible scenario is that MEKK3 
may directly phosphorylate IRAKM, leading to the activation of IRAKM and consequent 
release of IRAKM-MEKK3 from the receptor complex. This will be the future direction to 
study IRAKM-mediated MEKK3-dependent signaling pathway. 
Post-translational modification of IRAKM  
Among the four members of IRAK family, IRAK1 is the most characterized. Upon 
IL-1 or TLR ligands stimulation, IRAK1 is phosphorylated, ubiquitinated and degraded. 
Also it has been reported that IRAK1 may also undergo sumoylation besides 
phosphorylation and ubiquitination in TLR signaling. IRAK1, through Lysine 48 and 
Lysine K63-mediated ubiquination, is mediated by the E3 ligase β-TRCP and Pellino2, 
respectively [150, 151].  Recent study suggests that IRAK2 also undergoes 
phosphorylation and ubiquitination upon TLR ligand stimulation [173]. However, there is 
no report has been published on IRAKM modification. An ongoing project in our lab aims 
to find the phosphorylation sites of IRAKM in response to LPS treatment by mass 
spectroscopy analysis.  
IRAKM-dependent second wave of NFκB activation and gene expression 
In the absence of IRAK1 and IRAK2 (in IRAK 1/2 double-deficient cells), IRAKM 
is able to mediate prompt TLR-induced NFκB activation. This only indicates IRAKM 
Myddosome has the capability to activate NFκB. To further determine its physiological 
significance, we re-investigated TLR-induced NFκB activation in IRAKM single deficient 
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cells. Surprisingly, the late phase of TLR7-induced late phase NFκB activation was 
decreased in IRAKM deficient cells.   
By analyzing pro-inflammatory genes expression and protein production, we found 
that, although TLR-induced IRAKM-mediated signaling in IRAK1/2 double deficient cells 
can mediate the induction of mRNAs expression of pro-inflammatory genes in early time 
points, the protein production was total abolished. It suggests that IRAKM-mediated 
pathway alone is not sufficient to induce the production of cytokines and chemokines. This 
phenomenon indicates the critical role of TLR-induced IRAK1/2-dependent post-
transcriptional regulation in innate immune response.  
Our previous study about the role of IRAK4 kinase activity in TLR-induced gene 
expression identified a group of genes which are not regulated on post-transcriptional 
levels [73]. Consistently, the expression of these genes was also substantially reduced in 
IRAKM deficient cells compared to that in wild-type cells. Several of the genes are 
important for the activation and homeostasis of the macrophages (including ETS2, SOD2, 
Bcl-2A1D and GPR84) Interestingly, we found another group of IRAK-M-dependent 
genes including A20, SOCS1, SHIP1 and IκBα. These molecules are all well-known 
inhibitory molecules of inflammation. They not only negatively regulate TLR-mediated 
signaling pathway, but also control other critical inflammation-related signaling pathways, 
such as JAK-STAT pathways, TNFα-activated pathway, PI3K-Akt pathway [174-177]. 
This study provided a novel mechanism which IRAKM exerts an overall inhibitory effect 
in acute inflammatory response through producing inhibitory molecules as feedback 
regulation system. The advantage for such an inhibitory mechanism could be that IRAKM 
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may exert broader inhibitory effects not just on TLR/IL-1R but also on other cytokine 
signaling cascades, so that the inflammatory response can be effectively controlled.    
The gene expression data were consistent with the role of IRAK-M in TLR7-
induced second wave NFκB activation, since most of the IRAK-M-dependent genes were 
late genes (induced after 1 hour). However, it is still mysterious why IRAKM-MEKK3 
pathway is important for the late phase NFκB activation and gene expression. One possible 
answer is that IRAK1 is phosphorylated, ubiquinated and degraded upon TLR ligand 
stimulation, while IRAKM expression is induced upon treatment. Only IRAKM is left at 
late time points at which mediates second wave NKκB activation. Future detailed studies 
on the dynamic and kinetic change of IRAK family members and their roles in TLR 
signaling need to done to solve this question.  
IRAKM suppresses IRAK2-mediated translational regulation  
Previous studies from our lab found that IRAK-2 plays an important role in the 
regulation of TLR-mediated protein translation of cytokines and chemokines, including IL-
6, CXCL1 (KC) and TNFα. Although the mRNAs of these pro-inflammatory genes were 
induced at similar or reduced levels in IRAKM deficient BMDMs, their protein production 
were actually increased in the IRAKM deficient cells. Based on these observations we 
investigated the role of IRAK-M in the regulation of cytokine and chemokine translation. 
By poly-ribosome fractionation experiments, we determined that the translational 
efficiency of these genes were increased in the absence of IRAKM. Through co-
immunoprecipitation experiments, we found that IRAKM specifically interacts with 
IRAK2, not IRAK1. Therefore, we proposed that IRAKM suppress the pro-inflammatory 
cytokines and chemokines production through the interaction with IRAK2. However, it is 
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still unclear how IRAKM interacts with IRAK2 and inhibit its ability to mediate protein 
translation. Future studies are needed to detail the molecular mechanism of IRAK2-
mediated post-transcriptional control of pro-inflammatory genes and how IRAKM binds 
to and regulates IRAK2.    
 
B. The Role of IRAKM in Low Grade Inflammation 
It has been reported that IRAKM deficient macrophages/dendritic cells produce 
more cytokines and chemokines compared to wild-type control cells in response to high 
dose TLR agonists. Furthermore IRAKM expression in myeloid lineage cells is known to 
impair host defense during infection. Infection or sepsis can induce IRAKM expression 
which functions as negative feedback regulation of immune response.  This is an important 
mechanism which prevent sepsis-induced septic shock. However, the role of IRAKM in 
low-grade inflammatory diseases has not been reported before, to the best of our 
knowledge.  
High-grade inflammation versus low-grade inflammation 
High-level endotoxemia in human or experimental animals induces a robust, but 
transient immune response. Both pro- and anti-inflammatory mediators are activated, 
providing a compensatory mechanism to resolve inflammation and prevent further 
damages. This is an important and strict regulatory mechanism to maintain host 
homeostasis. Emerging evidence suggests that low-level endotoxemia-induced low-grade 
inflammation plays a crucial role during the pathogenesis and development of in several 
different chronic diseases. High-level endotoxemia-induced robust acute inflammation, 
low-level endotoxemia-mediated mild but persist chronic inflammation. However, the 
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molecular mechanisms of this persistent low-grade inflammation are still poorly 
understood.  
With our studies, we provide new mechanistic insight of low-grade chronic 
inflammation. IRAKM-mediated pathway is crucial for low-dose TLR ligand-induced pro-
inflammatory gene expression. Inflammation can be further amplified by IRAKM-
dependent Mincle expression on macrophages which can sense cell death. Mincle 
expression is very low in resting cells. It is highly induced in response to different cell 
stresses or danger signals, including TLR ligands. Recent study identified dead cell-
released SAP130, a nuclear protein, as the endogenous ligand for Mincle. Activation of 
Mincle signaling leads to cytokine and chemokine production and neutrophils infiltration. 
A recent study suggests that low-dose LPS treatment can lead to mitochondria dysfunction 
and cell necroptosis. Here we provide a direct evidence linking un-regulated cell death to 
inflammation. Also it provides a new angle to study chronic inflammatory disease.  
Alcohol induced liver disease and inflammasome activation  
 The pathogenesis of ALD is multifactorial and current studies suggest that the 
damage is the end result of the interplay among ethanol metabolism, inflammation and 
innate immunity. TLR4 mediated TLR signaling activation has been shown to be critical 
during the initiation and development of ALD. TLR4 has ability to activate two distinct 
pathways: MyD88-dependent and MyD88-independent. MyD88-dependent pathway is 
activated by the adaptors TIRAP and MyD88, which leads to activation of NFκB and to 
the induction of inflammatory cytokines. The second pathway (MyD88-independent) is 
activated by adaptors TRIF and TRAM, which activates IRF3 to induce Type I interferons 
(IFNs), as well as NFκB activation. The TLR4-induced MyD88-independent TRIF/IRF3-
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dependent cascade has been directly implicated in steatosis and inflammation in ALD. It is 
important to note that IL-1R, which exclusively signals through the MyD88 pathway, is 
required for ALD pathogenesis. However, it remains unclear how the MyD88-dependent 
pathway participates and contributes to the development and pathogenesis of ALD. Here 
our preliminary studies identify that downstream signaling components of MyD88, the 
IRAKM proteins, play a critical role in the development and pathogenesis of ALD. It has 
also been reported that inflammasome activation was observed in the liver from alcohol-
fed mice. Mice deficient in inflammasome components or IL-1R are protected from ALD. 
However, how inflammasome gets activated in the alcohol-fed liver is still unclear. In this 
study, we found SAP130 is also capable to activate caspase-1 inflammasome in BMDMs. 
Alcohol-feeding induced caspase-1 and IL-1β activation was also decreased in the liver of 
IRAKM and Mincle deficient mice. However, how Mincle-mediated pathway activates 
inflammasome in cooperating with low dose LPS is still not unclear. This will be the future 
direction of this study. 
  
C. IRAKM as a Target for Drug Development 
Dysregulated immune responses are involved in many chronic diseases, such as 
inflammatory bowel disease, atherosclerosis, rheumatoid arthritis and autism. TLR-
mediated inflammatory responses are suggested to be involved in the pathogenesis of some 
of these diseases. Therefore, suppression of the inflammatory response mediated by TLRs 
would be a direct and efficient treatment for these diseases. However, considering the 
critical function of TLR-mediated signaling in innate immune response, the side effects of 
such treatment might be detrimental and lead to susceptible to infection.  The observation 
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that IRAKM deficiency leads to increased pro-inflammatory cytokine and chemokine 
production during acute inflammation. While our study indicates that IRAKM-mediated 
MEKK3-dependent pathway is crucial in low-grade inflammation. IRAKM may be a better 
drug targets than other IRAKs in preventing chronic inflammation.   
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A. Abstract 
Low grade systemic inflammation is often associated with metabolic syndrome 
which plays a critical role in the development of the obesity-associated inflammatory 
diseases including insulin resistance and atherosclerosis. Here we investigate how TLR-
MyD88 signaling in myeloid and endothelial cells coordinately participates in the initiation 
and progression of high fat diet-induced systemic inflammation and metabolic 
inflammatory diseases. MyD88 deficiency in myeloid cells inhibits macrophage 
recruitment to adipose tissue and their switch to an M1-like phenotype. This is 
accompanied by substantially reduced diet-induced systemic inflammation, insulin 
resistance, and atherosclerosis. MyD88 deficiency in endothelial cells results in a moderate 
reduction in diet-induced adipose macrophage infiltration and M1 polarization, selective 
insulin sensitivity in adipose tissue, and amelioration of spontaneous atherosclerosis. Both 
in vivo and ex vivo studies suggest that MyD88-dependent GM-CSF production from the 
endothelial cells might play a critical role in the initiation of obesity-associated 
inflammation and development of atherosclerosis by priming the monocytes in the adipose 
and arterial tissues to differentiate into M1-like inflammatory macrophages. Taken 
together, these results implicate a critical MyD88-dependent interplay between myeloid 
and endothelial cells in the initiation and progression of obesity-associated inflammatory 
diseases. 
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B. Introduction 
The metabolic syndrome is characterized by a cluster of physiological alterations 
including glucose intolerance/insulin resistance, abdominal obesity, atherogenic 
dyslipidemia (low concentration of plasma high-density lipoprotein cholesterol and high 
concentration of plasma triglycerides), and elevated blood pressure. Occurring together, 
these conditions increase the risk for atherosclerosis and type 2 diabetes mellitus (T2DM), 
which are typical obesity-associated diseases that are endemic in developed countries, 
currently affecting 25% of the population and growing [178]. Recent investigations have 
increasingly shown that low grade systemic inflammation is often associated with 
metabolic syndrome, which probably plays a critical role in the development of these 
metabolic diseases [179-182]. Previous studies have shown that a high fat diet (HFD) can 
increase the gut permeability, triggering the accumulation of systemic inflammatory 
stimuli [183], including pathogen-associated molecular patterns (PAMPs), such as ligands 
for Toll-like receptors (TLRs), endogenous TLR ligands such as fatty acids and 
inflammatory cytokines, including Interleukin-1 (IL-1) [184-189]. Although inflammation 
is generally considered to be a localized reaction, it is now understood that a “systemic 
inflammatory response” can occur when inflammatory stimuli gain access to the circulation 
[180]. 
Genetic studies and mouse disease models have shown the participation of TLR 
and IL-1R in the development of HFD-induced systemic inflammation and obesity-
associated inflammatory diseases. TLR4 deficiency reduced diet-induced insulin resistance 
and systemic inflammation [189], while TLR2-deficient mice were partially protected from 
diet-induced obesity [190]. Human TLR4 null mutations are associated with reduced risk 
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of atherosclerosis [191]. ApoE-/- mice, a commonly used model, spontaneously develop 
atherosclerosis; deficiency in TLR4, IL-1 and IL-1R each reduced vascular inflammation 
and atherosclerosis in ApoE-/- mice [192-195]. These previous studies suggested that 
exogenous/endogenous TLR ligands and the pro-inflammatory cytokine IL-1 can activate 
IL-1R/TLRs in multiple tissues including adipose, liver, pancreas, aorta, heart and muscle. 
As a consequence, a chronic systemic inflammatory response is established which is 
strongly associated with the development of type II diabetes and atherosclerosis [183, 196, 
197]. Much effort has been devoted towards the understanding of IL-1R/TLR-mediated 
signaling mechanisms, with the long-term objective to identify new therapeutic targets and 
develop more effective anti-inflammatory small molecule drugs. Upon ligand stimulation, 
IL-1R and TLRs form either homo- or hetero oligomers. The adapter molecule MyD88 is 
recruited to all IL-1R/TLR oligomers, except TLR3, followed by the recruitment of the 
serine/threonine interleukin-1 receptor kinases (IRAKs) [127, 171, 198-200]. Genetic and 
biochemical studies revealed that through activation of MyD88-IRAKs, downstream 
kinases are organized by multiple adapter molecules into parallel and sequential signaling 
cascades, leading to activation of the transcription factor nuclear factor κB (NFκB) and 
MAPKs[129, 131, 132], resulting in the production of inflammatory cytokines and 
chemokines.  
Although TLR-MyD88 signaling has been implicated in obesity-associated 
inflammatory diseases, the molecular and cellular mechanisms are not completely 
understood. In this study, we investigated how TLR-MyD88 signaling in different cellular 
compartments coordinately participates in the initiation of HFD-induced systemic 
inflammation and metabolic inflammatory diseases. The cell-type specific MyD88-/- mice 
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are crucial, since complete MyD88-/- mice (1) are  immune compromised and prone to 
infection; (2) do not adequately reflect specific role of MyD88 in different cell types [201]. 
Indeed, several previous studies using complete MyD88-/- mice produced conflicting 
results regarding the role of MyD88 in obesity-associated inflammatory diseases, which 
might be due to the immune deficiency of complete MyD88-/- mice and the housing 
environment in different institutions [193, 195, 202]. Therefore, studies using cell-type 
specific MyD88-/- mice are necessary and timely to elucidate the mechanistic role of TLR-
MyD88 signaling in obesity-associated inflammatory diseases. 
Using cell-type specific MyD88-deficient mice, our findings for the first time 
demonstrate the MyD88-dependent cooperative actions of myeloid and endothelial cells in 
the development and progression of metabolic inflammatory diseases. MyD88 deficiency 
in myeloid cells (MyD88MC-KO) substantially reduced diet-induced systemic inflammation, 
insulin resistance, and atherosclerosis. Furthermore, deletion of MyD88 in myeloid cells 
prevented macrophage infiltration into adipose tissue and aborted a switch in ATM 
phenotype from M2-like to M1-like. Using an adipocyte-macrophage ex vivo co-culture 
system and adipocyte-derived endogenous TLR ligand FFA, we demonstrated the 
influence of adipocytes on MyD88-dependent induction of M1-associated genes in 
macrophages, indicating the cross-talk between adipocytes and macrophages. On the other 
hand, MyD88 deficiency in endothelial cells (MyD88EC-KO) showed moderate reduction in 
diet-induced adipose M1-like macrophages with selective insulin sensitivity in adipose 
tissue, and amelioration of spontaneous atherosclerosis. Both in vivo and ex vivo studies 
suggest that MyD88-dependent GM-CSF production from the endothelial cells might play 
a critical role in the initiation of obesity-associated inflammation and development of 
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atherosclerosis by priming the monocytes in the adipose and arterial tissues to M1-like 
inflammatory macrophages. Taken together, these results implicate a critical MyD88-
dependent interplay among adipocytes, macrophages and endothelial cells in the initiation 
of diet-induced systemic inflammatory state and metabolic diseases. 
 
C. Results 
Generation of myeloid- and endothelial-specific MyD88-deficient mice 
Endothelial cell-specific MyD88-deficient mice created by cre-lox technology were 
validated by PCR (Fig. 32A). Tie2eCre transgenic mice (generated using the Tie2 5’ 
promoter and first intron enhancer element) express Cre within endothelium of brain, heart, 
and liver, among others [203, 204]. It is important to note that Tie2eCre (distinct from 
Tie2Cre) is restricted to endothelium, and Cre expression is minimally leaky [203, 204]. 
MyD88 expression was abolished in CD31+ endothelial cells from the aortas of 
Tie2eCreMyD88fl/fl (MyD88EC-KO) mice compared to control (Tie2eCreMyD88fl/+, Con EC-
KO), but showed normal MyD88 expression in monocytes (Fig. 32A). To generate myeloid 
specific MyD88-deficient mice, we utilized CD11bCre transgenic mice (generated with the 
promoter for CD11b, an integrin expressed exclusively in the myeloid lineage) [204-206]. 
These mice express Cre in macrophages, microglia, as well as activated liver kupffer cells. 
CD11bCreMyD88fl/+ mice were bred to MyD88fl/fl to generate control mice 
(CD11bCreMyD88fl/+, ConMC-KO) and myeloid-specific MyD88-deficient mice 
(CD11bCreMyD88fl/fl, MyD88MC-KO). PCR analysis showed that MyD88 expression was 
diminished in CD11b+ monocytes derived from CD11bCreMyD88fl/fl (MyD88MC-KO) mice 
compared to that in ConMC-KO mice (Fig. 32A).  
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Figure 32. MyD88 deficiency in myeloid and endothelial cells improves diet-induced 
hyperglycemia and hyperinsulinemia. (A)PCR for MyD88 mRNA of mouse CD11b+ 
splenic monocytes (CD11b+ monocytes) and CD31+ primary aortic vascular endothelial 
cells (MAVECs) from MyD88EC-KO, MyD88MC-KO  and their respective littermate controls 
(ConMC-KO and ConEC-KO). Data are presented as mean ± SD based on 5-7 for each group 
and are representative of three independent experiments. Body weights of (B) MyD88MC-
KO or (C) MyD88EC-KO male mice and their littermate controls (maintained on a chow diet 
or HFD) were measured weekly from 6 to 26 weeks of age. (D) Serum fasting glucose and 
(E) fasting insulin levels were measured in MyD88MC-KO, MyD88EC-KO  male mice and 
their respective littermate controls fed on chow diet (6 months of age) or HFD (for 6 weeks 
or 3 months starting from 6 weeks old). (n = 9-11 mice per genotype). Data are 
representative of two independent experiments. 
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MyD88 deficiency in myeloid and endothelial cells reduce diet-induced insulin 
resistance  
We first analyzed metabolic parameters of MyD88MC-KO and MyD88EC-KO mice on 
chow diet or HFD. There were no substantial differences in weight gain over the course of 
20 weeks (Fig. 32B-C) with similar levels of serum cholesterol, triglycerides and non-
esterified fatty acids (data not shown) in MyD88MC-KO and MyD88EC-KO mice fed on chow 
or high-fat diet compared to their respective littermate controls. These results indicate that 
MyD88 deficiency in endothelial or myeloid cells did not affect diet-induced weight gain 
and lipid homeostasis. We then examined glucose metabolism in the MyD88MC-KO and 
MyD88EC-KO mice. Interestingly, after HFD (for 6 weeks and 3 months), fasting glucose 
and fasting insulin levels were substantially decreased in MyD88MC-KO mice compared with 
the littermate controls (Fig. 32D-E). By performing GTT, we found that HFD fed 
MyD88MC-KO mice had much improved glucose tolerance compared with the littermate 
controls (Fig. 33A-B). Endothelial MyD88 deficiency also improved insulin sensitivity, 
but the impact was more dramatic at early phase (6 weeks) compared to that after 3 months 
of HFD (Fig. 33C-D). As controls, we noticed that the glucose tolerance and insulin 
sensitivity in chow diet fed MyD88MC-KO and MyD88EC-KO mice were comparable with 
their respective littermate controls (Fig. 32D-E, data not shown).  
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Figure 33. Deletion of MyD88 in myeloid cells and endothelial cells reduces diet-
induced insulin resistance. GTTs (Glucose tolerance tests) in MyD88MC-KO male mice 
and littermate controls on high fat diet (HFD) for (A) 6 weeks or (B) 3 months starting 
from 6-week old (6 months old mice on chow diet as controls，data not shown). Area 
under curve (AUC) was calculated. GTT in MyD88EC-KO mice and their littermate controls 
on high fat diet (HFD) for (C) 6 weeks or (D) 3 months starting from 6-week old (6 months 
old mice on chow diet as controls，data not shown). AUC was calculated. Data are 
presented as mean ± S.E.M (n = 9-11 mice per genotype) and are representative of two 
independent experiments. (*P < 0.05, **P < 0.01) 
 
 
 
 
 
 
 
 
156 
 
Deletion of MyD88 in myeloid cells and endothelial cells preserves insulin signaling 
in different tissues  
Since MyD88 deficiency in myeloid and endothelial cells attenuated diet-induced 
insulin resistance, we then examined insulin sensitivity in several tissues (including 
adipose tissue, muscle and liver) by IP injecting HFD-fed mice with insulin or saline after 
an overnight fast. As expected, compared with normal chow fed mice, insulin-induced 
AKT phosphorylation, tyrosine phosphorylation of IRS1 (insulin receptor substrate 1) and 
IRS1 interaction with PI3K (p85-phosphoinositide 3 kinase) were greatly reduced in 
adipose tissue, liver and muscle of HFD-fed wild-type control mice (Fig. 34A-D), 
demonstrating diet-induced insulin insensitivity of these tissues. Interestingly, while 
insulin-induced AKT phosphorylation was preserved in all three tissues of HFD-fed 
MyD88MC-KO mice, endothelial-specific MyD88 deficiency only rescued insulin signaling 
substantially in adipose tissue(Fig. 34E-H). Consistently, insulin-induced IRS-1 tyrosine 
phosphorylation and its association with PI3K (p85) were preserved in adipose tissue, liver 
and muscle of HFD-fed MyD88MC-KO mice, but only restored in adipose tissue of HFD-fed 
MyD88EC-KO mice, compared to that in their respective HFD-fed littermate controls(Fig. 
34E-H). Thus, endothelial-derived MyD88 plays a more important role in HFD-induced 
insulin resistance in the adipose tissue than that in liver and muscle.  
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Figure 34. Deletion of MyD88 in myeloid cells and endothelial cells preserves insulin 
signaling. After overnight fast, 5-month-old of control group (CD11bCreMyD88fl/+ and 
Tie2eCreMyD88fl/+) male mice kept on chow diet or HFD were injected with either saline 
(-) or 25 mU/kg of insulin (+). (A) white Adipose tissues (WAT), (B) muscles and (C) 
livers were collected 5 minutes later. (E) white Adipose tissues (WAT), (F) muscles and 
(G) livers of MyD88MC-KO, MyD88EC-KO and control group male mice kept on HFD for 3 
months were collected at 5 minutes after saline or insulin injection. Protein extracts were 
prepared, immunoprecipitated with anti-IRS-1, followed by western analysis with 
antibodies for phosphotyrosine (PY20, pY) or p85-PI3K. The levels of IRS1, activated 
AKT (pSer473, pAKT) and total AKT, were determined by immunoblotting of the original 
lysates. (D and H) The levels of pAKT and AKT were quantified by densitometry. The 
ratio of pAKT to AKT was expressed as a mean ± S.E.M. (*P < 0.05, **P < 0.01). (n = 4 
mice per genotype). The results are representative of three independent experiments. 
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Myeloid- and endothelial-specific MyD88 deficiency protect mice from 
atherosclerosis in ApoE-/- mice 
Atherosclerosis is a chronic inflammatory disease of the arteries, representing the 
underlining cause of the majority of cardiovascular disease. Obesity is an independent risk 
factor for the development of cardiovascular atherosclerosis. Obesity-induced insulin 
resistance and impaired glucose metabolism can exacerbate atherosclerosis. To study the 
impact of MyD88 deficiency in endothelial or myeloid cells on the pathogenesis of 
atherosclerosis, we employed the ApoE-deficient mice, which spontaneously develop 
hypercholesterolemia and atherosclerosis. Since female ApoE-/- mice were shown to 
develop more severe phenotype than male ApoE-/-[207, 208], we decided to use the female 
mice in this model. MyD88MC-KO, MyD88EC-KO mice and respective littermate controls 
were crossed to ApoE-/- mice to generate MyD88MC-KOApoE-/-, MyD88EC-KOApoE-/- mice 
and control mice (ConMC-KOApoE-/- and ConEC-KOApoE-/- mice). Total plasma cholesterol 
levels and cholesterol distribution were similar among 18-week old female MyD88MC-KO 
ApoE-/-, MyD88EC-KO ApoE-/- and their respective littermate controls either on chow diet 
or HFD (data not shown). 
We first compared the severity of atherosclerosis in chow fed MyD88MC-KOApoE-
/-, MyD88EC-KOApoE-/- and their respective littermate controls at 18 weeks of age. En face 
and aortic root section analysis of atherosclerotic lesions showed about 60-70% reduction 
in both MyD88MC-KO ApoE-/- and MyD88EC-KO ApoE-/- mice compared to littermate controls 
(Fig. 35A-D). Thus, MyD88 deficiency in endothelial or myeloid cells inhibited vascular 
lesion formation in this model of spontaneous atherosclerosis. Consistently, under chow 
diet MyD88 deficiency in myeloid or endothelial cells had similar impact on insulin 
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sensitivity of aortas compared to that in their littermate controls (Fig. 35E). We then 
examined expression of inflammatory genes in arterial tissue of both MyD88MC-KOApoE-/- 
and MyD88EC-KOApoE-/-mice. The expression levels of M-CSF, MCP-1, iNOS, VCAM-1, 
ICAM-1, and especially GM-CSF, were substantially reduced in the arterial tissue of 
MyD88 EC-KOApoE-/-mice, whereas TNFα, IL-6 and IL-1 were similarly decreased in 
arterial tissue of MyD88EC-KOApoE-/- and MyD88MC-KOApoE-/- mice compared to that of 
littermate controls (Fig. 36A-B).  
Since it is well known that the pathology of atherosclerosis in ApoE-/- mice is 
further aggravated upon HFD feeding, we then compared diet-induced atherosclerotic 
lesions of the endothelial- and myeloid-specific MyD88-deficient mice with their littermate 
controls. En face and aortic root section analysis of atherosclerotic lesions showed about 
70% versus 40% reduction respectively in lesion areas of MyD88MC-KO ApoE-/- mice and 
MyD88EC-KO ApoE-/- mice compared to their littermate controls (Fig. 35A-D). It is 
important to note that HFD substantially induced insulin resistance in the aortas of wild-
type control mice. Both MyD88MC-KO ApoE-/- and MyD88EC-KO ApoE-/- mice showed 
improved insulin sensitivity of aortas compared to their littermate controls (Fig. 35E). The 
expression of inflammatory genes (CXCL1, TNFα, IL-6, IL-1) was more dramatically 
decreased in arterial tissue of MyD88MC-KO ApoE-/- than that in MyD88EC-KOApoE-/-mice 
compared to their respective littermate controls (Fig. 36C-D). On the other hand, the 
expression of several inflammatory genes (M-CSF, MCP-1, iNOS, VCAM-1 and ICAM-
1) were equally decreased in arterial tissue of MyD88 MC-KO ApoE-/- and MyD88 EC-
KOApoE-/-mice compared to littermate controls (Fig. 36C-D). It is important to note that 
the expression of GM-CSF was more dramatically decreased in arterial tissue of MyD88EC-
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KO ApoE-/- than that in MyD88MC-KOApoE-/-mice compared to that in littermate controls 
(Fig. 36C-D). Lastly, through the analysis of gene expression in aorta, we did notice that 
the expression of Arg1 and IL-10 were always enhanced in the arterial tissue of either chow 
or HFD fed MyD88EC-KO ApoE-/- and MyD88MC-KOApoE-/- mice compared to that in their 
respective littermate controls (Fig. 36A-D), which will be further discussed below. 
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Figure 35. Myeloid - and endothelial-specific MyD88 deficiency protect mice from 
atherosclerosis. (A)MyD88MC-KO ApoE-/-, (B) MyD88EC-KO ApoE-/- female mice and their 
respective littermate controls (ConMC-KO ApoE-/- and ConEC-KO ApoE-/-), were fed on chow 
diet or HFD for 12 weeks beginning at 6 weeks of age. Enface (oil-red O staining) analysis 
was done for the whole aorta tree from end of the curvature of the aortic arch to the iliac 
bifurcation from these mice. Total mean lesion area was quantified based on image-
analysis by Photoshop software shown. Data are presented as mean ± S.E.M (n = 9-12 mice 
per genotype) and are representative of two independent experiments. (*P < 0.05, **P < 
0.01). Cross-sections of aortic roots from (C) MyD88MC-KO ApoE-/-, (D) MyD88EC-KO 
ApoE-/- female mice and their respective littermate controls fed on chow diet or HFD for 
12 weeks were stained with oil red O (Scale bar=250μm). Total mean lesion area was 
quantified by Photoshop software and shown as mean ± S.E.M and are representative of 
three independent experiments.. (*P < 0.05, **P < 0.01). (n = 6-7 mice per genotype).  (E) 
Aortas of MyD88MC-KO ApoE-/-, MyD88EC-KO ApoE-/-  and control group female mice kept 
on either chow diet or HFD for 3 months were collected at 5 minutes after saline or insulin 
injection. Protein extracts were analyzed as described in Fig. 2A-D. The levels of pAKT 
and AKT were quantified by densitometry. The ratio of pAKT to AKT was expressed as a 
mean ± S.E.M. (*P < 0.05, **P < 0.01). (n = 4 mice per genotype). The results are 
representative of three independent experiments.  
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Figure 36. MyD88 deficiency in myeloid and endothelial cells ameliorates arterial 
tissues inflammation under hypercholesterolemia and diet-induced systemic 
inflammation. Total RNA of aortas was isolated from MyD88MC-KO ApoE-/- female mice 
and littermate control mice on chow diet (A) or HFD (B); MyD88EC-KO ApoE-/- female mice 
and their respective littermate controls on chow diet (C) or HFD (D); and followed by 
quantitative real-time PCR and normalized to β-actin for the indicated genes. The mean 
value of each gene in control groups on chow diet was set to 1. The mean value of each 
gene in mice on HFD was normalized to that in their respective controls on chow diet. Data 
are presented as mean ± S.E.M (n = 9-12mice per genotype) and are representative of two 
independent experiments. (E) Protein levels of IL-1β, IL-6, TNFα and CXCL1 in the serum 
from MyD88MC-KO ApoE-/-, MyD88EC-KO ApoE-/- female mice and their respective 
littermate controls were analyzed by ELISA. (n = 7-9 mice per genotyping).  Data are 
presented in as mean ± S.E.M. (*P < 0.05, **P < 0.01). The results are representative of 
two independent experiments.  
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Myeloid-derived MyD88 is required for HFD-induced systemic inflammation 
Recent studies have shown a direct link between “chronic systemic inflammation” 
and diet-induced metabolic syndrome and consequent obesity-associated inflammatory 
diseases [180, 209-221]. Low-grade inflammation triggered by the HFD was indeed 
detected in the circulation of control mice, whereas diet-induced serum pro-inflammatory 
cytokines (IL-1, IL-6, TNF and CXCL1) were greatly reduced in MyD88MC-KO mice (Fig. 
36E). On the other hand, the deletion of MyD88 in endothelial cells only moderately 
reduced serum levels of these pro-inflammatory cytokines (Fig. 36E). As shown in Fig. 
35A-D, myeloid MyD88 also plays a more critical role than endothelial MyD88 in HFD-
induced atherosclerosis, suggesting that systemic inflammation might contribute to HFD-
induced exacerbation on atherosclerosis. Under systemic inflammation, in addition to ox-
LDL and IL-1, the endothelium is probably also activated by other circulating 
inflammatory stimuli through MyD88-independent pathways, including TNFα and IL-
6[222]. Taken together, our results suggest that while both myeloid and endothelial MyD88 
participate in the initiation of obesity-induced inflammatory diseases, myeloid MyD88 
might play a more dominant role in disease progression through its impact on systemic 
inflammation.  
 
Myeloid MyD88 participates in HFD-induced switching of adipose tissue 
macrophages (ATM) from M2-like to M1-like 
Metabolic-triggered inflammation in white adipose tissue plays a key role in 
initiation of inflammatory diseases associated with metabolic syndrome, by directly 
impacting local and systemic insulin signaling and consequent long-term systemic 
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inflammation [223-227]. Obesity-induced adipose tissue inflammation is characterized by 
the presence of an increased number of adipose tissue infiltrating macrophages [228]. 
Compared to littermate controls, MyD88MC-KO mice showed markedly reduced infiltration 
of macrophages and fewer so called “crown-like structures (CLS)”, which are associated 
with inflammation and apoptotic/necrotic adipocytes (Fig. 37A-B and F4/80 levels in 
37D). In support of the histology, mRNA expression levels of inflammatory genes were 
greatly decreased in adipose tissue of MyD88MC-KO mice compared to controls (Fig. 37C).  
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Figure 37. Deletion of MyD88 in myeloid cells and endothelial cells reduces diet-
induced adipose tissue inflammation. MyD88MC-KO, MyD88EC-KO male mice and their 
respective littermate controls on HFD for 14 weeks were sacrificed and epididymal fat pad 
was collected. (A) Paraffin sections of epididymal fat pad were stained with anti-F4/80 
antibody (Scale bar=50μm). Arrowheads indicate F4/80 positive staining; representative 
CLSs were enlarged and shown in the insert. (B) The number of CLSs was counted. Results 
are shown as mean± S.E.M of five different sections per mouse and are representative of 
five mice per genotype with similar results. The results are representative of two 
independent experiments. (C-D) Total adipose tissue RNA from MyD88MC-KO, MyD88EC-
KO and their respective littermate control mice were analyzed by quantitative real-time PCR 
and normalized to β-actin for the indicated genes. Data are presented as mean ± S.E.M (n 
= 9-11 per genotype) and are representative of two independent experiments.  (*P<0.05, 
**P < 0.01). MyD88MC-KO ApoE-/-, MyD88EC-KO ApoE-/- male mice and their respective 
littermate controls fed on either chow diet (E) or HFD (F) for 12 weeks were sacrificed 
and epididymal fat pad was collected. Total adipose tissue RNA were analyzed by 
quantitative real-time PCR and normalized to β-actin for the indicated genes. Data are 
presented as mean ± S.E.M (n = 5-6 per genotype) and are representative of two 
independent experiments. (*P<0.05, **P < 0.01). 
 
ATMs consist of at least two different phenotypes, classically activated M1-like 
macrophages and alternatively activated, resident M2-like macrophages. In obesity, 
infiltrating M1-like macrophages lead to an overall switch in adipose tissue phenotype, 
associated with insulin resistance and chronic inflammation [224, 228-238]. Interestingly, 
we found that gene markers for M2-like macrophages, including IL-10, C-type mannose 
receptor 2(CD206), Arginase-1, and macrophage galactose N-acetyl-galactosamine–
specific lectin 1 (Mgl-1) were increased in adipose tissue of MyD88MC-KO, while M1-like 
marker CD11c was decreased (Fig. 37D), which is consistent with the improved adipose 
inflammatory status of these mice. When gated on CD11b+F4/80+ cells from adipose 
tissue of HFD-fed mice, the elimination of MyD88 in myeloid cells increased the number 
of M2-like macrophages (CD11c-CD206+) with decreased M1-like macrophages 
(CD11c+CD206-), confirming the critical role of MyD88-dependent signaling in HFD-
induced ATM switching from M2- to M1-like macrophages (Fig. 38A). We then sorted for 
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M1-like (F4/80+CD11c+) and M2-like (F4/80+CD206+) macrophages from adipose 
tissues of HFD-fed MyD88MC-KO and control mice, followed by gene expression analysis. 
Inflammatory gene expression (iNOS and IL-6) was much higher in M1-like than that in 
M2-like macrophages and substantially reduced in MyD88-deficient M1- and M2-like 
macrophages compared to their corresponding control macrophages, respectively (Fig. 
38B). On the other hand, M2-associated gene expression (Mgl1 and IL-10) was much 
higher in M2-like than that in M1-like macrophages and significantly increased in MyD88-
deficient M2- and M1-like macrophages compared to their corresponding control 
macrophages (Fig. 38B). These data indicate that deletion of MyD88 in myeloid cells 
aborted HFD-induced switch of ATMs from M2- to M1-like subtype at cellular and 
molecular levels.  
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Figure 38. MyD88 participates in HFD-induced switching of adipose tissue 
macrophages (ATM) from M2 to M1. (A) Stromal vascular fraction (SVF) cells from 
epididymal fat pad of 6 month old MyD88MC-KO, MyD88EC-KO mice and their respective 
littermate controls on HFD were analyzed by flow cytometry. CD11b+F4/80+ (ATMs) 
were further analyzed with anti-CD11c and anti-CD206 antibodies. M1-like 
(F4/80+CD11c+) cells and M2-like (F4/80+CD206+) subsets were shown as mean ± 
S.E.M (n = 9-12 mice per genotype) and are representative of two independent experiments. 
(*P<0.05, **P < 0.01). (B)Total RNA isolated from M1- or M2-like macrophages was 
analyzed by quantitative real-time PCR and normalized to β-actin for the indicated genes. 
The mean value of each gene in M1-like cells from control groups was set to 1. Data are 
presented as mean ± S.E.M (n = 5-7 per genotype) and are representative of two 
independent experiments. (C)Total RNA was isolated from M1-like (F4/80+CD11c+) cells 
or M2-like (F4/80+ CD206+) cells in aortic lesions and analyzed by quantitative real-time 
PCR and normalized to β-actin for the indicated genes. The mean value of each gene in 
M1-like cells from control groups was set to 1. Data are presented as mean ± S.E.M (n = 
5-6 mice per genotype and are representative of two independent experiments. (*P<0.05, 
**P < 0.01).  
 
 
Similar M1- and M2-associated gene expression patterns were observed in adipose tissues 
of mice bred onto ApoE-/- background fed on HFD (Fig. 37D and Fig. AI-37E-F). It is 
interesting to note MyD88 deficiency in myeloid cells also led to a shift from M1-
associated [iNOS; TNF, IL-1 and IL-6] to M2-like [Arg1 and IL-10] gene expression in 
arterial tissue of chow and HFD fed mice (Fig. 36A and AI-5C). This finding was 
confirmed by immunestaining of sections of aortic roots of MyD88MC-KO mice and 
littermate control mice on both chow diet and HFD (Fig. 39A-D). MyD88 deficiency in 
myeloid cells indeed led to a shift from M1-like (F4/80+iNOS+) to M2-like 
(F4/80+Arginase1+) macrophages in the aortic lesions of mice on chow diet or HFD (Fig. 
39A-D). This result was further corroborated by gene expression profile from sorted 
macrophages from aortic tissues of HFD-fed mice. Inflammatory gene expression (iNOS 
and IL-6) was substantially reduced in sorted MyD88-deficient M1- (F4/80+CD11c+) and 
M2-like (F4/80+CD206+) macrophages compared to their corresponding control 
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macrophages, respectively (Fig. 38C). Importantly, M2-associated gene expression (Arg1 
and IL-10) was much higher in M2-like than that in M1-like macrophages and significantly 
increased in MyD88-deficient M2-like and M1-like macrophages compared to their wild-
type control macrophages, respectively (Fig. 38C).   
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Figure 39. Deletion of MyD88 in myeloid cells and endothelial cells prevents M1 
macrophages polarization in arterial tissue under hypercholesterolemia. 
Immunostaining of atherosclerotic lesions from MyD88MC-KO ApoE-/-, MyD88EC-KO ApoE-
/- female mice and their respective littermate controls on chow diet (A) or HFD (B) for 3 
months. Macrophages were identified as F4/80+ (red) cells. Co-expression of F4/80 and 
iNOS (green) or Arg1 (green) was identified by image overlay. Inset: magnification of the 
zone delimited in the frame. Arrowheads indicate representative M1-like (F4/80+iNOS+) 
or M2-like (F4/80+Arg1+) cells (scale bar=20μm) (n = 4-5 mice per genotype). The results 
are representative of three independent experiments.  (C) Lesional macrophage content as 
determined by percentage of F4/80 positive staining area (mean ± S.E.M). (D) Enumeration 
of M1-like or M2-like macrophages by immunofluorescence in aortic root sections as 
shown in G. Results are shown as average ± S.E.M of five different sections per mouse and 
are representative of 4-5 mice per genotype with similar results. (*P<0.05, **P < 0.01)  
 
Since myeloid-derived MyD88 had a dramatic impact on the ATM phenotype, we 
set up an adipocyte-macrophage ex vivo co-culture system to explore the cross-talk 
between adipocytes and macrophges. BMDMs and 3T3L1 adipocytes were cultured in the 
bottom and inner wells of Boyden chambers, respectively, which permitted passage of 
humoral factors between the chamber wells. Pro-inflammatory cytokine/chemokine 
mRNAs and proteins in the supernatant were higher in macrophages co-cultured with 
adipocytes than those in macrophages cultured alone (Fig. 40A). The effects of co-
culturing were augmented by the increase of ratios of adipocytes/macrophages (Fig. 40A). 
Interestingly, we also found that Arginase-1 and CD206 (M2 markers) expression were 
reduced by co-culturing (Fig. 40B). Furthermore, the expression of M1-associated genes 
including IL-12a, IL-12b, IRF5 and NOS2 was concomitantly upregulated by the increase 
of ratios of adipocytes/macrophages (Fig. 40C). All these effects were reduced in 
MyD88KO BMDMs (Fig. 40A-C), demonstrating that MyD88 participates in the cross-
talk between adipocytes and macrophages, which might play a critical role in HFD-induced 
switching of ATMs from M2-like to M1-like phenotype. The next question is what the 
relevant ligands here. ATMs are exposed to high local concentrations of FFAs released 
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from enlarged adipocytes and augmented by increased lipolysis in obesity [239-242]. We 
indeed detected FFA in the conditioned media of the co-culture experiment of adipocytes 
and macrophages by ELISA (Fig. 40D). This finding suggests that FFA from adipocytes 
might serve as a TLR ligand to activate macrophages in our co-culture system. In support 
of this, we found that  palmitate-induced inflammatory gene expression was substantially 
reduced in MyD88-deficient macrophages compared to that in control cells, while 
completely abolished in TLR4-/- and partially impaired in TLR2-/- macrophages, 
suggesting the possible role of saturated fatty acids (SFAs) in promoting TLR-MyD88-
dependent switching of ATMs from M2-like to M1-like inflammatory macrophages (data 
not shown).  
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Figure 40. MyD88-dependent cross-talk between adipocytes and macrophages 
promotes M1 polarization. Bone marrow-derived macrophages (BMDMs) of WT and 
MyD88KO male mice were plated in the bottom wells of Boyden chambers, with or 
without (indicated as M) 3T3 adipocytes in the inserts at a ratio of 1:1 or 5:1 (adipocytes: 
BMDMs cell numbers). mRNA expression levels of (A) CXCL1, IL-6, TNF-α, IL-1β, (B) 
Arginase-1, CD206, (C) IL12a, IL12b, IRF5 and iNOS in the BMDMs were analyzed. The 
expression of mRNA normalized to β-actin expression. The data are presented as fold 
induction over the levels of mRNAs in WT macrophages cultured alone. (n = 5 wells in 
each group) Data represent the mean ± S.E.M. of the results from three independent 
experiments. (D) Concentration of FFA in the supernatant was measured by ELISA (n = 5 
wells in each group). Data are expressed as mean ± S.E.M of the results from three 
independent experiments. (*P<0.05, **P < 0.01). 
 
Endothelial MyD88 mediates GM-CSF production to prime M1-like inflammatory 
macrophages 
Interestingly, MyD88EC-KO mice also showed moderate reduction in HFD-induced 
M1-like macrophages in adipose tissue (Fig. 37C-D and Fig. 38A-B). Consistently, 
endothelial-specific MyD88 deficiency rescued insulin signaling substantially in adipose 
tissue (Fig. 34E & H). Furthermore, MyD88 deficiency in endothelial cells (MyD88EC-
KOApoE-/-) showed substantial reduction in lesion areas, aortic wall inflammation 
(including a shift from M1- to M2-like macrophages) and improved insulin sensitivity of 
aortas in both chow and HFD-fed mice (Fig. 35B, 35D, 35E, 36B, 36D, Fig. 38C  and 
39A-D). Based on these results, we hypothesized that MyD88-signaling in endothelial cells 
mediates the cross-talk with macrophages to impact on the initiation of atherosclerosis and 
diet-induced exacerbation on atherosclerotic lesions. Interestingly, we noticed that the 
expression of GM-CSF was substantially decreased in the arterial tissue and adipose tissue 
of MyD88EC-KO mice compared to controls (Fig. 36B & D, 37C and 41A). Immunostaining 
showed that GM-CSF was indeed co-localized with CD31+ endothelial cells in the aortic 
root lesions of ConEC-KOApoE-/- mice, which was abated in that of the MyD88EC-KOApoE-/- 
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mice, demonstrating MyD88-dependent GM-CSF expression in endothelial cells (Fig. 
41B). GM-CSF is well-known for its function in promoting monocyte differentiation 
towards M1 pro-inflammatory macrophages [131, 243-251]. Based on our results and 
previous studies on GM-CSF, we proposed that MyD88-dependent signaling in endothelial 
cells induces the production of GM-CSF, which in turn primes the monocytes/macrophages 
to become M1-like inflammatory macrophages.  
To test this hypothesis, we need to know the relevant ligands for the MyD88-
dependent signaling in endothelial cells. Ox-LDL (oxidized and related modified forms of 
low density lipoproteins) is an endogenous TLR2/4 ligand, which accumulates in the vessel 
wall and is an emerging cardiovascular risk factor [238, 252]. Ox-LDL may trigger TLR 
signaling in macrophages and as well as directly on endothelial cells. In addition to ox-
LDL, the endothelium, the interface between vascular structures and blood, can also be 
activated by a variety of circulating inflammatory stimuli [222], includ -6 
and IL-1. Therefore, the most relevant ligands for MyD88-dependent signaling in 
endothelial cells are ox-LDL and IL-1. Interestingly, we found that both ox-LDL and IL-1 
can strongly induce GM-CSF expression in primary endothelial cells, which was 
completely abolished in MyD88-deficient endothelial cells (Fig. 41C). We wondered then 
whether GM-CSF produced by ox-LDL- and IL-1-treated endothelial cells is able to 
influence the macrophage function. We indeed found that the conditioned medium from 
ox-LDL-treated wild-type endothelial cells (but not MyD88-deficient endothelial cells) 
was able to induce GM-CSF-target gene PPBP (CXCL7,[246, 251]) in CD11b+ monocytes 
and enhanced the expression of M1-associated genes including IL-12a, IL-12b and iNOS 
(Fig. 41D). Similar results were observed with IL-1-treated endothelial cells (data not 
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shown). Neutralization with anti-GM-CSF greatly reduced the expression of PPBP and 
M1-associated genes in monocytes in response to the conditioned medium from ox-LDL-
treated endothelial cells (Fig. 41D). Moreover, the conditioned medium from ox-LDL-
treated wild-type endothelial cells (but not MyD88-deficient endothelial cells) was able to 
increase the ratio of CD11c (M1) to CD206 (M2), which was also blocked by anti-GM-
CSF, supporting the role of GM-CSF in monocyte differentiation towards M1-like 
macrophages (Fig. 41D). It is important to note that ox-LDL used in this study was 
generated by using MPO/H2O2/Nitrite system (see methods). We found that the ox-LDL 
generated by this protocol can consistently activate TLR-induced inflammatory genes and 
synergize with GM-CSF for up-regulation of M1-associated genes [253-262]. 
Since ox-LDL has been shown to directly act on macrophages in vivo [263-266], 
we wondered whether it is possible that GM-CSF produced by ox-LDL activated 
endothelial cells synergizes with SFAs and ox-LDL to further promote M1-like 
proinflammatory macrophages. Palmitate and ox-LDL indeed enhanced the expression of 
M1-associated genes in GM-CSF-primed macrophages as compared to that in M-CSF-
primed macrophages (Fig. 41E). Interestingly, the expression of M1-associated gene 
expression was more robustly enhanced in the adipocyte-macrophage ex vivo co-culture 
system when using GM-CSF-primed macrophages as compared to that of M-CSF-primed 
macrophages (Fig. 41F). Taken together, these results suggest a potential role of GM-CSF 
in priming ATMs to become M1-like macrophages during their cross-talk with adipocytes. 
It is important to note that endothelial-specific MyD88 deficiency substantially reduced 
HFD-induced GM-CSF expression in adipose tissue (Fig. 37C), which was correlated with 
selective rescue of insulin signaling in adipose tissue of HFD fed MyD88EC-KO mice (Fig. 
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34E and 34H). These findings implicate the MyD88-dependent involvement of endothelial 
cells in the cross-talk between adipocytes and macrophages, which might be important for 
the initiation of obesity-associated inflammatory diseases. In support of this, endothelial 
MyD88 deficiency improved insulin sensitivity more dramatic at early phase (6 weeks) 
compared to that after 3 months of HFD (Fig. 33C-D); and MyD88EC-KOApoE-/- mice 
showed greater reduction in atherosclerotic lesions developed under chow diet (70% 
reduction) than that in HFD (40% reduction).  
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Figure 41. Endothelial MyD88 mediates GM-CSF production to prime M1 
inflammatory macrophages. (A) Protein level of GM-CSF in whole aorta lysate taken 
from MyD88MC-KO ApoE-/-, MyD88EC-KO ApoE-/-  female mice and their respective 
littermate controls on chow diet or HFD for 12 weeks beginning at 6 weeks of age were 
analyzed by ELISA. Data are expressed as mean ± S.E.M (n=5-6 per genotype) of the 
results from three independent experiments. (*P<0.05, **P < 0.01). (B) Immunostaining 
of GM-CSF (green) in conjunction with CD31 (red) were performed for frozen sections of 
aortic roots from MyD88MC-KO ApoE-/-, MyD88EC-KO ApoE-/-  female mice and their 
respective littermate controls on chow diet (3 months of age). Then the tissues were 
examined by confocal microscopy. Arrowheads indicate representative CD31+ GM-CSF+ 
cells (scale bar=20μm, L: lumen, A: arterial wall). Shown as are representative of five mice 
per genotype with similar results (C) Wild-type (WT) and MyD88-deficient (MyD88KO) 
primary aortic endothelial cells (ECs) were treated with ox-LDL (100 μg/ml) or IL-1 (1 
ng/ml) for the indicated times (time 0 were treated with native LDL). Protein levels of GM-
CSF in supernatant from cells treated for 24 hours were analyzed by ELISA. The levels of 
GM-CSF mRNA were measured by real-time PCR and presented as fold induction over 
the expression of WT cells at time 0. (D) WT and MyD88 KO ECs were treated with ox-
LDL for 24h, then changed into fresh medium. After 48h, the medium was collected and 
used to culture sorted CD11b positive splenic monocytes for 24h with or without anti-GM-
CSF neutralizing antibody (conditioned medium, conditioned medium + anti-GM-CSF). 
Monocytes were cultured in normal medium as negative control (vehicle). Monocytes in 
normal medium were treated with 50 ng/ml recombinant GM-CSF alone as positive control 
(GM-CSF). Total RNA of monocytes was subjected to real-time PCR to measure the 
relative expression of CD11c, CD206, IL-12a, IL12b, iNOS and PPBP. The fold induction 
was calculated as compared with vehicle group. (E) Bone marrow derived cells were 
cultured in DMEM supplemented with 20% FBS and 20 ng/ml GM-CSF or 50 ng/ml M-
CSF for 7 days, followed by treatment of ox-LDL and FFA (16:0; Palmitate, 5μM)  as 
indicated. Total RNA was subjected to real-time PCR to measure the expression of IL-12a, 
IL-12b, iNOS and PPBP. The fold induction was calculated as compared with the cells 
primed by M-CSF at time 0. (F) BMDMs of WT male mice primed by either M-CSF or 
GM-CSF were plated in the bottom wells of Boyden chambers, with or without 3T3 
adipocytes in the inserts at a ratio of 5:1 (adipocytes: BMDMs cell numbers). mRNA 
expression levels of IL12a, IL12b, IRF5 and iNOS in the BMDMs were analyzed. The fold 
induction was calculated as compared with the cells primed by M-CSF and cultured alone. 
mRNA expression was normalized to β-actin expression. (C-F) Data represent the mean ± 
S.E.M. of triplicate samples from a single experiments, and all results are representative of 
three independent experiments. (*P<0.05, **P < 0.01). 
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D. Discussion 
The study presented here aimed to address how TLR signaling in different cellular 
compartments contributes to the initiation and pathogenesis of obesity-associated 
inflammatory diseases through the specific deletion of MyD88 in endothelial cells or 
myeloid cells. MyD88 deficiency in myeloid cells ameliorated diet-induced systemic 
inflammation and global insulin resistance, preserving insulin sensitivity in all the tested 
tissues including muscle, liver and adipose tissue. On the other hand, endothelial-specific 
deficiency of MyD88 improved diet-induced insulin resistance at early phase with 
moderate effect on systemic inflammation, selectively restoring insulin sensitivity in 
adipose tissue. While both myeloid- and endothelial-derived MyD88 were equally critical 
for the initiation of atherosclerosis in chow fed ApoE-deficient mice, myeloid MyD88 
clearly plays a more critical role than endothelial MyD88 in HFD-induced atherosclerosis. 
Taken together, these results for the first time demonstrate the non-redundant role of 
MyD88-dependent signaling in myeloid and endothelial cells for the development and 
progression of atherosclerosis and metabolic inflammatory diseases.  
The participation of macrophages and endothelium in atherosclerosis has been 
extensively studied. In this study, we found that MyD88 deficiency in endothelial or 
myeloid cells inhibited vascular lesion formation in chow fed ApoE-deficient mice, with 
similar reduction in atherosclerotic area (60-70%). It is interesting to note that MyD88-
dependent pathology in chow fed ApoE-deficient mice is restricted to the aorta, since under 
chow diet ApoE deficiency does not influence myeloid or endothelial MyD88-dependent 
WAT macrophage abundance, polarization or inflammatory cytokine production. These 
results clearly indicate the critical role of the MyD88-dependent pathway in the interplay 
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between the endothelium and macrophages in the aortic tissue during the initiation of 
atherosclerosis. The key initiating event in atherosclerosis is retention and oxidation of 
LDL in the vascular wall [267]. Our study suggests that endothelial cell activation by ox-
LDL through the TLR-MyD88-dependent pathway probably plays an important role in the 
initiation of atherosclerosis. While ox-LDL strongly induces the expression of GM-CSF in 
a MyD88-dependent manner in endothelial cells, the expression of GM-CSF was greatly 
reduced in the arterial tissue of the chow fed MyD88EC-KOApoE-/- mice compared to that in 
the control mice. GM-CSF was indeed detected in endothelial cells of atherosclerotic 
lesions, which was abolished in the MyD88EC-KOApoE-/- mice. Furthermore, ox-LDL-
induced expression of M1-associated genes was more robust in GM-CSF-primed 
macrophages than that in M-CSF-primed macrophages. Therefore, MyD88-dependent 
GM-CSF production from endothelial cells might serve as an important link between 
endothelial cells and macrophages by promoting M1-like inflammatory macrophages. In 
support of this, GM-CSF has been shown to be important in plaque development. Using 
the hypercholesterolaemic ApoE-/- mouse, it was found that GM-CSF treatment resulted in 
increased atherosclerotic lesion extent [268, 269] . LDLR-null mice have been employed 
in a study which combined 5-bromo-2’-deoxyuridine pulse labeling with en face 
immunoconfocal microscopy to demonstrate that systemic injection of GM-CSF markedly 
increased intimal cell proliferation (including dendritic cells), whilst functional GM-CSF 
blockade inhibited proliferation[270]. Therefore, in addition to macrophage polarization, 
the impact of GM-CSF on dendritic cell proliferation may also contribute to the reduced 
lesions in our endothelial cell-MyD88 deficient mice. Future studies using cell-type 
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specific GM-CSF receptor knockout mice will be required to clarify the pathogenic role of 
GM-CSF in atherosclerosis.  
Interestingly, when the mice were fed the HFD, there was a dramatic reduction 
(70%) in atherosclerotic area in MyD88MC-KO ApoE-/- mice, but a more moderate reduction 
(40%) in MyD88EC-KO ApoE-/- mice. The question is why myeloid MyD88 plays a more 
critical role than endothelial MyD88 in HFD-induced atherosclerosis. It is important to 
note that myeloid MyD88 deficiency led to greater improvement in HFD-induced systemic 
inflammation (circulating TNFα, IL-6 and IL-1) and global insulin resistance than that by 
endothelial-specific MyD88 deficiency. Under HFD-induced systemic inflammation, in 
addition to ox-LDL, the endothelium can also be activated by a variety of circulating 
inflammatory stimuli [222], including TNFα and IL-6. As a result, the activation of 
endothelium, the interface between vascular structures and blood, becomes less dependent 
on the MyD88-dependent pathway over the course of HFD. Consistently, endothelial 
MyD88 deficiency improved global insulin resistance more dramatic at early phase (6 
weeks after HFD) than that after 3 months of HFD. 
One important question is how systemic inflammation is initiated in a HFD setting. 
Previous studies have suggested that metabolic-triggered inflammation in white adipose 
tissue plays a key role in the initiation of metabolic syndrome [223, 225-227]. ATMs are 
exposed to high local concentrations of FFAs released from adipocytes in obesity, and 
these serve as important activating ligands for TLR4 and TLR2 signaling in macrophages 
[231, 237, 241, 271-273]. The results from our co-culture model suggest that MyD88 
participates in the cross-talk between adipocytes and macrophages and FFA released by 
adipocytes might be one of the initial ligands for TLR-MyD88 in this cross-talk. The 
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cytokines (e.g. IL-1 and IL-6) may feedback on adipocytes to further promote this cross-
talk [274-278]. Consistently, compared to controls, MyD88MC-KO mice showed markedly 
reduced infiltration of macrophages and decreased adipose expression of inflammatory 
genes. Furthermore, the elimination of MyD88 in myeloid cells increased the number of 
M2-like macrophages (CD11c-CD206+) with decreased M1-like macrophages 
(CD11c+CD206-) in the adipose tissue, confirming the critical role of MyD88-dependent 
signaling in HFD-induced ATM switching from M2- to M1-like macrophages. Myeloid-
specific MyD88-dependent switch of ATMs from M2-like to M1-like might play a key role 
in the initiation of obesity-associated inflammatory diseases. However, it is important to 
note that in addition to adipose tissue, myeloid-specific MyD88 deficiency also preserved 
insulin sensitivity in liver and muscle, which probably contribute to the improvement of 
HFD-induced global insulin resistance and systemic inflammation. Since CD11bCre 
mediates deletion of floxed sequences in myeloid cells, we have now crossed MyD88fl/fl 
mice with LysMCre mice to delete MyD88 in macrophages. Preliminary data from 
LysMCreMyD88fl/fl mice showed similar results with that in MyD88MC-KO mice as 
compared to the littermate controls. 
Interestingly, MyD88EC-KO mice also showed moderate reduction in macrophage 
infiltration, M2-like to M1-like switching and adipose expression of those pro-
inflammatory cytokine and chemokine genes. While FFAs released from adipocytes might 
directly act on endothelial cells, IL-1 released from FFA-induced M1-like macrophages 
could also activate endothelium through a paracrine manner. While IL-1 strongly induced 
the expression of GM-CSF, the GM-CSF levels were substantially reduced in adipose 
tissue of HFD fed MyD88EC-KO mice. IL-1-induced GM-CSF in endothelial cells was able 
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to promote M1-like inflammatory macrophages. Furthermore, the expression of M1-
associated gene expression was more robustly enhanced in the adipocyte-macrophage ex 
vivo co-culture system when using GM-CSF-primed macrophages as compared to that of 
M-CSF-primed macrophages. Thus, endothelial MyD88 might impact on switching of 
ATMs from M2-like to M1-like through the production of GM-CSF, which may account 
for the selective rescue of insulin sensitivity in adipose tissue of HFD fed MyD88EC-KO 
mice. In support of this, endothelial deletion of MyD88 also moderately reduced M1-like 
macrophages in the aortas with substantial reduction of GM-CSF expression, which 
correlated with improved insulin sensitivity of aortic tissues from HFD-fed MyD88EC-KO 
mice. It is important to mention that the GM-CSF levels were not significantly reduced in 
liver and muscle of HFD-fed MyD88EC-KO mice (unpublished data, Yu and Li), which 
might explain why these two tissues remain insulin insensitive in HFD-fed MyD88EC-KO 
mice.  
It is important to note that in addition to MyD88, TLR4 also utilizes TRIF to 
mediate NFκB activation to upregulate inflammatory gene expression. TRIF deficiency 
[279] or TRIFLPS2 lack-of-function mutation were shown to be atheroprotective in 
hyperlipidemic LDL receptor knockout (LDLr−/−) mice [280]. Both studies supported a 
critical role of TRIF-dependent pathway in the pathogenesis of atherosclerosis. However, 
it is important to point out that TLR4 specifically utilizes TRIF to mediate the activation 
of transcription factor IRF3 to upregulate Type 1 IFN production which in turn impacts on 
IL-10 production [166]. Furthermore, it was reported that TRIF is not required for TLR4 
signaling in endothelial cells [281], which was confirmed by our own studies in primary 
aortic vascular endothelial cells (Yu and Li, unpublished data). Therefore, mice with cell-
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type specific TRIF deletion will be critical reagents for future studies to compare the 
molecular and cellular mechanisms by which MyD88- versus TRIF-dependent pathway 
contributes to the development and pathogenesis obesity-associated inflammatory diseases. 
In summary, this study has demonstrated that MyD88-dependent signaling in both 
myeloid and endothelial cells contributed to the initiation/progression of atherosclerosis 
and as well as the development and pathogenesis of HFD-induced inflammatory diseases. 
Both myeloid- and endothelial-derived MyD88 are critical for the initiation of 
atherosclerosis in chow fed mice. One possible mechanism is that ox-LDL activates 
endothelial cells to produce GM-CSF, which in turn primes the monocytes in the arterial 
tissues and synergizes with ox-LDL to promote M1 inflammatory macrophages. On the 
other hand, MyD88-dependent signaling in myeloid cells makes a greater contribution to 
the development of HFD-induced systemic inflammation and consequent exacerbation on 
atherosclerosis. FFAs released from adipocytes act on ATMs to promote HFD-induced 
switching of ATMs from M2-like to M1-like, resulting in systemic inflammation and 
aggravating atherosclerotic lesions. Nevertheless, endothelial-derived MyD88 still has a 
noticeable contribution to the diet-induced inflammatory diseases, possibly also through 
the production of GM-CSF to feedback on macrophages. Future studies are required to 
elucidate how the cell-type specific MyD88-mediated signaling events contribute to the 
cross-talks among adipocytes, macrophages, and endothelial cells to establish the diet-
induced inflammatory state, leading to inflammatory diseases associated with metabolic 
syndrome.  
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E. Materials and Methods 
Animals. CD11bCre transgenic mice were provided by G. Kollias (Biomedical 
Sciences Research Centre ‘‘Alexander Fleming’’) [205]. Tie2eCre transgenic mice were a 
gift of X.-Y. Fu (National University of Singapore) [203]. MyD88 flox mice were provided 
by A. DeFranco (University of California, San Francisco) [282]. All these transgenic mice 
used backcrossed 10 times to C57/ BL 6 background. ApoE-/- mice in the C57/BL6 
background were purchased from Jackson laboratory. Mice were housed in a specific 
pathogen-free facility (12-h light/dark cycle) and were fed either standard rodent chow or 
a high fat, Western style diet (HFD, Harlan Teklad 88137) [283-286]. Animals were fasted 
overnight and blood samples were taken for assessment of insulin (Crystal Chem), 
FFA(Cayman), cholesterol (Sigma), triglycerides (Sigma) and IL-1β, IL-6, TNF-α, 
CXCL1 (R&D systems) levels according to manufacturer’s instructions. All experimental 
procedures were carried out with the approval of the Institutional Animal Care and Use 
Committee of Cleveland Clinic (Cleveland, OH).  
Primary cell isolation. Bone marrow derived macrophages (BMDMs) were 
differentiated from bone marrow flushed from the tibia and femur of mice using 
Dulbecco’s Modified Eagle’s Media (DMEM). The cells were cultured in DMEM 
supplemented with 20% FBS and 30% L929 supernatant for 5 days. Aortic endothelial 
cells (MAVECs, ECs) were harvested from mouse aorta under sterile conditions as 
previously described [287]. The aorta was excised; all periadventitial fat was removed, and 
the aortic pieces were placed onto Matrigel in DMEM plus 15% heat-inactivated FBS 
following the methods outlined by Shi et al [288]. After 3 days, the aortic explants were 
removed, and the endothelial cells were allowed to grow in DMEM plus 15% heat-
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inactivated FBS supplemented with 180 μg/ml heparin and 20 μg/ml endothelial cell 
growth supplement. At confluence, the cells were passaged using dispase and then cultured 
for 2 days in DMEM plus 15% heat-inactivated FBS containing d-valine to eliminate 
possible fibroblast contamination. After 2 days, the EC were returned to growth medium 
without d-valine and allowed to grow to confluence. Mouse endothelial cell cultures were 
used in experiments from passages 2–4. Spleens were minced and digested with Liberase 
Blendzyme 2 for 15 min in PBS at 21°C, passed through a 40-mm cell strainer, treated with 
ACK Buffer (Lonza) to remove red cells, and resuspended in PBE (PBS with 0.5% BSA, 
endotoxin free; 1mM EDTA). splenocytes were subsequently sorted on a Dako MoFlo. 
Postsort analysis confirmed purity of 96% and viability of 95%.  
Biological reagents and cell culture. Human low density lipoprotein (LDL, 
1.019<density<1.063) was isolated from plasma of normolipidemic donors by sequential 
ultracentrifugation. Native and modified LDL preparations were tested for possible 
endotoxin contamination using a Limulus amebocyte lysate kit (Cambrex, Walkersville, 
MD). Oxidized LDL (ox-LDL) was prepared by incubating LDL (0.2 mg protein/ml) at 
37°C in 50 mM sodium phosphate (pH 7), 100 mM DTPA (diethylene-triamine-pentaacetic 
acid)  in the presence of 30 nM myeloperoxidase, 100 mg/ml glucose, 20 ng/ml glucose 
oxidase (grade II; Boehringer Mannheim Biochemicals, Indianapolis, IN), and 0.5 mM 
NaNO2 for 8 hours unless otherwise specified. Preliminary studies demonstrated that under 
these conditions, a constant flux of H2O2 (0.18 mM/min) is generated by the glucose 
oxidase system. Unless otherwise stated, oxidation reactions were terminated by addition 
of 40 mM butylated hydroxytoluene (from a 100 mM ethanolic stock) and 300 nM catalase 
to the reaction mixture[289]. FFA solutions were prepared as described previously [290]. 
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Briefly, 100mM palmitate (Sigma No. P-0500) stocks were prepared in 0.1M NaOH at 
70°C and filtered. Five percent (wt/vol) FFA-free BSA (Sigma No. A-6003) solution was 
prepared in double-distilled H2O and filtered. A 5mM FFA/5% BSA solution was prepared 
by complexing an appropriate amount of FFA to 5% BSA in a 60°C water bath. The above 
solution was then cooled to room temperature and diluted 1:5 in RPMI 1640 without FBS 
to a final concentration of 1 mM FFA/1% BSA. Antibodies against MyD88, β-actin and 
phosphotyrosine (PY20) were purchased from Santa Cruz Biotechnology. Antibodies 
against p85-PI3K, GM-CSF, M-CSF and AKT were purchase from Abcam. Anti-Insulin 
receptor substrate 1 (IRS1) antibody was purchased from Upstate Biotechnology. Anti- 
Phospho-Akt (Ser473) Antibody, anti-arginase1 and anti-iNOS was purchased from Cell 
Signaling. Anti-F4/80 was purchase from Ab serotec. 3T3 L1 pre-adipocytes were cultured 
in DMEM, 10% FBS and 1% penicillin/streptomycin, and differentiated using the 
Adipogenesis Kit at 37°C and 5% CO2 (Cayman Chemical). Differentiation was initiated 
1 day after 100% confluence was reached. Confluent 3T3-L1 cells preadipocytes were 
treated with 50ml initiation medium containing 500μM IBMX, 10μM Dexamethasone, 
10μg/ml insulin in DMEM/10% FBS for 2 days. Afterwards, medium was changed to 40ml 
progression medium consisting of DMEM/10% FBS supplemented with 10μg/ml insulin. 
The 3T3-L1 cells were incubated with progression medium for 2 days. Subsequently, 
medium was changed at day 6 into 50ml fresh DMEM/10% FBS followed by another 2 
day incubation at 37°C. Eight days after the initiation of differentiation, 3T3-L1 cells were 
ready for co-culture experiments.  Preadipocytes were only differentiated and used prior to 
passage 12 greater than 95% of cells displayed the fully differentiated phenotype. For the 
co-culture system, differentiated 3T3-L1 adipocytes were co-cultured with differentiated 
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BMDMs in DMEM/10% FBS for a maximum of 24 hours using 6-well plates containing 
transwell inserts with a 0.4m² porous membrane. 1*104 BMDMs were seeded on the 
bottom of the well, while 1*104 or 5*104 3T3-L1 adipocytes were seeded with into the 
insert. BMDMs cultured in the well without adipocytes seeded were set as control culture. 
After 24 hours of incubation, supernatants were collected, centrifuged for 10 minutes at 
10,000g and 4°C; samples were stored at −20°C for cytokines measurement. mRNA was 
collected from BMDMs for further gene expression analysis. 
Glucose tolerance test (GTT)/Insulin tolerance test (ITT). GTTs were 
performed by intraperitoneal injection (IP) of 2g/kg body weight of dextrose (Abbott 
Laboratories) after overnight fast. For ITTs, mice were injected with insulin (1mU/g BW, 
Sigma) IP after 3 hour fasting. Blood samples were obtained at 0, 15, 30, 60, 90, and 120 
minute time points and glucose levels were measured with an ultra-one glucometer.  
Insulin signaling analysis. Epididymal fat, liver and quadriceps muscle were 
collected from mice in the basal state or 5 minutes after an IP injection of insulin (25 
mU/kg), and quickly frozen in liquid nitrogen. Frozen tissues were homogenized on ice in 
a Triton-containing lysis buffer (0.5% Triton X-100, 20 mM HEPES (pH 7.4), 150 mM 
NaCl, 12.5 mM β-glycerophosphate, 1.5 mM MgCl2, 10 mM NaF, 2 mM dithiothreitol 
(DTT), 1 mM sodium orthovanadate, 2 mM EGTA, 1 mM phenylmethylsulfonyl fluoride 
and complete protease inhibitor cocktail from Roche), then ground and rocked for 1 hour 
in the cold room. Cellular debris was removed by centrifugation at 10,000 x g for 5 minutes. 
Immunoprecipitations were performed with the indicated amount of lysates. Supernatants 
were incubated with 5 μg of polyclonal antibody overnight and then incubated with protein 
A beads for another 1 hour at 4°C. Samples were washed extensively with lysis buffer 
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before solubilization in sodium dodecyl sulfate (SDS) sample buffer.Bound proteins and 
whole lysates (40 μg) were resolved by 4-12% or 4-20% SDS-polyacrylamide gel 
electrophoresis and transferred to nitrocellulose membranes (BioRad). Individual proteins 
were detected with the specific antibodies and visualized on film using horseradish 
peroxidase-conjugated secondary antibodies (BioRad) and Western Lightning Enhanced 
Chemiluminescence (Perkin Elmer Life Sciences). The levels of IRS1, p85-PI3K, activated 
AKT (pSer473, pAKT), and total AKT, were determined by immunoblotting of the whole 
lysates. Protein extracts were immunoprecipitated with anti-IRS-1, followed by western 
analyses with antibodies specific for phosphotyrosine (PY20, pY) or p85-PI3K. 
Atherosclerosis lesion measurements. Atherosclerotic lesions were quantified by 
2 independent and blinded assessments [291]. Mice were sacrificed by pentobarbital 
overdose, perfused with phosphate buffered saline (PBS) and 10% formalin 
(Formaldefresh, Fisher), and the entire aortic tree, including the heart, dissected free of fat 
and other tissue. Aortae were stained with oil red O, and digitally scanned. En face lesion 
area was assessed using Adobe Photoshop software, analyzed by Mann-Whitney U test. 
Data are expressed as percent of total aortic area ± S.E.M. 
Immunohistochemistry. Freshly isolated adipose tissues were fixed with 
phosphate-buffered formalin overnight, then paraffin wax embedded and subsequently 
deparaffinized. Sections of 5 μm were incubated overnight with monoclonal anti-F4/80 
antibody (AbD Serotec). After washing in PBS, slides were stained and developed using 
ABC staining system (Santa Cruz Biotechnology) and counterstained with hematoxylin 
(Sigma-Aldrich). The total number of cells and crown-like structure were counted in 10 
different high-power fields from each section. Frozen aortic root sections were blocked 
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with 2% bovine serum albumin (diluted in PBS) containing 0.1%  sodium azide for 1 hour 
followed by overnight incubation with the primary antibody (1:50 dilution for anti-GM-
CSF, and 1:100 for anti-CD31; or 1：50 for anti-F4/80, 1:100 for anti-Arginase1 and 1:100 
for anti-iNOS) at 4oC. After washing in PBS, slides were incubated with the fluorochrome-
conjugated secondary antibody (Alexa fluor-488 labeled donkey-anti-rat IgG and Alexa 
fluor-594 labeled mouse-anti-rabbit IgG, or Alexa fluor-488 labeled mouse-anti-rabbit IgG 
and Alexa fluor-594 labeled donkey-anti-rat IgG 1:200 diluted in blocking buffer ) for 2 hr 
in the dark at room temperature, washed again in PBS and mounted with VECTASHIELD 
containing anti-fade reagent (Vector Laboratories, Inc., Burlingame, CA). Fluorescent 
images were acquired using a LEICA confocal microscope. No specific immunostaining 
was seen in sections incubated with PBS rather than the primary antibody. 
Flow cytometry. The visceral adipose tissue (epididymal fat pad) and aorta were 
digested as described previously [229, 292]. SVF cells from adipose depots and aortic 
single cells were stained with anti-F4/80, CD11b, CD206, and CD11c (eBiosciences) to 
identify macrophage subsets. FACS analysis was conducted using FACS Calibur (BD 
Pharmingen) and the FACS data was analyzed by post collection compensation using 
FlowJo (Treestar Inc) software. 
Quantitative real-time PCR. Total RNA was prepared from endothelial cells or 
BMDMs of mice with TRIzol reagent (Invitrogen). Tissues were preserved in RNAlater 
solution (Ambion), and subsequently homogenized in TRIzol reagent. Three micrograms 
of total RNA were then used for the reverse transcription reaction using SuperScript reverse 
transcriptase (Invitrogen). Quantitative PCR was performed using an AB 7300 Real-Time 
PCR System, and gene expression was examined by SYBR GREEN PCR Master Mix 
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(Applied Biosystems). PCR amplification was performed in triplicate, and water was used 
to replace cDNA in each run as a negative control. The reaction protocol included 
preincubation at 95°C to activate FastStart DNA polymerase for 10 min, 40 cycles of 
amplification beginning with 15 seconds of denaturation at 95°C, followed by 
annealing/extension for 60 seconds at 60°C. The results were normalized to the 
housekeeping gene mouse β-actin. Primer sequences were designed using online tools from 
GeneScript. The primer sequences used will be distributed upon request. 
Statistical analysis. Data are expressed as mean ± S.E.M. Differences were 
analyzed by Student t-test and one-way ANOVA. P ≤ 0.05 was considered significant.   
 
 
 
 
 
 
 
 
 
 
 
 
